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ABSTRACT
BACKGROUND AND AIMS
Cerebral palsy (CP) is the most common physical disability of childhood
occurring in 1 in 500 live births in developed countries. Although CP starts in
infancy because of a lesion in the developing brain, it is usually not
diagnosed until about 19 months. The problem with late detection has meant
that early neurorehabilitation is not accessed until motor impairment is
evident. Consequently the dose of active intervention during the critical
period for brain plasticity is often inadequate. Little evidence exists for the
effectiveness of early intervention (EI) protocols for infants with CP. In
particular, interventions that take a motor learning approach and focus on
the task and environment as well as the child, are rarely used. The aim of this
research was to evaluate the effectiveness of a motor learning intervention on
infants at high risk of CP who were identified early in infancy.
METHODS
A literature review was conducted to explore current practice and evidence
regarding how and when CP is diagnosed. Then a systematic review and
meta-analysis was carried out to evaluate the effectiveness of environmental
enrichment interventions on the motor outcomes of infants with CP. A
prospective study assessed the feasibility of detecting CP in an Australian
context using the General Movements Assessment (GMA).
An EI enrichment programme “GAME” (Goals, Activity and Motor
Enrichment) was then developed based on contemporary motor learning
theory and within the framework of family centred practice. GAME was
tested in a feasibility 12-week pilot (n=13) and then in a larger (n=30)
randomised controlled trial (RCT).
RESULTS
Meta-analysis of five studies demonstrated a small positive effect
(SMD=0.39) for environmental enrichment interventions compared to
standard care. Accuracy for detecting CP using the GMA was 98%
(sensitivity) and 94% (specificity). Results of both RCTs demonstrated an
advantage in motor outcomes for infants in GAME at all time points on both
norm referenced and criterion referenced outcome measures.
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CONCLUSION
Early identification of infants with CP is possible using evidence based tools.
Motor outcomes for infants with CP can be advanced by early and specific
motor learning interventions offered in an enriched home environment.
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Chapter 1: INTRODUCTION
1.1. The problem: How to optimise the motor development of very young
infants with or at the highest risk of cerebral palsy
1.1.1 Cerebral Palsy
Cerebral palsy (CP) is the most common physical disability of childhood
affecting 34,000 Australians with approximately 700 new cases diagnosed each
year. The current definition of CP is “a group of disorders of the development of
movement and posture, which are attributed to non-progressive lesions of the
developing fetal or infant brain” (1). The motor impairments of CP are variable
and range from a mild to severe and may be unilateral or bilateral, affecting all
limbs, the trunk and neck. Consequently the activity limitations of CP are also
variable and the condition is considered highly heterogeneous. The
heterogeneity of CP is suggested in the definition (“group of disorders”) and is
evident in the variation in antecedents, motor ability, the predominant motor
patterns of CP, and the presence of secondary impairments that are frequently
co-occurring in CP.
The Gross Motor Function Classification System (GMFCS) is a universally used
system that classifies CP according to level of motor function (2). Children in
levels I and II walk independently and according to CP Register data account
for 60% of all CP (3). Children at level III ambulate with assistive devices and
often become non- ambulators in adolescence (4). Those classified as levels IV
and V are wheelchair dependent where independence in operating a wheelchair
and the ability to weight-bear for transferring are often the separating factors
between levels. Children in levels GMFCS IV and V account for 30 % of all CP
(3). Manual ability has also been classified for children over four years of age
with the Manual Ability Classification Scale (5)
CP can also be described by the predominant type of movement disorder, with
spasticity the most common form (85-90%) followed by dyskinetic CP (4-7%) (6).
Many people have a mixed presentation with either spasticity or dyskinesia as
the predominant disorder.
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In addition to motor difficulties, a diverse range of secondary impairments often
accompanies CP. A recent systematic review found that 3 in 4 people with CP
experience pain, 1 in 4 are non-verbal, over 40% have a cognitive impairment
and 1 in 4 have a vision impairment (7). In addition secondary impairments may
arise as a result of the “natural history” of CP leading to debilitating
contractures and joint deformity and a functional decline in motor ability (4).

1.1.2 Therapeutic Interventions for CP
Rehabilitation interventions are the standard of care for children with CP, and
available interventions broadly fall into 3 categories; (i) those that aim to
improve function; (ii) those that aim to prevent secondary impairments from
occurring; and (iii) those that provide compensation by adapting the
environment around the child (6). A number of systematic reviews demonstrate
that high quality evidence exists for some interventions that aim to improve
motor function in children with CP including constraint induced movement
therapy (CIMT), bimanual training, goal directed training and goal oriented
home programmes (8). However there are still many interventions with poor
supporting evidence that are part of the standard care of children with CP. The
lack of evidence is in part due to difficulties in conducting studies of high
methodological quality with children of heterogeneous conditions. Indeed many
of the intervention studies that have been show to be effective are of more
homogenous samples, for example hemiplegia (9). The heterogeneity of CP is
increasingly thought to be a significant contributor to the difficulties
encountered when studying interventions for this diverse group of people (10).
1.1.3 Motor Trajectories in CP
Typically developing children display a relatively predictable sequence of motor
milestone acquisition although there is some variation in age of attainment (11).
During the first year of life infants learn to sit, crawl on hands and knees, stand
with assistance and about 50% walk unassisted by their first birthday.
Concurrently, infants are developing increasingly complex reach and grasp
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behaviours and by 12 months are able to use both hands to reach for, transfer
and grasp and release objects
The heterogeneity of CP in terms of motor function has been well described in a
landmark study in 2002, the Ontario Motor Growth Study. Individual scores on
the Gross Motor Function Measure were mapped against age and stratified by
GMFCS levels to create motor development curves for CP (12). These curves are
useful for predicting likely mobility outcome and are widely used as a tool to
discuss prognosis with families as well as plan realistic rehabilitation goals. The
study and resulting gross motor curves demonstrated that children with CP
achieve 90% of their gross motor development potential by age 5 across all
GMFCS levels, after which a plateauing effect occurs. Children at GMFCS level
V reach this point before 3 years of age (Figure 1).
Figure 1: Steepest portion of CP Motor Curves (Figure used by permission
from JAMA
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As would be expected, the steepest portion of the curves occur between 0 - 2
years although in this large cohort study only 68 of the 657 children (10%) were
between one and two years of age. Infants under one are not reported in this
study. In other words, very little is known about the motor trajectory of infants
with CP before the age of two. Tabulated reference percentiles are available for
children from two years demonstrating the great variance even within GMFCS
levels (13). There are no equivalent curves for infants and toddlers.
Infants with brain lesions usually have slower motor development than their
age matched peers due to the impaired development of sensorimotor pathways
and their target structures (motoneurons and muscle) (14). The location and
extent of the brain lesion is one of several factors that predict outcome severity
in children with CP. White matter injuries (WMI) are the most common type of
injury accounting for up to 46% of all CP (15). About two thirds of infants with
WMI will have milder motor impairments (GMFCS I-II) with hemiplegia and
diplegia the more common motor distribution types. Cystic periventricular
leukomalacia (cPVL) is often associated with non-ambulant CP especially when
it is bilaterally distributed and occupies more than 5% of the hemispheres (16).
Grey matter lesions occur in about 25% with hemiplegia the most common
outcome (17). Hypoxic Ischaemic Encephalopathy (HIE) can lead to mild or
severe outcomes with injuries to the basal ganglia and thalamus often leading to
dyskinetic CP affecting all limbs. Where injury only involves the white matter
motor disability may be milder (18). Similarly maldevelopment of the brain can
result in severe motor and cognitive disability or mild motor dysfunction (19).
Although the degree and location of damage to the motor areas of the brain is
predictive of outcome, associated impairments such as cortical vision
impairment, cognitive delay and uncontrolled epilepsy also impact on motor
development and function.
1.1.4 Early Intervention evidence in CP
Not only is little known about the motor trajectories of infants with CP, the early
intervention literature for CP is also problematic. Good evidence exists for the
effectiveness of interventions for older children with CP that take a goal-
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oriented and motor learning approach to therapy (8). Studies in both children
with CP and adults with acquired brain injury have demonstrated that the
repeated practice of task – specific activities leads to improvements in gross
motor function and performance of daily activities (20-22). Evidence in the field
of early intervention in CP is far less convincing. A recent search of the
Cochrane Database of Systematic Reviews and Physiotherapy Evidence
Database (PEDro) over the last 10 years identified 6 systematic reviews (23-28)
evaluating child-focused early intervention programmes for infants 0 - 2 at high
risk of CP (Table 1). Of these systematic reviews four focus only on preterm
infants, and only two specifically evaluate the impact of early intervention on
infants with CP. One of these is paper 2 of this thesis (28). A great deal of
variability exists in programmes typically offered to high risk infants and
although cognitive and social gains have been shown in studies of preterm
infants, motor gains are generally not found. Even cognitive gains are generally
not maintained after intervention ceases (27).
The main types of interventions that have been studied in infants for the
purpose of advancing motor development vary and include
Neurodevelopmental Therapy (NDT) (29), general developmental stimulation,
developmental skills approach (30) and conductive education (31). To date there
is little evidence to show that motor outcomes can be influenced significantly by
any of these approaches over and above what is expected from natural
development (32).
TABLE 1: Systematic reviews evaluating child focused interventions in children
0-2 years (2005-2015)

CITATION

Benzies et al;
2013

(23)

POPULATION

Preterm

INCLUDED

MOTOR

NON-MOTOR

INTERVENTIONS

OUTCOMES

OUTCOMES

Various

Not reported

Significant

programmes that

positive

included parents

maternal
depression,

SR and MA
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anxiety and
self efficacy
Blauw-

Preterm

Various

Mixed results

Hospers et al;

At risk of

programmes

NDT

2005

disability

aiming to

ineffective

CP

improve motor

Specific and

development

general

24

Mixed results

programmes
might have
beneficial
effects
depending on
age of infant
Fernandez et

Preterm

Physiotherapy

Mixed results;

al; 2012

infants

intervention

studies

programmes

heterogeneous
Not reported

25

Schulzke et

Preterm

Physical activity

al; 2014

infants

programmes

26

Not reported

Positive effect
on weight gain

SR and MA

and linear
growth

Spittle et al;
2012

Preterm

27

SR and MA

Various child

Small effect in

Significant

oriented

short term

positive

programmes

cognitive

Morgan et al;

CP/high risk

Programmes

Small positive

2013

of CP

including an

effect at end

environmental

of treatment

SR and MA

enrichment

period

(Paper 2 of this

component

28

Not reported

thesis)

SR= systematic review; MA=meta-analysis
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1.1.5. Diagnosing CP
One of the key reasons for the paucity of EI trials for infants with CP relates to
age of detection of CP. A problem with many EI trials aiming to recruit infants
with CP is that they unintentionally end up with a mixed group including some
participants with mild motor dysfunction, some with normal outcomes and only
a few with CP. For example, although premature infants are regarded as “highrisk” only 10% or less will go on to have CP making it difficult to generalise
findings from the high number of studies of this population (3). Underpowered
trials for CP are the consequence of late detection.
Although CP results from an injury to the developing brain (i.e. occurs in
infancy) a formal diagnosis is often not made until the second year of life. In
Australia the average of diagnosis is 17 months for children who were
monitored closely after birth as well as for those who present with motor delay
during late infancy (unpublished data from Australian Cerebral Palsy Register).
Only infants with a history of neonatal encephalopathy are diagnosed earlier, at
an average of 13 months. Confirming a diagnosis of CP is typically a complex
process. When infants are closely monitored because of neonatal risk factors
such as prematurity or encephalopathy, motor delays might be noted earlier
although a “wait and see” approach is often preferred (6). The chance that an
identified brain injury might not lead to the activity limitations necessary for a
CP diagnosis leads practitioners to be cautious. For children with no apparent
risk factors, investigations typically begin when it becomes apparent that motor
milestones are not being reached, in particular sitting or standing. However as
many standardised motor tests are not specifically predictive of CP (33) and
some “tell-tale” motor signs such as spasticity do not appear until the second
year, it can still be some time before an official diagnosis is given. Before making
a diagnosis, medical professionals wish to rule out other potential conditions
(34) and ensure the condition is not progressive. Brain imaging is widely used to
document the presence and extent of injury and increasingly sophisticated tools
are under development (35). However, clinical research also documents
outcomes that do not seem to “match” imaging findings (36) and up to 15% of
children with CP have normal neuroimaging. Nevertheless, a number of
!
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systematic reviews have demonstrated that certain defined patterns of injury in
the grey and or white matter nearly always lead to CP indicating the importance
of appropriately timed neuroimaging in the diagnostic process (15,16,18,37).
Prechtl’s Qualitative Assessment of General Movements (GMA) (38) a
diagnostic observational tool, has been shown to be predictive of neurological
outcome, particularly CP, in high- risk preterm and term-born infants. Spittle
and colleagues demonstrated a correlation between abnormal GMs and
abnormal white matter and suggest that a combination of GMs assessment and
structural MRI in high-risk infants is a logical approach to early detection of CP
(39). Despite numerous publications and high quality systematic reviews this
approach to early detection is still not commonly used (38). Published
algorithms for diagnosing CP do not include GMA and recommend
neuroimaging when tone is assessed as high (34). The combined use of GMA
and appropriately timed neuroimaging is a potential solution to the problem of
late detection.
Standard of care for infants at high risk of CP includes in the first instance,
frequent monitoring, and early intervention (EI) if motor delay appears to be
worsening. Accessing EI however, can be dependent on a confirmed diagnosis
or a sufficient description of “at risk “ status. There is a growing body of
research indicating that this period of time is the critical window of infant brain
development. An increasing amount of neuroscience literature demonstrates
that perinatal damage to the developing corticospinal tract is worsened by
inactivity (41). Martin and colleagues found in a cat model of CP, that activity
based therapies delivered early, re-established corticospinal connections and led
to improved control of the affected limbs (42). In humans the first 18 months of
life are considered critical for development of the corticospinal tracts (42, 43).
Theoretically, infants with brain injuries affecting the motor regions of the brain
ought to respond best to active interventions applied as early within this critical
window as is possible.
The tendency for late diagnosis, coupled with service dependent diagnostic
criteria, creates a problem for timely access to interventions that aim to optimise
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the neural organisation occurring during this time period. Additionally once
infants are referred, the model and type of service provision to these children is
variable. A recent intervention study in the US found that the variation in
standard care for high risk infants varied enormously with more than 50% of
participants in the study unable to access physical therapy intervention before
12 months of age (44).
We hypothesised late detection and thus low dose early intervention was
standard of care (described in chapter 7) in our region. In a survey of NICUs in
Sydney in 2011, prior to the implementation of GMA in most NICUs, we found
that the average amount of EI received by an infant at high risk of CP in the first
year of life was only 14.2 hours (survey questions and table of outcomes listed in
appendix 1). Moreover, the inclusion criteria for follow up post discharge varied
from site to site. Some had no standard follow up for infants with HIE for
example, whereas others followed all infants with HIE until early childhood. It
seems likely that a proportion of infants at high risk of CP might be “slipping
through the cracks” despite the existence of follow up services.
1.1.6 Neuroplasticity and motor function
It is the intrinsic ability of the brain to change and organise itself that provides
the scientific background to the purported benefits of rehabilitation.
Neuroplasticity has been the subject of both basic science and clinical research
for several decades. Demonstrable changes in structure, function and
connections at the molecular and cellular level provide scientists and clinicians
with confirmation that injuries to the brain are not static and that exploiting
these mechanisms might be the solution to recovery. The search for
interventions to harness neuroplasticity mechanisms is ongoing in many fields
(45). A number of studies have investigated the place of pharmacological
interventions in animal models (46) or repetitive Transcranial Magnetic
Stimulation in changing the levels of excitability in the corticospinal tract (47).
Clinically feasible rehabilitation protocols aim to harness activity - dependent
plasticity mechanisms by providing repetitive experience to retrain functional
skills lost as a result of injury. Adult stroke studies have demonstrated changes
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in neural organisation as a result of motor training, for example studies of CIMT
have demonstrated structural neuroplastic change (48). Researchers and
clinicians in the rehabilitation field want to know the type and intensity of
clinically feasible strategies that can be used to promote optimal neural
organisation. Allied health professionals providing interventions to infants with
CP urgently need evidence based protocols that are grounded in neuroscience.
At the same time as advances in neuroscience have been progressing, the focus
of developmental research has shifted from a neuro-maturational framework,
sometimes referred to as “disembodied development”, to one of an interaction
of multiple dynamic systems or “embodied development” (49, 50). In these
contemporary frameworks purposeful motor behaviours are understood to
emerge from a convergence of child-specific (biomechanical and physiological),
task-specific and environmental constraints and processes. A variety of novel
and ground-breaking experiments have shaped our understanding of how
normal motor development progresses and ought to form the basis of motor
intervention programmes. Some of these findings are listed below:
1. Biomechanical factors influence motor development at a very young
age. Thelen demonstrated over 30 years ago that the loss of the stepping
reflex was attributed not to increasing supraspinal inhibition, the
prevailing assumption of the day, but increasing body mass rendering
the infant’s leg muscles too “weak” to lift the legs against gravity (51).
Thus “practice” of stepping maintained muscle strength and led to earlier
walking and retention of the stepping reflex, an observation that had
previously been attributed solely to the effects of neuromaturation (52).
2. Infants who are developing typically learn by trial and error and
display high levels of variability in movement solutions for achieving a
motor goal (53).
3. Task constraints influence the emergence of motor skills. Studies by
Fetters and colleagues showed that by simply changing the weight of a
mobile positioned for kicking, both the frequency and pattern of kicking
behaviours could be altered in infants as young as 4 months of age (54).
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4. Environmental factors influence the rate and trajectory of motor
development. Child rearing practices across different cultures (55) and
parent training of specific motor activities have been shown to advance
the emergence of motor skills (56-57).
5. Intensity of practice is a determining factor in the rate of motor
development. A study examining the characteristics of the emergence of
walking postulated that the amount, variability of and distribution of
practice were crucial factors in the successful development of walking
(56). Repetition is a key principle of motor learning.
“Dynamic systems” provide the theoretical background to evidence based
motor learning interventions for children with CP including goal - directed
training (GDT) or functional training (59). This approach uses mutually agreed
upon, meaningful goals to shape the intervention plan. Then aspects of the
desired goal are considered in relation to child-specific (for example muscle
strength), task specific (task analysis is used to “break down” the task into
components), and environment specific characteristics. Frequent repetitive task
practice is a key component of this intervention and a coaching framework may
be used with children of suitable age and cognition (60). To date, the application
of GDT has demonstrated positive results in older children with cerebral palsy
and adults with acquired brain injury however there have been no published
studies using this approach in young infants with CP. Goal oriented
interventions for infants at high risk of CP that utilise principles of motor
learning could be a potential solution for advancing the motor trajectories of
these children during the critical neuroplastic window.
1.1.7 Enriched environments
The study of Enriched Environments (EE) has been proven to enhance
neuroplasticity in animal studies and in adults with neurological disorders.
Gains documented include improved memory and motor recovery (61).
Environmental enrichment is arguably a potential rehabilitation “solution” for
those with brain injuries and studies of the contribution of EEs to recovery after
adult stroke are underway (62). While animal studies use consistent animal
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housing set-ups, it is more difficult to describe the “essential ingredients” of an
enriched environment in human rehabilitation settings. It seems in the human
context more is known about deprivation and its negative consequences than is
known about enrichment (63). Multiple studies of “at risk” children, most
notably premature infants and those from low socioeconomic groups, have
examined the value of enrichment in enhancing outcomes. These studies
demonstrate significant benefits in cognitive and behavioural development via
the enrichment of either home or day care environments, or from a variety of
early intervention programmes that aim to enhance the child’s learning
environment (64, 27).
The home environment has for many years been recognised as a keycontributing factor to favourable outcomes for children at risk. The International
Classification of Function and Disability (ICF) also highlights the importance of
environmental factors in influencing activity and participation of children with
disabilities (65). Maternal mental and physical health and confidence, sleep,
child rearing practices, socioeconomic factors (66) and support networks are all
regarded as important contributors to child health and development (67). In
fact, the home environment is considered so crucial that service delivery
frameworks that are family centred are now considered standard of care in early
intervention and child rehabilitation programmes (68). Family Centred Practice
recognises the family as the constant in the child’s life and that families are
invaluable partners to health professionals. Family centred care aims to enhance
the competencies of the family in their care giving role.
Early Intervention programs for infants who are at risk of poor developmental
outcomes aim to enrich the child’s environment. These programmes tend to be
home based, educational in nature and rely on the parents/carers to provide the
interventions with the support of various professionals (69,70). Recent
systematic reviews have demonstrated that although home -based early
intervention programs for infants regarded as “at risk” are the norm, a positive
impact on motor development is yet to be clearly demonstrated (24,27).
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1.2 Research Questions
The thesis brings together a series of papers investigating the feasibility of
detection of CP early in infancy and the effectiveness of environmental
enrichment and early motor learning interventions on the motor outcomes of
young infants at high risk of CP. This research addresses the following
questions:
•

Is it possible to detect CP early in an Australian context?

•

If it is possible to detect CP early, then at what age can it be detected and
what are the best tools to accurately identify CP in infancy?

•

How effective is early intervention for improving motor outcomes of
infants with CP?

•

Does environmental enrichment influence the motor outcomes in infants
with CP?

•

Can motor learning interventions effective in older children with CP be
implemented for infants with CP or who are at very high risk of CP?

•

Does a home-based, goal oriented rehabilitation approach that educates
and supports parents to practice motor tasks with their baby lead to
improved outcomes for infants with CP?

1.3 Aims of research
In response to the research questions, the aims of this thesis are:
1. To review the literature regarding the early detection of CP
2. To review the evidence for the effectiveness of interventions aimed at
enriching the environment of infants with CP or at high risk of CP
3. To assess the sensitivity and specificity of the General Movements
Assessment for detecting CP in infants 3-4 months of age in an Australian
context
4. To develop and describe the content of a goal oriented motor learning
intervention that combines environmental enrichment, intensive motor
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training and parent education called GAME (Goals Activity and Motor
Enrichment)
5. To test the feasibility of early detection of CP using the GMA to recruit
infants to a pilot RCT of GAME intervention and to test the outcomes of
GAME after 12 weeks of intervention compared to usual care
6. To test the efficacy of GAME in a larger RCT on motor outcomes in the
short and longer term

1.4 Outline of studies
An outline of the studies and how they fit together in this thesis is portrayed in
Figure 2. In the first 2 studies the problem and consequences of late diagnosis of
CP is discussed. The paucity of evidence for the effects of EI for infants with CP
is a product of a lack of a systematic approach to early detection and the dearth
of intervention protocols based on basic science and of effective rehabilitation
strategies that work in older children with CP.
Figure 2: Diagrammatic representation of the studies
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The solution to this problem is the subject of the remaining studies. Study 3
represents the result of a knowledge translation project that was coordinated to
embed the use of the GMA into clinical practice. A rater network was
established and infant assessment and outcome data collected across 5
recruitment sites. The sensitivity and specificity of the GMA for detecting CP in
this Australian rater network is detailed.
Studies 4-6 describe the aims, methods and results of a novel EI approach for
infants at high risk of CP. The intervention, GAME (Goals – Activity – MotorEnrichment), is described and tested in both a small (phase 1) pilot study and
then in a larger (phase 2) RCT.
The final chapter draws together the findings and limitations of the study and
discusses future directions for research in the field.
Study 1: (Chapter 2)
Aim 1: To review the literature regarding the early detection of CP
A literature review was conducted to describe the risk profile of CP in
neonates and to identify the assessment tools with the highest predictive
capacity to detect CP in infancy.
Results 1: High level evidence exists that CP can be detected early
Study 2: (Chapter 3)
Aim 2: To review the evidence for the effectiveness of interventions aimed at
enriching the environment of infants with CP or at high risk of CP
A systematic review was undertaken to summarise the evidence of the
effectiveness of environmental enrichment interventions in infants with
CP. In the absence of a formal definition of environmental enrichment for
humans, a working definition based on animal literature is proposed. A
meta-analysis combines data from five studies that compared
environmental enrichment interventions with standard care.
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Results 2: A small positive effect on motor outcomes exists for the benefits of
interventions including environmental enrichment compared to standard care.
Study 3. (Chapter 4)
Aim 3: To assess the sensitivity and specificity of the General Movements
Assessment for detecting CP in infants 3-4 months of age in an Australian
context.
A knowledge translation project was conducted to enable early detection
of CP. A targeted training programme in Prechtl’s Qualitative
Assessment of General Movements in Sydney’s Neonatal Intensive Care
Units was undertaken. Data collected from five sites over a 30-month
period was analysed to determine if sensitivity and specificity of
detecting CP in 3-4 month old infants was comparable to internationally
published rates.
Results 3: Diagnostic accuracy for detecting CP using the GMA was comparable
to international rated with a sensitivity of 98% and specificity of 94%.
Study 4. (Chapter 5)
Aim 4: To develop and describe the content of a goal oriented motor learning
intervention that combines environmental enrichment, intensive motor training
and parent education called GAME (Goals Activity and Motor Enrichment)
A clinical protocol for a goal-directed, intensive motor training
intervention (labelled GAME) in infants was devised, based on published
literature.
Results 4: After it was tested in a small pilot (study 5) the protocol for a larger
RCT (study 6) was developed and published.
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Study Five: (Chapter 6)
Aim 5: To test the feasibility of early detection of CP using the GMA to recruit
infants to a pilot RCT of GAME intervention and to test the outcomes of GAME
after 12 weeks of intervention compared to usual care.
The GAME protocol was tested in a small pilot study. This pilot aimed to
test both the feasibility of the recruitment and randomisation strategies as
well as the acceptability of the intervention to parents. Outcome data
from the pilot study were used to conduct a power analysis for the
randomised controlled trial, to ensure the study had adequate sample
size to detect change if present.
Results 5: Twelve weeks of GAME intervention resulted in favourable motor
outcomes compared to standard care. The intervention was clinically feasible to
do and recruitment and randomisation procedures were acceptable to all
stakeholders.
Study Six (Chapter 7)
Aim 6: To test the efficacy of GAME in a larger RCT on motor outcomes in the
short and longer term
A single blind randomised controlled trial (RCT) with 2 groups was used
to evaluate whether improved motor outcomes in infants with (CP) result
from GAME OR standard care. Results are reported after 16 weeks of
intervention and at one year.
Results 6: Between-group differences favouring GAME intervention were found
in motor skills after 16 weeks of intervention. Furthermore, at 12 months
corrected age, GAME participants had significantly higher motor function and
cognition scores compared to standard care.
1.5 Significance of the research
In Australia, 700 new cases of CP are diagnosed each year. By 2050 there are
expected to be over 47, 000 people living with CP in Australia. CP is more
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common in any year than the most common types of cancer, stroke and road
traffic accidents and is in the top five most costly conditions on a per capita
basis of 15 conditions studied by Access Economics in recent years (68). The cost
of CP was estimated at 1.47 billion in 2007, and 43% of this cost is borne by
individuals with CP and their friends and families, and is almost certainly an
underestimate. The recent introduction of the National Disability Insurance
Scheme in Australia will see costs for services for people with CP continue to
rise with more of the financial burden falling to government. Evidence based
interventions are important not only to minimise the impact of CP on the quality
of life for children and their families but also to assist government and policy
makers to allocate resources and efforts to programmes shown to be effective.
The findings of this research have the potential to improve the outcomes of
these children by reducing the age of detection of CP thus allowing early access
to intervention. This study is unique because previous interventions with this
population either (a) started late i.e. outside the optimal neuroplastic window,
because of a “wait and see” method of diagnosis; or (b) utilised a normalisation
of movement approach for example, Neurodevelopmental therapy (NDT),
which have been shown to be ineffective. This research makes a unique
contribution to advancing knowledge about early intervention for infants at
high risk of CP because it instead tests the effectiveness of proven effective
interventions in older children in this younger population. Since motor learning
interventions have not been tested in very young infants it is still unknown if
severity of impairment can be minimised by taking advantage of neuroplastic
mechanisms very early in life using activity based protocols such as those
contained in this research programme.
1.6 Ethics
Ethical approval was obtained from the Human Research Ethics Committees of
the Children’s Hospital at Westmead, the University of Notre Dame Australia,
Cerebral Palsy Alliance and Royal Prince Alfred Hospital (appendix a). The
larger RCT was registered on the Australian and New Zealand Clinical Trials
Registry (ACTRN12611000572965) in 2012.
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APPENDIX 1:
Survey questions:
1. When an infant is discharged from the NICU is high risk of CP discussed?
2. What is the routine follow up plan? Is it related to birthweight, medical
conditions or gestational age?
3. At what ages are they followed up and by whom?
4. What assessments do they have and at what ages?
5.Are they referred to allied health? Who/where/why? What is frequency of
intervetnion?
7. What is the usual age for a definitive diagnosis of CP to be given
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McIntyre S, Morgan C, Walker K, Novak I. Cerebral palsy - don't delay.
Dev Disabil Res Rev. 2011; 17:114-29
This first paper provides a narrative review of the difficulties of
diagnosing CP and gives a rationale regarding the importance of the
early detection of CP. The paper outlines the difficulties of applying
diagnostic labelling to a condition known as an “umbrella term” in the
absence of readily available biomarkers.
The concept of “high risk of CP” is discussed with reference to premature
infants, term infants with neonatal encephalopathy and term infants with
no apparent risk factors who later go on to be diagnosed with CP. Data
indicated that it is possible to find and therefore study these infants early
to advance the early intervention evidence base.
The assessment tools with the highest predictive power for CP are
summarised, enabling recommendations to be made that aim to:
1. Enable earlier and accurate diagnosis of CP for high-risk infants
2. Provide an evidence based care pathway for children born
preterm or term and at high risk of CP
3. Facilitate earlier referral to early intervention during critical
periods of child development
Author Contributions:
All authors have participated in the concept and design of the
paper and in drafting and revising the manuscript.
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KW wrote the developmental section
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IN drafted clinical practice algorithms
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Cerebral palsy (CP) is the most severe physical disability within the
spectrum of developmental delay. CP is an umbrella term describing a
group of motor disorders, accompanied by many associated impairments.
The disability is a result of injuries to the developing brain occurring any
time from the first trimester of pregnancy through to early childhood.
However, for the great majority, their full etiological causal pathway
remains unclear. It is important to discriminate as early as possible
between: (a) mild or nonspecific motor delay, (b) developmental coordination disorder, (c) syndromes, (d) metabolic and progressive conditions,
and (e) CP with its various motor types and distributions. The most promising predictive tool for CP is the general movements assessment, which
assesses the quality of spontaneous movements of infants in the first 4
months of life. We propose a change in diagnostic practice. We recommend a shift away from referral for intervention following a formal (most
often late) description of CP, to one of referral for intervention
which occurs immediately once an infant is considered “at risk” of CP.
C 2013 Wiley Periodicals, Inc.
V

Dev Disabil Res Rev 2011;17:114–129.

Key words: cerebral palsy; early diagnosis; general movements;
perinatal risk factors; neonatal risk factors; brain injury

INTRODUCTION
lobal developmental delay is an umbrella term that
describes two or more delays in the area of speech
and language, social and emotional, cognitive and
motor development. Children with cerebral palsy (CP) often
fall under the umbrella of global developmental delay, but CP
cannot be considered “delay,” as children do not “grow out
of it.” Health professionals need to understand what clinical
features distinguish CP from other motor disorders, so the
most effective interventions can be commenced earlier. The
American Academy of Pediatrics have developed a policy for
the surveillance and screening of developmental disorders
(Council on Children with disabilities et al., 2006), however
this paper focusses specifically on CP. The objectives of this
review are fivefold:

G

1. Describe the nature of CP and what makes it different to
other motor or learning disorders.
2. Outline the prevalence of CP.
3. Determine who is at high risk of CP, what are the predictors
and early signs?
4. Identify tools that help clinicians to accurately predict CP.
' 2013 Wiley Periodicals, Inc.

5. Present an evidence based algorithmic approach to recognizing CP and developing intervention plans.

In the early months of life, global developmental delay
and CP present similarly, if delayed, acquisition of developmental milestones is the only comparator. It is the movement
disorders (e.g., spasticity and dystonia), the level of functional
impairment, and the associated impairments that set CP apart
from other milder motor disorders or learning disorders such
as developmental coordination disorder (DCD). DCD is less
severe and 25 times more common than CP affecting !5–6%
the population and current practice is not to diagnose before
the age of 5. As a result, the diagnosis of CP is often delayed
while the possibility of DCD is explored.
DCD is primarily a learning problem where children
can achieve normal movement patterns and skills but have
problems with learning and planning the movements. CP
conversely is a physical disorder, where children are not able
to achieve the normal movement patterns and the primary
problem is motoric not learning, although deficits in learning
may compound the motor problem.
DCD is used to refer to children who fulfill a certain
criteria; poor motor performance which significantly interferes
with activities of daily living which are not explained by any
medical, neurological, or psychosocial condition. Thus a child
with CP whose motor disability is neurological cannot have a
diagnosis of DCD [Blank et al., 2011]. The physical disability
of CP is life-long whilst DCD is more apparent in the window where the child is learning key motor skills for example,
catching a ball, dressing independently, and handwriting.
WHAT IS CEREBRAL PALSY?
CP is an umbrella term which “describes a group of disorders of the development of movement and posture, causing
activity limitations, which are attributed to nonprogressive disturbances that occurred in the developing fetal or infant brain.
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Table 1. Classification by Motor Type
ACPRa 1
Reid, 2011a
Spasticty:

Dyskinesia:

Ataxia:
Hypotonia:

a

Overactive muscles that display a velocity-dependent
85 – 91%
resistance to stretch. Spasticity can cause secondary
impairments such as loss of muscle length, joint
dislocation and pain.
Dyskinesia is either athetosis or dystonia. Athetoid CP is 4 – 7%
hypotonic with hyperkinesia characterized by involuntary writhing-stormy movement and can
co-occur with chorea. In contrast, dystonic CP is
hypokinetic, involving involuntary, abnormal twisting
postures or repetitive movements with hypertonia.
Tone is typically fluctuating.
Ataxia results in tremors with a shaky quality. Ataxic
4 – 6%
CP involves a loss of muscular coordination where
movements have abnormal force, rhythm, and accuracy.
Pure, generalized hypotonia (decreased muscle tone) is the 2%
least common CP motor-type. Some argue that pure
hypotonia should not even be considered a cerebral palsy
sub-type.

Australian Cerebral Palsy Register.

The motor disorders of CP are often
accompanied by disturbances of sensation,
cognition,
communication,
perception, and/or behavior, and/or by
a seizure disorder” [Bax et al., 2005].
This most recent definition acknowledges the complexity of the condition
and the impact of the associated
impairments.
What are the Fundamental Facts
We Know About Cerebral Palsy?
Classification of cerebral palsy guides intervention decision making
CP is a heterogeneous condition,
and to elucidate prognosis and guide
selection of the most appropriate interventions (e.g., constraint induced
movement therapy for hemiplegia and
selective dorsal rhizotomy for diplegia)
three major classifications are applied;
motor-type, topography, and function.
Clinicians often remark that a child may
have two or three different descriptions
of their CP within one medical file, evidencing the poor reliability of these
traditional classification systems. Tables
1 and 2 outline the traditional motor
types and topographies of CP and the
proportions of a CP population with
each type. In this paper, we refer to the
Australian Cerebral Palsy Register
(ACPR) when reporting rates and for
international comparisons the Swedish
Register and a study by Reid et al.
[2011a] where registers throughout the
world are compared.
To solve the problem of low interrater (and sometimes intra-rater) reliability

when identifying topographical subtype,
the Surveillance of Cerebral Palsy Europe
[SCPE, 2000] has recommended that traditional topographies be combined into
two easily definable topographies: Unilateral (one side of the body), Bilateral (both
sides of the body). The ACPR instead
applies a limb by limb coding using the
Australian Spasticity Assessment Scale
(ASAS) [Love, 2007]. The ASAS scores
the muscles’ response to rapid passive
movement without the subjectivity and
wording ambiguities of the modified Tardieu and Ashworth scales [Mutlu et al.,
2008]. Nonspastic motor types are also
coded, resulting in a “stick figure diagram” of motor impairment, which
provides an objective picture of the CP.
Figure 1 presents the CP description
form. The descriptive form is also clinically useful for treatment decisionmaking, such as pharmacological options

and contracture management. The ASAS
is currently undergoing further reliability
studies, but it is freely available for
use along with the description of CP
form: http://www.kemh.health.wa.gov.au/
services/register_developmental_anomalies/
documents/CP%20Description%20Form%
20-%20WARDA%20website.pdf.
The gold standard tool for reliably
describing motor function in CP is the
gross motor function classification system (GMFCS) [Palisano et al., 1997].
GMFCS provides a common language
that conjures up a “picture” of a child
with CP. GMFCS is a five level classification system of gross motor function
in people with CP. The classification is
based on the person’s ability to self initiate movement with a focus on sitting,
transferring, and mobilizing [Palisano
et al., 1997]. Different classification
descriptions exist at different age
groups. Table 3 summarizes the system
for 2–4-year olds, to coincide with the
most common time of recognition and
the proportion in a CP population with
each level of GMFCS.
It should be noted that whilst the
GMFCS classification can be applied to
infants, about 40% change classification
levels by age 2. After 2 years, the classification system is stable and thus GMFCS
reassessment is recommended after age 2
[Gorter et al., 2008]. This is clinically
and diagnostically very important,
because parents are anxious to learn early
about the severity of their child’s condition for future planning but in reality the
most accurate description of function and
severity can only be given at 2 years.
The presence of associated impairments and
functional limitations affects the child’s
outcome
For many children with CP, it is
not just a physical disability. When
seeking to prognosticate the severity of

Table 2. Classification by Topography
ACPRa
Hemiplegia:

Hemiplegia/monoplegia is the involvement of one side of the 38%
body. The upper limb is usually more affected than the
lower limb. Strong early hand preference or hand disregard
is sometimes the first sign of a problem.
Diplegia:
Diplegia is where both the legs are affected and are more
36%
affected than the upper limbs.
Quadriplegia
Quadriplegia refers to the presence of spasticity in all four
26%
(Tetraplegia)
limbs; where the affect on the arms is equal or more than
the legs. Trunk and oro-facial involvement is also to be
expected. In rare cases, one limb is spared and this is
referred to as triplegia.
a

Australian Cerebral Palsy Register.
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Table 3. Classification by Gross Motor Function at 2-4 Years
ACPRa
Level I:
Level II:
Level III:
Level IV:
Level V:

a

Floor sits independently, hands-free. Walks without
assistive devices.
Floor sits independently, hands-free with balance
affected. Walks using an assistive mobility device.
Floor sits using w-sitting. Walks short distances indoors
using a hand-held mobility device with assistance.
Floor sits when placed, uses hands for balance. Rolls,
creeps or crawls for short distances.
Unable to sit independently. No form of independent
mobility.

32%
27%
12%
14%
15%

Proportion in Australia with each level of GMFCS.

CP and determine intervention plans,
assessment of associated impairments
must also occur. The likelihood and severity of associated impairments increase
with the severity of motor impairment
[Himmelmann et al., 2006; Odding
et al., 2006]. Some have reported that
associated impairments impact more on
function and quality of life than the
motor impairment [Himmelmann and
Uvebrant, 2011]. A meta-analysis of CP
registers calculated the overall rates of
associated impairments and functional
limitations in the CP population to be:
three in four are in pain; one in two
have an intellectual disability; one in
three cannot walk; one in three have a
hip displacement; one in four cannot
talk; one in four have epilepsy; one in
four have a behavior disorder; one in
four have bladder control problems; one
in five have a sleep disorder; one in five
dribble; 1 in 10 are blind; 1 in 15 are
tube fed; and 1 in 25 are deaf [Novak
et al., in press]. Many will have a number of these impairments, and the
presence of these impairments complicates therapy, decreases health status and
quality of life for the individual and
their family, and increases costs for the
family and to society. The associated
impairments of CP will now be discussed briefly.
Epilepsy. Epilepsy
can
potentially
severely limit the quality of life for the
person with CP and their family, and
adults with CP and epilepsy are less likely
to find employment [Michelsen et al.,
2005]. Epilepsy occurs in 30% of individuals with CP [Arnaud et al., 2008;
ACPR Group, 2009]. In 2% of individuals with CP, their epilepsy will be
resolved by the time they turn 5 years of
age [ACPR Group, 2009]. For those
whose seizures are not resolved, epilepsy
is a lifelong condition. Rates of epilepsy
are higher in those with: spasticity born
116

at term (48%) compared with preterm
(28%); bilateral CP (34–87%) compared
with unilateral (23%); and those with
intellectual impairment (61%) compared
with no intellectual impairment (19%)
[Carlsson et al., 2003; Wichers et al.,
2005; Himmelmann et al., 2006].
Intellectual
impairment. Intellectual
impairment can be defined by low general intellectual functioning as measured
by IQ scores, in combination with difficulties with adaptive behavior, all
manifesting before the age of 18. Practically, this means that people with an
intellectual impairment have memory
deficits, difficulty reasoning, learning
new skills, attending and organizing information. 50% of individuals with CP
have an intellectual impairment and
between 20 and 30% [Jarvis et al., 2005;
McManus et al., 2006] have a severe intellectual impairment. Formal assessment
of intellect is essential (but at times difficult) for an individual with CP.
Communication. Communication disability can have a major impact on the
individual with CP and their family.
Impairment in this domain can impact
on both understanding of language and
expression. For individuals who have
severe communication impairment,
social isolation and poor self-esteem can
result. Between 20 and 30% of people
with CP are nonverbal which means
that systems to support other forms of
communication are required [Arnaud
et al., 2008; ACPR Group, 2009;
Andersen et al., 2010; Parkes et al.,
2010]. They are more likely to be nonverbal if they are non-ambulatory
(GMFCS IV-V, 57%) compared to
those who are able to walk (GMFCS IIII, 4%) [Shevell et al., 2009]. Augmentative and alternative communication
(AAC) systems, which can range from
low/light technology systems such as
signing or use of alphabet charts to high

technology systems such as speech
generating devices, may be used to
communicate. It is a fundamental
human right to have the opportunity to
communicate; however, high technology AAC systems are expensive,
requiring wait listing and for some individuals will mean that they are unable
to access systems that would support
them to communicate.
Vision. Vision impairments can range
from mild requiring glasses, to functionally blind. About 5–12% of
individuals with CP have a severe
impairment, or are functionally blind
[McManus et al., 2006; ACPR Group,
2009]. Another 30% will have a mild to
moderate vision impairment.
Hearing. Hearing impairments can also
range from a mild impairment to bilateral deafness. Bilateral deafness occurs
in 2% of people with CP while other
hearing impairments occur in a further
10% [Surman et al., 2006; ACPR
Group, 2009]. Assessment of vision and
hearing in children with CP should be
thorough and done early, as it can
impact greatly on their ability to learn
and achieve milestones.
Other. Other impairments strongly
associated with CP are hip dislocation
(8%), displacement (27–35%) [Hagglund
et al., 2005; Soo et al., 2006] and spine
deformities, sleep disorders (23%)
[Newman et al., 2006], pain (70%)
[Jahnsen et al., 2004; Arnaud et al.,
2008], eating (8% tube fed) [Shevell
et al., 2009; Sigurdardottir and Vik,
2011], excessive drooling (22%) [Parkes
et al., 2010], bladder and bowel control
complaints (24%) [Roijen et al., 2001],
and behavior difficulties (26%) [Parkes
et al., 2008]. These less well-understood
impairments are more likely to occur
with bilateral CP and intellectual
impairment.
CP is the most common physical disability
in childhood with prevalence unchanged for
60 years
The overall prevalence of CP is
!0.2% of the population (i.e., 1 in 500)
in developed countries. As can be seen
by a projected age distribution of one
state in Australia (Fig. 2), even though
the injury responsible for CP occurs in
the developing brain, it is a lifelong
condition, with most patients having a
normal life expectancy. In reality, CP is
not just a condition of childhood.
The true incidence of CP cannot
be estimated as there are a proportion of
infants who die in the intrapartum, neonatal and infant period, who had brain
lesions that may or may not have met
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Figure 1 Cerebral palsy description form. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.].

the criteria for CP. It has been suggested
therefore that the closest rate to incidence (for CP) is prevalence of neonatal
survivors (NNS). Western Australia
(WA) is one register that reports in this
manner, and is also one of the longest
running CP Registers in the world. CP
is mandatorily reported in WA, therefore it is assumed that this register has as
close to a total population cohort as is
possible. WA’s CP rates reported in
2006 are 2.78/1,000 NNS increasing to
3.9/1,000 when post-neonatal CP is
taken into account [Blair and Watson,
2006; Watson et al., 2006]. NNS are
important when rates are reported by
gestational age stratum. The lower the
gestational age stratum, the more rates
differ between NNS and live births. It is
particularly important for those at the
youngest gestational ages. When reporting rates in the birth years 2005 and
2006 for those born between 20 and 27
weeks in WA, the rate per 1,000 NNS
was 72 (95% CI 32–110) compared to

live births 51 (95% CI 24–79) [Watson,
2012, personal communication]. If neonatal deaths are not taken into account,
live births give a misleading lower rate.
In term births (371 weeks), where the
rate of intrapartum/neonatal death is
proportionally much less, the difference
between NNS 1.7 (95% CI 1.4–2.1)
and live births 1.7 (95% CI 1.4–2.0)
becomes inconsequential. Despite this
denominator being the most accurate,
for comparison live births are the most
widely used denominator.
Estimates of prevalence throughout the world vary depending on the
methodology of “count,” percentage
ascertained and variations in selection
criteria. CP Registers have identified
rates ranging between 1.4 and 2.77/
1,000 live births; surveillance programs
range between 2.1 and 3.6/1,000 live
births; and cross-sectional surveys range
between 1.05 and 4.1/1,000 live births.
The two largest data sets, the ACPR
and the SCPE both have an overall
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birth prevalence of 2/1,000 live births.
In developing countries, it is thought
that incidence is higher as the public
health measures that help prevent some
CP cases are not freely available in
developing countries [Blair and Watson,
2006]. All data sets across the world
agree there is a higher proportion of
boys diagnosed with CP. Although CP
is found across all socio-economic
classes, there is a clear association
between low birth weight and low
socio-economic status, and in normal
birth weight ranges, rates of CP are
2.42/1,000 live births for those in the
lowest socio-economic groups, compared to 1.29/1,000 for the most
affluent groups.
The overall rate of 2/1,000 has
been fairly stable over the last 60 years
in contrast to the dramatic falls in perinatal mortality rates. However, there
have been some trends in gestational
age stratum, shown in Figure 3. Rates
in the extremely and very low
117

Figure 2 Estimated number of people living with CP in New South Wales, Australia. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]

gestational groups rose during the
1980s, but are now trending down.
Moderately premature infants’ rates
have decreased slightly, while in term
infants the rates are unchanged [Blair
et al., 2001; Watson et al., 2006].
Because the majority (>73%) of infants
are born over 32 weeks gestational age,
the increases and decreases in the
extremely and very preterm groups
have made little difference to the overall rate.
Identification of infants “at-risk of cerebral
palsy” is possible; assessment and screening
should follow
Since there are no identifiable
biomarkers to accurately predict CP,
and clinical risk factors only identify
subpopulations of infants at risk [McAdams and Juul, 2011], understanding
the term “causal pathways” is important. CP atiologies are described in
terms of causal pathways, as there is
very rarely one specific cause of brain
damage severe enough to cause CP.
Much research has been published that
attempts to discern the risk factors that
lie on one or more causal pathways to
CP. What researchers are beginning to
realize is how little is known about
how these risk factors interact on causal
pathways. Risk factors can be described
according to when they occur or when
they are identified. The following
examples have been identified for CP:
! Prior to conception: Previous gynecological history of stillbirths/multiple miscarriages/neonatal death/premature birth,
family history of CP and other genetic
predispositions, maternal diagnoses, for
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example, intellectual impairment, epilepsy and low socioeconomic status.
Early pregnancy: Infection, birth defects,
multiple births, male gender, and other
genetic predispositions.
During pregnancy: Maternal disease, for
example, thyroid disorders, pregnancy
complications, for example, preeclampsia
and bleeds in the second and third trimester, infection and inflammation,
intrauterine growth restriction (IUGR),
placental abnormalities and other precursors to premature birth.
Around the time of birth and the neonatal
period: An acute intrapartum hypoxic
event, stroke, seizures, hypoglycemia, jaundice, and infection.
Postnatal period: Infections, accidental
and nonaccidental injuries, stroke both
spontaneous and following surgery.

The rate of CP in neonatal survivors varies significantly with level of
risk at birth. To describe the risk of
developing CP, infants have been separated into three distinct groups shown
in Figure 4: (1) premature infants (30–
40% of all CP); (2) term born infants
who shortly after birth have neonatal
encephalopathy (NE), a clinically
defined syndrome of disordered neonatal brain function (15–20% of all CP);
and (3) term born “healthy” infants,
who do not require special care in the
neonatal period (40–50% of all CP) and
do not appear to have identifiable risk
factors at birth [Badawi et al., 2005;
Wu et al., 2006; McIntyre et al., 2011].
Premature infants. When considering
which babies are at risk of CP, preterm
infants commonly come to mind. The
risk of CP increases as gestational age

Figure 3 Gestational age specific rates/1,000 live births in WA, 1980–2006. [Color figure can
be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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decreases, therefore babies born at 36
weeks’ gestation are at much lower risk
than those born at 24 weeks. As a
result, rates in premature infants range
between 3 and 80/1,000 neonatal survivors, reflecting the wide variation in
levels of risk across premature gestations. Premature infants constitute up to
40% of infants who develop CP [Kirby
et al., 2011]. So why are premature
infants at increased risk of CP, and
which ones are at the highest risk?
The group of preterm infants can
be separated according to gestational
age, with the first subgroup being
extreme prematurity, generally considered less than 28 weeks’ gestation.
There is much data in the literature
which depicts the outcomes of
extremely premature infants and much
research has been conducted in this age
group [Hoon and Faria, 2010; Reid
et al., 2011b]. In the 1970s and 1980s,
the frequency of CP in this gestational
age group increased. This was attributed
to the increasing survival of extremely
preterm infants and their predilection to
germinal matrix hemorrhage and periventricular leukomalacia (PVL) [Stanley
and Watson, 1992; Hagberg et al.,
1996]. Evidence from population-based
samples in Europe, Australia and the
United States, and analyses from CP
Registers in Australia and Europe
describing trends in prevalence, subtypes, and severity, suggest that this rise
in frequency of CP in extremely preterm infants has reached its peak and is
now decreasing [SCPE, 2000; Reid
et al., 2011b; Watson, 2012, personal
communication]. Up to 10% of
extremely preterm infants (variations in
reports exist from as low as 3–10%) and
up to 5% of infants between 28 and 31
weeks gestation will be described as
having CP [Himpens et al., 2008; Watson, 2012, personal communication].
Practice point. Mothers whose labor is
imminent (and prior to 30 weeks gestation) should now be offered magnesium
sulphate for neuroprotection of their
child. Meta analyses have shown that
CP can be reduced by 30% for infants
under 30 weeks gestation [Crowther
et al., 2002].
CP Registers in Europe report
that this trend for decreasing rates continues into the group of late preterm
infants (32–36 weeks’ gestation or
1,500–2,499 g) [Andersen et al., 2011].
The overall prevalence of CP in these
children had dropped from 12.2 per
1,000 live births in 1983 to 4.5 per
1,000 in 1997. There is conflicting evidence in Australia, with the rate being

maintained at between 5 and 7/1,000
live births since the early 1980s [Watson et al., 2006].
Cerebral lesions in particular
PVL,
intraventricular
hemorrhage
(IVH) and intracranial hemorrhage
(ICH) grade III and IV, are the most
important predictors of CP in very preterm infants [Tran et al., 2005; Beaino
et al., 2010; Himpens et al., 2010]. In
particular, PVL lesions in the corona
radiata above the posterior limb of the
internal capsule (PLIC) observed in coronal sections have been used to
accurately predict motor prognosis
[Nanba et al., 2007]. The presence of
lesions in this region was highly predictive of CP (GMFCS 1 or higher) with
sensitivity 100% and specificity 97%. A
study by Himpens et al. [2010] that
investigated the predictive value of
ultrasound in brain injury found that
deep grey matter lesions are a significant predictor for severe versus mild
and moderate CP (OR 5 6), and that
cerebral infarction and hemorrhage
grade IV are strong predictors of unilateral spastic CP versus bilateral spastic
CP (OR 5 49 and 24, respectively, P
< 0.001).
Recently, there has been increasing interest in and evidence regarding
the possible effects of intrauterine infection or inflammation early in the
postnatal course, leading to CP. Carlo
et al. [2011] recently argued that a late
prenatal and/or early neonatal exposure
to inflammation may predispose infants
to neurodevelopmental impairment.
Wu and Colford [2000] also found that
clinical chorioamnionitis was associated
with an increase in CP in preterm
infants (OR 5 1.9) and term infants
(OR 5 4.7).
Transient
hypothyroxinaemia,
bronchopulmonary dysplasia (BPD),
and necrotizing enterocolitis have also
been associated with premature birth
and a later description of CP. A recent
study of 1,047 preterm infants (<28
weeks) demonstrated that while all
infants with BPD had a higher risk of
CP those who were mechanically ventilated until 36 weeks PMA had at least
a fourfold increased risk of CP [Van
Marter et al., 2011]. In addition, preterm infants who have had surgery to
repair a patent ductus arteriosus, or
who required home oxygen have also
been identified as at increased risk of
CP [Tran et al., 2005].
Practice point. Infants born premature
are at high risk of CP if they have
abnormal cerebral imaging and a more
complex course. These infants should
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receive a general movements (GM)
assessment before term equivalent age,
and be referred to active surveillance
and early intervention when they leave
the hospital. (see Pathway A Figure 5,
to be discussed in the following
section).
Term infants with and without neonatal
encephalopathy
The overall rate of CP for term
infants has been consistently 1.4–1.7/
1,000 live births over the past 30 years
[Watson et al., 2006; Himmelmann
et al., 2010]. Multiple births born at
term are at four times the risk of CP
than singletons born at term. The risk
rises again for surviving twins after the
death of a cotwin [Pharoah, 2006].
Risk factors associated with the development of CP in the term population
also include congenital malformations,
maternal age over 35 years, chorioamnionitis,
preeclampsia,
placental
abnormalities, meconium aspiration
syndrome, IUGR, transient metabolic
abnormalities, respiratory distress syndrome, neonatal infections and seizures.
[Shankaran, 2008; McIntyre et al.,
2012]. One of the most well known
risk factors for term-born infants is NE.
The second piece of the pie (Fig.
4), with a well-recognized predilection
to develop CP are term or near term
infants with NE. For term born infants
with NE, the rate of CP is between
100 and 125/1,000 neonatal survivors,
and those born with severe NE are at
the highest risk of CP of all infants.
Infants with moderate to severe (Sarnat
Stage 2 or 3) NE account for one in
four cases of term CP [Badawi et al.,
2005]. Kurinczuk et al. [2010] report
an incidence of NE between 2.5 and
3.5 per 1,000 live births and that !30%
of cases in developed countries are associated with evidence of an acute
intrapartum hypoxic event. These
include sentinel birth events that are
also rare but important risk factors for
CP in term infants, such as placental
abruption, cord prolapse, severe intrapartum hemorrhage, severe shoulder
dystocia, and a tight nuchal cord. It is
estimated that up to 8% of CP is attributable to an acute intrapartum event
with moderate to severe NE [Blair and
Stanley, 1997].
Practice point. Infants with moderate to
severe NE following an acute intrapartum event benefit from hypothermia.
This intervention prevents CP in one
out of eight of those treated [Jacobs and
Tarnow-Mordi, 2010]. A number of
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Figure 4 Rate of CP in NeoNatal Survivors. [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]

adjuvant therapies to help those that do
not respond to cooling alone are currently in animal model and phase 1
neonatal studies, for example, erythropoietin,
melatonin,
xenon,
and
topiramate [Gonzalez and Ferriero,
2009].
In term infants with moderate to
severe NE, imaging showing basal ganglia/thalamus injury has a positive
predictive value for CP of 88% [de
Vries et al., 2011]. In a study of 173
term infants with NE, the basal ganglia/
thalamus pattern of injury was associated with the most severe motor and
cognitive outcomes at 30 months
[Miller et al., 2005].
Practice point. Term infants with moderate to severe NE and a basal ganglia/
thalamus injury should be automatically
described as “At high risk,” and go
straight to Pathway B (Figure 5). They
should receive a GMs Assessment, be
referred to active surveillance and early
intervention when they leave the
hospital.
The remaining infants with NE
that go on to be described as having
CP have antenatal risks such as IUGR,
intrauterine infection, metabolic abnormalities, syndromes, and birth defects
[Badawi et al., 1998; Kurinczuk et al.,
2010]. Perinatal arterial stroke occurs in
!1.7/100,000 live births. In the newborn period, it can also result in NE,
but the majority of these infants present
after the immediate neonatal period
with seizures or hemiparesis. Mothers
with preeclampsia and infants who have
IUGR are at risk of perinatal arterial
stroke [Shankaran, 2008]. Stroke with
abnormalities involving the cerebral
peduncle are also highly predictive of
CP PPV 78% [de Vries et al., 2011].
Practice point. Infants with a cerebral
birth defect, or stroke with involvement
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of the cerebral peduncle should be
identified as “at risk” of CP and should
join Pathway B (Figure 5) at
“assessment for CP.”
The risk of developing CP in term
infants who have received routine care at
birth, the third group of infants who go
on to develop CP, is !1/1,000 neonatal
survivors and these infants are at the lowest risk. However, they represent 45% of
all infants with CP and numerically comprise the largest group (Fig. 4). Why do
these apparently “neurologically normal”
children at birth develop CP, and can we
identify them earlier so they can have
access to active surveillance and early
intervention?
From a total population case control study in Western Australia,
McIntyre et al. [2011] compared the
clinical descriptions of 295 term infants
with CP with 442 term control infants
none of which required special care.
They identified six independent predictors of CP in the neonatal period:
abnormal fontanelle OR 4.4 (95% CI
0.8–23); abnormal tone OR 7.3 (95%
CI 2–26.8); birth defects identifiable in
the newborn period OR 5.2 (95% CI
2.4–10); ventilatory assistance restricted
to the labor room only OR 2.9 (95%
CI 2.2–12); abnormal consciousness
referred to irritability and lethargy, but
none were comatosed OR 3.7 (95% CI
2–7); and in the small group with
abnormal temperature regulation temperature was down or fluctuating, not
high OR 4.1 (95% CI 1.2–14). A number of these predictors are reminiscent
of criteria for mild NE, and the presence of two or more of these factors
yielded a high specificity (99%), but
low sensitivity (14%) for CP. This is
not surprising considering the unknown
etiology of this group of infants. Of this
low risk group who had CP, 58% did

not have any of these neonatal factors,
yet 60% of these infants had moderate
to severe CP.
This is not the first time a finding
like this has been reported. The
National Collaborative Perinatal Project
reported that most children with CP
did not derive from groups at high risk
(low Apgar scores, or the presence of
neonatal signs). About 43% were examined and classified as “neurologically
normal” in the neonatal period and
concluded that a large proportion of
CP cases remain unexplained [Nelson
and Ellenberg, 1986; Ellenberg and
Nelson, 1988]. Earlier still, in 1970,
Eva Alberman attempted to model
what were at that time the three most
important risks around birth: (1) parity
>4; (2) abnormal method of delivery—
breech, face or shoulder delivery, internal version, or delivery by an untrained
person; and (3) neonatal illness in the
1st week of life—convulsions, cyanotic
attacks, cerebral signs, hypothermia,
jaundice, Rh incompatibility, or serious
illness. Infants were at the highest risk
of disability when all three of these risks
were apparent. They were only a small
group (0.1% of total births), but more
importantly only 0.2% of those with a
disability. When any combination of
these three risks were used, 13.2% of all
live births were classified as at risk, and
this identified 26.3% of all those with a
disability. A striking finding was that
74% of all those with CP, severe mental
handicap, hearing, and sight impairments could not be identified using this
model.
Very little has changed for those
born at term without any noticeable signs
during the neonatal period since the first
studies of these cohorts in the 1950s. For
these infants, failure to reach major
motor milestones, such as rolling, sitting
or standing, have often been the catalyst
for the commencement of developmental assessments and interventions. Given
that the window for milestone attainment in typically developing children is
quite broad [WHO Multicenter Growth
Reference Study Group, 2006], this usually leads to a “wait and see” approach
where infants receive no intervention
during their period of rapid neural development. In view of the fact that every
second child with CP will be born at
term and requires no special care in the
neonatal period, it is imperative that
frontline health professionals such as
pediatricians, general practitioners and
allied health practitioners have a best
practice pathway to follow when a parent
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Figure 5 Recommended assessment for identification of infants at risk of CP.

presents with a child who falls into this
category.
Practice point. When parents bring
their term born child (3 months to 3
years of age) that did not require special
care when born to a health professional
with concerns regarding motor development or abnormal posturing they
should go straight to Pathway B at
“screen for CP.” We propose that a
tiered approach as developed by Rosenbaum et al. [2009] should be adopted.
They recommend using the ages and
stages questionnaire 1 three extra ques-

tions for parents. Consideration should
also be given to risk factors during
pregnancy and signs of mild NE in the
neonatal period. When an abnormal
result is derived, Pathway B (Figure 5)
should be followed to “assessment for
CP” through standardized motor
assessments.
The description of cerebral palsy is traditionally given late but can be given earlier
This review is timely as “it is
now universally accepted that the earliest possible diagnosis and treatment (of
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CP) are essential to prevent, or at least
minimize, the handicapping effects of a
disability and to make the most of the
assets a child possesses” [Alberman and
Goldstein, 1970]. Yet, paradoxically, 40
years later families are not automatically
receiving early intervention while they
“wait and see” whether their child will
“catch up” from simply a slower motor
developmental trajectory or if their
child actually has CP or DCD or an intellectual impairment with associated
motor difficulties.
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Figure 5 (Continued)

CP registers indicate the average
age for a description of CP to be given
is 19 months, but the range is wide.
For those with severe motor impairment the description of CP can be
given as early as 1 week but may take
up to 3 years, and less surprisingly for
those with mild or moderate motor
impairment the description of CP is
given anywhere between 1 week and 5
years of age [Watson et al., 2006]. The
burgeoning body of recent neuroplasticity literature suggests that intensive,
repetitive, task-specific intervention for
CP ought to commence very early
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while the brain is most plastic (i.e., in
the first 2 years of life), which is almost
never the case when the family is taking
part in “wait and see” monitoring prior
to description.
Good evidence shows that earlier
detection of CP is both possible and
accurate and, more importantly, diagnostic-specific early intervention is
therefore possible. Rather than waiting
for a formal description of CP to be
given, infants should be identified as “at
high risk of CP” when they are high
risk, and therefore commence diagnostic-specific early intervention straight

away. For those who are not at high
risk but have early signs, they should be
regularly comprehensively assessed to
ensure access to the most appropriate
early intervention.
Why is Cerebral Palsy Missed and
Why is the Description so Difficult
for Doctors to Make?
Health professionals hesitate to use
the terminology CP early for a number
of reasons, but importantly the condition
is not a diagnosis; it is a “clinical
description.” There are no biological
markers or definitive tests for CP. The
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Figure 5 (Continued)

term does not infer etiology, and it has
no prognostic value as severity and associated impairments are incredibly
variable. However, 86% of parents know
something is wrong with their child
before a description of CP is given [Baird
et al., 2000]. Leading up to this point in
time, most parents experience being told
by their medical team that the plan is to
“wait and see.” When health professionals use the term “wait and see,” the
intention is to use this time to rule out
other diagnoses, delay the delivery of

bad news or provide time for the child
to grow out of it.
Rule out other diagnoses
Doctors first rule out other diagnoses that may explain the symptoms.
This is an important step as there are
other conditions that mimic the early
signs of CP which can have important
treatment implications, such as: neurodegenerative conditions (e.g., Ataxia
Telangiectasia); metabolic syndromes
(e.g., Glutaric acidemia); and genetic
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conditions (e.g., Trisomy 18, Angelman
Syndrome, Cornelia de Lange syndrome) [Badawi et al., 1998].
Delay the delivery of bad news
Doctors sometimes delay the
delivery of bad news while exploring
the possibility of a less severe, more
common disorder such as DCD. Differential diagnosis is critical as it informs
the selection of intervention strategies
suited to the specific condition. For
example, effective intervention for
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pediatrician who may lack access to the
relevant maternal-fetal and/or neonatal
medical history. The pediatrician may
then be assessing a healthy baby that
may just appear slightly “delayed,” and
it is not until later in infancy that the
gravity of the problem may be evident,
precipitating a late diagnosis.

Figure 6

DCD involves cognitive approaches
best suited to school-aged children,
whereas CP intervention uses a variety
of pharmacological, motor, social and
cognitive intervention approaches that
can commence early in life. It is therefore important that children with CP
are differentiated earlier in order to get
the right interventions early.
Provide opportunity to grow out of it
Doctors sometimes delay the
delivery of bad news to provide enough
time for the possibility that the child
may “grow out of it.” However for
those few whose motor signs resolve,
commonly they transpire to have an intellectual impairment or behavioral
problems [Nelson and Ellenberg, 1981].
The brain injury responsible for
CP may be suspected or even confirmed in the neonatal period, but the
diagnosis for many does not occur until
the motor impairments and activity limitations inherent in the definition are
observable. This lag time is not useful
to families or to the child.
“. . .. . .I am very worried about my
son, he is 5 months old, and over the last
month I have noticed he seems to go
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into strange positions, I especially notice
it each time I pick him up. I went to the
GP, who agreed and thought I should
see a pediatrician. I went to the pediatrician who agreed they were unusual and
said let us see how he is when he is 10
months old. That is too long to wait! So I
went to another pediatrician who agreed
again, it was abnormal, so now I am
booked to go to a physiotherapist for further tests, and after that they will decide
what to do” but I do not know what to
do now. . .” (Personal communication,
February 4, 2012, parent discussion with
first author over the phone).
System barriers to description are
also potentially at work. For example,
for any mother and her newborn,
obstetricians hold vital information
about maternal-fetal health. If the baby
is premature or ill, care is immediately
transferred to neonatal specialists, where
the primary patient is now the infant,
not the mother, and some of the relevant preconception and pregnancy
history about risk factors for CP may
not be passed on. When the infant is
well and discharged from hospital, care
is likely to be transferred to a community based general practitioner or

What are the Most Important
Things that can be Done in Clinical
Practice to Describe Cerebral Palsy
Earlier?
We propose a new clinical pathway that is designed to circumvent the
existing screening and diagnostic barriers
by tying together the relevant evidence
needed to make an earlier diagnosis and
commence earlier intervention (see
Pathways A and B). These pathways
have been developed using GRADE
level evidence [Guyatt et al., 2008] and
“traffic lights” to signify the effectiveness of the interventions [Novak and
McIntyre, 2010]. Green equals “go,”
(high quality evidence to support
the use of the intervention, therefore
use this approach). Yellow equals
“measure” (low quality or conflicting
evidence supporting the effectiveness of
the intervention). Red equals “stop”
(high quality evidence indicating ineffective interventions) [Novak and
McIntyre, 2010].
The serious nature of these standard care limitations has led us to
conclude that “waiting and seeing” is
potentially harmful to children with CP
and their families. We therefore have
identified solutions to three of the
major problems relating to the late diagnosis of CP, which are timely and
possible for the health system to redress:
New clinical diagnostic and intervention
pathways
When the system fails to recognize a child with CP very early due to
using the “wait and see” monitoring
mode, this decision essentially ensures
that infants receive limited or no diagnostic-specific intervention within the
critical window of brain development.
The window of brain development,
where the brain is actively sprouting
and pruning in response to activity, is
often misspent in children with CP. In
Pathways A and B, we review the evidence for early intervention possibilities
in CP. The evidence tells us quite
clearly that general early intervention
and parent interventions, designed to
enhance in-home care characterized by
positive
interactions,
categorically
improve a child’s cognition with the
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best effect seen in children of low
socio-economic status. However, more
recent neuroplasticity evidence suggests
that a skill-based, high-intensity practice
approach to early intervention is
required to impact on motor outcomes,
as is the case in most adult brain injuries. These newer types of motor
learning approaches, which are effective
in older children with CP, require
urgent study within the CP infant population. It is therefore the responsibility
of the health professional who observes
major risk factors or a motor delay to
investigate further, diagnose “at risk of
CP” early, and refer to early intervention at a minimum to optimize their
cognitive function. We outline a way
to do this via systematic use of risk factor history taking, neurobehavioral
predictive tools, in addition to MRI
(Pathways A and B).
Promotion of a climate for new research that
will improve outcomes
Late description of CP is creating
a major problem for recruitment of
infants to promising early rehabilitative
and potentially curative studies. Lack of
diagnosis is impeding the advancement
of regenerative medicine, early intervention and other well-recognized
treatments for CP yet to be tested in
the earlier years, for example, medical
interventions for tone management,
reflux, and epilepsy. When a health
professional identifies an infant at high
risk for CP, coupled with referral to
early intervention trials, it will help to
accelerate future discoveries for these
children and change the landscape of
the diagnosis and prognosis.
Promotion of good family mental health and
resilience for the long-term
If late description is not helping
infants or research, are we helping
parents by sheltering them from bad
news? A population study conducted in
Britain found that parental dissatisfaction with delayed diagnosis of CP is
associated with higher rates of parental
depression [Baird et al., 2000]. So it
would appear that sparing parents from
bad news is unhelpful. Therefore early
recognition and provision of early preventative mental health support for
families may help parents manage the
inevitable stress, which could help
improve family outcomes long-term.
The concept of “at risk” is not a
new one. During the 1960s in the
United Kingdom, there were “at risk”
registers, with the usual accompanying
debate over their value and cost effec-

tiveness. It was deemed not practicable
to have universal screening of all children, but it was felt essential that all
children at risk be monitored. In a letter
to the Lancet in 1967 defending the
concept, Dr Ronald Mac Keith and colleagues wrote, “by the criterion of
identifying handicaps which are in some
cases undoubtedly, and in other cases
probably, benefited by having treatment
started without delay, developmental
and neurological assessment from the
age of 5 months is neither difficult nor
inefficient” [Mac Keith et al., 1967].
The concept itself was deemed by most
to be a sound one. The problem at this
time was the “at risk” criteria used was
identifying up to 60% of all live births
in an area. The goal of these programs
was to screen 10–20% of all births to
identify the majority of the invisible
handicaps that is, those that would otherwise not be identified until the 4th
and 5th years of life. We recommend
that the “wait and see” period is
reframed to the “wait and be” period,
where children are diagnosed “at risk of
CP” early and are immediately referred
to diagnostic-specific early intervention.
What Tools can be Used to
Accurately Predict and Identify
Early Signs of Cerebral Palsy?
Imaging
Practice point. All children with a presumed or suspected brain injury should
have magnetic resonance imaging (MRI).
Neuroimaging is used as an integral part of the diagnostic process
[Krageloh-Mann and Horber, 2007].
MRI is the gold-standard neuroimaging
technique for elucidating the pathogenesis of CP: white matter damage of
immaturity (WMDI) including PVL,
lesions of the deep grey matter, malformations, focal infarcts, and cortical and
subcortical lesions [Bax et al., 2006].
Cranial ultrasound (CUS) is a safe and
inexpensive alternative used in the neonatal intensive care unit (NICU) to
detect structural changes in the newborn brain. However, MRI has higher
sensitivity and specificity than CUS as a
predictor of CP in very low birth
weight (VLBW) infants [Mirmiran
et al., 2004]. Despite strong correlations
between clinical findings and MRI, 12–
14% of children with CP will have normal MRIs [Bax, 2006; Krageloh-Mann
and Horber, 2007] and therefore MRI
should not be used in isolation for making the description of CP.
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Newer techniques and technologies are being developed which are
likely to advance the role of imaging in
the diagnostic process and treatment
selection process. Advanced neuroimaging techniques such as diffusion
weighted imaging (DWI) and diffusion
tensor imaging (DTI) have been utilized to more specifically identify
diffuse or subtle white matter injuries
[Hoon and Faria, 2010]. Magnetic resonance spectroscopy (MRS), provides
measures of brain biochemistry and is
proving an effective tool in understanding prognosis in NE and preterm
infants [Ancora et al., 2010; Van Kooij
et al., 2012]. Large deformation diffeomorphic metric mapping (LDDMM),
where a 3D atlas of the brain is produced, shows great promise for
illuminating the structural brain abnormalities that occur in CP with the
potential for informing selection,
design, and measurement of rehabilitation interventions [Faria et al., 2011].
General neuromotor and developmental
assessments
Many neuromotor and developmental
assessments
with
sound
psychometric properties exist for infants
and young children. For diagnostic purposes, tools with predictive properties
are the most worthwhile. However,
there has been a historical preference by
pediatricians and neonatal follow-up
teams to use discriminative tools that
assess a combination of: abnormal muscle tone of the trunk and extremities;
the presence of primitive reflexes; the
quality and quantity of voluntary movement (e.g., milestone acquisition); and
the presence of involuntary movement.
The problem with this persistent practice is that these tools are only useful
for discriminating between infants who
are developing typically from those
who are not. Determining who is typically developing and who is not is even
more complicated in premature infants
because they have their own developmental trajectory [Heineman and
Hadders-Algra, 2008; Spittle et al.,
2008a]. Routinely used neuro observations and standardized developmental
tests were not designed to specifically
detect the presence of CP and thus further compound the complexity of the
CP diagnostic process. They may be
helpful to some diagnosticians but will
lack adequate specificity for most.
Ideally the aim of monitoring
ought to be to differentiate why some
children are not developing normally,
to enable diagnostic-appropriate best125

available evidence-based intervention to
be provided. This paper will now focus
on the evidence for the best available
tools for predicting and recognizing
CP, distinct from tools better suited to
suspecting global developmental delay
(GDD). Clinometric reviews indicate
that different tools need to be used at
different ages to describe and detect CP
and that a combination of tools is best
practice [Heineman and Hadders-Algra,
2008; Spittle et al., 2008a].
Practice point. A combination of risk
factor history taking, neurological examination that includes assessment of
quality of movement, volitional movement and neuroimaging are required. A
health professional with clinical expertise and experience in motor
development should interpret and evaluate the findings generated by these
assessments (Figure 6).
Tools predictive of cerebral palsy
Qualitative assessment of general movements
[Einspieler et al., 2004)]. Of all the
tools available to predict CP, GMs is
consistently the most predictive, with
specificity and sensitivity rates higher
than MRI [Burger and Louw, 2009].
The GMs assessment measures the quality of spontaneous movements with the
infant lying supine. Scoring is done by
trained assessors via observation of
video footage and can be used from the
preterm period until 20 weeks post
term age (PTA). Two distinct time
periods for assessment exist; the writhing period (up to 9 weeks PTA) and
the fidgety period (from 9 to 20 weeks
PTA). In both periods, the infant is
scored with “normal” or “abnormal”
GMs. Abnormal GMs are then further
classified. In the writhing period,
abnormal GMs known as “cramped
synchronized” have been shown to be
highly predictive of CP (sensitivity
5100%; specificity 5 40%; PPV59.4%;
NPV5 100% [Spittle et al., 2009]. If
the abnormal GM of “cramped synchronized” is followed by the abnormal
GM “absent fidgety” (in the fidgety period) this has consistently shown the
highest predictive value for CP (Darsaklis and Snider, 2011).
A recent systematic review of 17
studies demonstrated the accuracy of
the GMs assessment in predicting neurodevelopmental outcomes in infants up
to 2 years with a sensitivity !92% and
specificity !82% [Burger, 2009]. The
GMs assessment has been found to be
superior to ultrasound findings in predicting CP [Einspieler et al., 2004]
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When correlated with MRI findings,
namely white matter injury, the GMs
assessment (specifically “absent fidgety”)
has been shown to accurately predict
CP 100% of the time in very preterm
infants [Spittle et al., 2008a] Evidence
of the predictive value of GMs in full
term infants with hypoxic ischemic
encephalopathy (HIE) has also been
demonstrated [Prechtl et al., 1993].
Importantly, the GMs assessment has
good clinical utility because it is quick,
inexpensive, and noninvasive. Rater
training is provided by the GMs trust.
Hammersmith infant neurological assessment
[Haataja et al., 1999]. The Hammersmith assessment is based on the
Dubowitz and Dubowitz [1981] assessment of the newborn and is a simple
method of examining infants between 2
and 24 months of age. There are three
parts to the examination: neurologic
signs, developmental milestones, and
behavior. In the first section, the neurologic exam, an optimality score is
obtained from the assessment of cranial
nerve function, posture, quality and
quantity of movement, tone, and
reflexes and reactions. The second and
third sections do not form part of the
overall score but give important additional
information
regarding
developmental progress. Recent studies
have demonstrated the predictive value
of the Hammersmith infant neurological
assessment (HINE) for CP. A large
study [Pizzardi et al., 2008] of 658
infants who were either preterm or
term with NE were prospectively studied from birth until 12 months
corrected age. ROC curve analysis was
used to test the predictive power of the
HINE. Global HINE scores showed
high prediction of CP at all ages (ROC
curve areas above 0.9), but most importantly movement quality and quantity
test items had even higher predictive
power.
A retrospective study of 70 infants
diagnosed at 2 years with CP observed
a strong (r 5 282) negative correlation
between HINE scores at 3–6 months of
age and levels of GMFCS [Romeo
et al., 2008a]. Infants in GMFCS levels
3–5 scored below 40, whereas those in
levels 1–2 scored between 40 and 60.
Combined use of the HINE and GMs
at 3 months PTA can be used to
describe an infant as at “high risk” of
CP [Romeo et al., 2008b].
Practice point. Routine follow-up for
preterm and sick infants should be
scheduled at three-months and sixmonths corrected, not the conventional

four-months, to enable medical teams
to use the best predictive tools to help
make the description of CP earlier.
Practice point. When examining infants,
do not discount CP when spasticity or
dyskinesia is not identified. A period of
time lapses between the original damage
to the developing brain, whether in
utero or during early infancy/childhood,
and
the
appearance
of
impairments. It is well known that the
brain, which begins development in
utero, continues to develop during
childhood. Thus a child’s neural development is “age-specific,” so brain
dysfunction will manifest according to
the brain’s development at that age
[Hadders-Algra, 2004]. Compared with
a mature brain which responds to injury
with specific and localized signs, a
young infant may present with generalized and nonspecific signs (e.g.,
hypotonia) [Kuban and Leviton, 1994;
Hadders-Algra, 2004]. It is proposed
that further brain development in an
infant, including myelination of axons
and maturation of basal ganglia neurons,
must occur before spasticity and dyskinesia can manifest [Kuban and Leviton,
1994]. The infant with hypotonia may
thus “develop” spasticity and dyskinesia
by the age of 1 or 2 years, as the complexity of neural functions increases
[Kuban and Leviton, 1994; HaddersAlgra, 2004].
Movement assessment of infants [Chandler
et al., 1980]. The movement assessment of infants (MAI) is a criterionreferenced scale that evaluates neuromotor dysfunction in high risk infants
at 4, 6, 8, and 12 months of age. The
assessment is carried out by a therapist
and takes 30–60 min to complete,
requiring a manual but no specialized
equipment. The MAI assesses tone,
primitive reflexes, equilibrium reactions,
and volitional movement. The test has
been shown to be twice as sensitive as
the Bayley scales of infant development
in detecting early signs of CP [Harris,
1987]. Studies of predictive values at 4
and 8 months of age report sensitivity
rates ranging from 73.5 to 96.0 and
specificity of 62.7–78.2 [Spittle et al.,
2008b]. A recent investigation of the
predictive validity of the MAI at 6
months of age demonstrated a significant correlation between MAI scores
and Bayley scales of infant development
at 12 months, although sensitivity and
specificity for CP were not reported
[Metgud et al., 2011].
Other useful assessments. Several other
neuromotor assessments, such as the test

DEV DISABIL RES REV " CEREBRAL PALSY—DON’T DELAY " MCINTYRE

ET AL

of infant motor performance (TIMP)
[Campbell, 2005], The neuro-sensory
motor
development
assessment
(NSMDA) [Burns et al., 1989], and the
Alberta infant motor scale (AIMS)
[Piper and Darrah, 1994], are appropriately used to discriminate infants with
abnormal motor function from those
typically developing. All have sound
psychometrics. Of these tools, the
TIMP has been shown to be sensitive
to change in response to intervention
[Campbell et al., 1995].
Assessment summary.
! High risk infants should be routinely
assessed using the GMs preferably three
times; during early admission, around
term corrected (if preterm) and at 9–14
weeks (corrected for gestational age).
! “High risk of CP” designation should
be given to infants at 9–14 weeks (corrected) with a combination of absent
fidgety GMs and white matter injury
on MRI.
! After 20 weeks (corrected), use the
HINE or MAI.
! MRI is the best imaging tool to elucidate the pathogenesis of CP and should
be offered to all infants who have
abnormal findings.
! Use the CP description form to
describe motor type and severity to
inform intervention planning.

CONCLUSION
Until recently, CP was considered
unpreventable, incurable, and almost
untreatable. However, preventive efforts
including: rubella vaccination, iodine
supplementation in areas of severe iron
deficiency, anti-D vaccination, preventing methyl–mercury contamination,
reducing the number of embryos transferred in invitro fertilization (IVF) (in
Australia), and enforcing laws for seat
belts and fencing around swimming
pools have been successful prevention
strategies. Recently, magnesium sulfate
and hypothermic intervention have also
started to prevent a small proportion of
CP. Both of these interventions occur
very early and require health professionals to be mindful of CP as a potential
outcome that could be prevented or
cured. With advances in medical, public
health, and allied health research, the
likelihood of further breakthroughs are
probable.
Further research is required to
determine why infants born at term, not
at “high risk” of CP in the newborn period go on to develop CP. Health
professionals need to be aware that 45%

of all CP falls into this category. Therefore we recommend prompt response to
parental concerns with screening and
assessments as outlined, followed by immediate referral for intervention for
those infants then considered “at risk.”
Premature and term infants with
brain injury identified on MRI are at
high risk of CP. We have identified
pathways which make recognizing “at
high risk” of CP easier for health professionals. We propose a change in
diagnostic practice, a shift away from
referral for intervention following a formal (most often late) description to one
of referral when an infant is “at high
risk” of CP. This will provide the opportunity for targeted research in early
intervention, thus providing optimal
outcomes for children with CP.
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Early intervention (EI) has been espoused as the standard of care for children
at high risk of neurodevelopmental disability since the 1990s with the
introduction of the “Individuals with Disabilities Education Improvement
Act (IDEA)” in the USA. The aims of EI are broad and are based on the
principles of neuroscience, which highlight the importance of intervening in
the early years to optimise neuroplasticity mechanisms. For infants with
brain lesions, the role of experience - dependent plasticity is significant.
This paper explores the effect of a known “active ingredient” for recovery in
animal studies – environmental enrichment. The evidence for the effect of
environmental enrichment in programmes designed for infants and very
young children with CP is summarised systematically and data from five
studies combined to demonstrate a small positive effect of environmentally
enriching interventions on infant motor outcomes.
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abstract
BACKGROUND AND OBJECTIVES: Neuroplasticity evidence from animals favors an early enriched environment for promoting optimal
brain injury recovery. In infants, systematic reviews show environmental enrichment (EE) improves cognitive outcomes but the effect
on motor skills is less understood. The objective of this review was to
appraise the effectiveness evidence about EE for improving the motor
outcomes of infants at high risk of cerebral palsy (CP).
METHODS: A systematic review was conducted. Cochrane Central Register of Controlled Trials (PubMed), Cumulative Index to Nursing and
Allied Health Literature, Education Resource Information Center, SocINDEX,
and PsycINFO databases were searched for literature meeting inclusion criteria: randomized controlled trials; high risk of /diagnosis of
CP; .25% participants #2 years; parent or infant interventions postdischarge; and motor outcomes reported. Data were extracted using
the Cochrane protocol regarding participants, intervention characteristics, and outcomes. Methodological quality was assessed using risk
of bias assessment and GRADE.
RESULTS: A total of 226 studies were identiﬁed. After removing duplicates and unrelated studies, 16 full-text articles were reviewed, of
which 7 studies met inclusion criteria. The risk of bias varied
between studies with the more recent studies demonstrating the
lowest risk. Enrichment interventions varied in type and focus,
making comparisons difﬁcult. A meta-analysis was conducted of
studies that compared enrichment to standard care (n = 5), and
totaled 150 infants. A small positive effect for enrichment was
found; standardized mean difference 0.39 (95% conﬁdence interval
0.05–0.72; I2 = 3%; P = .02)
CONCLUSIONS: EE looks promising for CP, and therefore high-quality
studies with well-deﬁned EE strategies are urgently required.
Pediatrics 2013;132:e735–e746
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Children with cerebral palsy (CP) reach
∼90% of their gross motor potential by
age 5 and even younger for the more
severely impaired,1 so effective interventions for optimizing early motor
development are vital. As with typically
developing children, the ﬁrst 2 years
are critically important for cognitive
and motor development2 because the
brain is experiencing continuous
spontaneous plasticity. Pediatricians,
who are responsible for making the
diagnosis of CP and referral to rehabilitation, therefore require up-todate evidence about effective early
interventions for children with CP.
The value of enriched environments in
enhancing brain recovery at both
structural and chemical levels has been
repeatedly demonstrated in animal
studies.3,4 Effects of enrichment include improved memory and motor
function.4 Replication of animal data
ﬁndings within humans is still undergoing experimentation, with one of
the early challenges being how to deﬁne an “enriched human environment.” No single agreed deﬁnition of
environmental enrichment (EE) in human infants exists. In animal studies,
an EE is deﬁned as an environment that
facilitates enhanced cognitive, motor,
and sensory stimulation.4 Although
there are no agreed parameters for
enrichment, these animal housing
conditions typically include high levels
of complexity and variability with arrangement of toys, platforms, and
tunnels being changed every few days
to promote motor learning and memory. Researchers have postulated that
it is the voluntary and challenge
aspects of these environments that are
crucial. Animals are not forced to perform activities; rather their engagement with the environment is active
and playful.5 The motor opportunities
afforded by EE are a critical success
factor. An intriguing theoretical question is whether an EE where an animal
e736
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can practice a task and engage in any
amount of physical exercise can be
actually distinguished from speciﬁc
motor training, as with humans. Some
animal researchers consider training
a discrete intervention, whereas others include training as a “rehabilitative
enrichment” component of the EE.6 Either way, EEs offer opportunity for
motor learning and “training,” and for
the purposes of this article we considered training inclusive of environmental adaptations to enhance training,
as 1 form of motor-speciﬁc enrichment.7
Because no agreed deﬁnition exists,
the ﬁndings of this review must be
interpreted with attentiveness to the
deﬁnition we posed from literature.
Animal EE ideas are difﬁcult to replicate
within human experiments because
humans experience an individualized
level of complexity and variability within
their daily lives. In addition, unlike
animals, human infants cannot voluntarily access their environment because motor maturation occurs later;
for example, ambulation is not present
at birth. Consequently infants are dependent on their parents for access to
both generalized and motor-speciﬁc EE.
Much more is known about the negative
impact of deprivation on child development, inferring that EE and activitydependent plasticity are vital.8–11 Wellunderstood examples include the
following: (1) institutionalized children
within deprived environments display
intellectual quotients 20 points lower
than peers,12,13 which is reversible when
EE is applied within orphanages13; (2)
children living in chronic poverty experience slower growth, worse health,
and lower intellectual ability unless EE
protective factors are in place (eg,
parental responsivity and acceptance,
availability of learning materials, safe
play areas, and a variety of experiences)14; (3) typically developing children experience delayed sitting skills
from parents conscientiously following

the Sudden Infant Death Syndrome
“back to sleep” program, which deprives
children of experiences in prone, but is
fortunately remediable15; and (4) typically developing children experience
delayed walking from regular use of
infant walkers, whereas Jamaican
infants walk earlier owing to parental
handling techniques.16,17 It should be
noted that these latter examples have
only a short-term inﬂuence on motor
development in typically developing
children, and it is not known if these
environmental inﬂuences beneﬁt or
disadvantage infants with motor disorders in any way. Motor-enrichment
interventions have recently been trialed in preterm and typically developing infants. Reaching training
delivered by caregivers to their preterm infants was able to partially
ameliorate the delayed reaching skills
often observed in the preterm population.18 Similarly, training parents to
practice speciﬁc motor tasks with
typically developing infants accelerated the rate of motor development in
both the short and long term.19,20
In the small amount of literature about
the beneﬁts of EE for infants at risk for
brain injury, we know that premature
infants demonstrate neurobehavioral
beneﬁts from sensory-speciﬁc EE activities, such as massage21 and music.22
Developmental care interventions for
premature infants have been shown to
deliver modest short-term gains, but
with some trials showing no beneﬁt at
all.23 Some programs, such as The
Newborn Individualized Developmental
Care and Assessment Program, a sensory-speciﬁc EE and cue-based intervention for high-risk infants, has been
shown to positively inﬂuence brain
function and motor development.24
Generic EE via early interventions, such
as the Head Start program,25 provide
cognitive beneﬁts short-term, especially for infants from lower socioeconomic backgrounds whose risk of
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environmental deprivation is higher.
Similarly, systematic reviews show favorable short-term cognitive beneﬁts
from generic EE programs offered to
premature infants.26,27 Because only
∼8% to 15% of premature infants will
go on to have CP,28 it is not clear whether
interventions aimed at preterm infants
will have clear beneﬁts for infants with
CP. In contrast, “traditional” physical
and occupational therapy earlyintervention approaches, such as neurodevelopmental treatment (NDT), have
not been shown to be effective in improving motor outcomes in infants or
older children with CP, despite the
theoretical possibility of providing
sensory-enrichment cues for learning
motor skills.29,30
Given that optimization of neuroplasticity is the aim of all rehabilitation,
it is important for those who deliver
early-intervention services to understand the parental and EE-intervention
role that in turn is informed by knowing
the important components of EE for
infants with brain injury. Indeed, the

importance of the role of parents in
providing optimal home environments
for at-risk infants,31 as well as arranging opportunities for motor training,
have been highlighted in recent
reviews.32
Because interventionists use the term
EE without deﬁnitional or procedural
precision, it is important to be clear that
not all therapy interventions are
enriching. In some standard care
interventions, manual handling techniques are applied with the child’s role
being largely passive. This contravenes
animal EE deﬁnitions, in which active
exploration of complex and variable
environments is required. For the
purposes of this review and in the absence of an agreed infant EE deﬁnition,
we proposed an operational deﬁnition
of infant EE, consistent with the animal
literature (Fig 1). Infant EEs are interventions that aim to enrich at least 1 of
the motor, cognitive, sensory, or social
aspects of the infant’s environment for
the purposes of promoting learning.
Examples include interventions aiming

to enhance parent-infant interaction,
educate parents about assisting their
child’s skill development, provide opportunities for active motor learning
(self-generated motor activity) by
adapting the physical and play environment, or provide comprehensive
programs aimed at enrichment across
a number of domains.
The purpose of this study was to systematically review the evidence for the
effectiveness of EE interventions (either
generic EE or motor-speciﬁc EE; eg,
motor training) for infants at very high
risk of CP, which explicitly sought to
improve motor outcomes.

METHODS
The method used was a systematic
review and meta-analysis with reporting according to the Preferred
Reporting Items for Systematic Reviews
and Meta-Analyses statement.33 A
comprehensive search was conducted
of the following databases between
May and August 2011 and updated in

FIGURE 1
Environmental enrichment—infancy.
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May 2012: The Cochrane Library, including the Cochrane Database of Systematic Reviews and the Cochrane
Central Register of Controlled Trials
(inclusive of PubMed); the Cumulative
Index to Nursing and Allied Health Literature; PsycINFO; Education Resource
Information Center; and SocINDEX.
Types of Studies
Included studies were randomized
controlled trials (RCTs). Systematic
reviews were also retrieved but not
appraised as per conventions. Controlled studies and studies in languages
other than English were excluded.
Types of Participants
Participants were either infants with
a conﬁrmed diagnosis of CP of any
subtype or severity, or infants designated “at high risk” of CP using the best
predictive tools available, namely, abnormal general movements (absent
ﬁdgety) or abnormal brain imaging
(cranial ultrasound or magnetic resonance imaging). Studies were included
in which 25% of participants were 2
years of age or younger at the time of
study enrollment.
Types of Interventions
EE Interventions
EE interventions of interest were those in
which the infant’s environment was
enriched via parent training or coaching in parent-infant interaction or in
various stimulation activities, speciﬁcally those for motor learning; or where
the physical environment was modiﬁed,
adapted, or constructed to enable motor skill attainment; or where therapists
provided intense, targeted motor skill
practice aimed at enhancing plasticity.
Interventions that solely focused on
enriching parent well-being for improving parent outcomes but not for
improving child motor outcomes were
excluded. The effects of regular parental
caregiving were not speciﬁcally teased
e738
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out for either the EE or comparison
group, because if effective for promoting motor development, we would
expect as a function of randomization
that positive parental caregiving was
evenly distributed between both
groups. Studies of “NDT plus” were included in the EE categorization if, and
only if, the added elements of the intervention (ie, the “plus” component)
clearly involved EE.
Comparison Interventions
Comparison interventions were those
deemed “standard care” as provided by
physiotherapists and included traditional approaches, such as NDT or Vojta.
NDT and Vojta were not considered
enrichment interventions by our deﬁnition, because NDT and Vojta, despite
modernization, continue to fundamentally focus on passive therapist-delivered
facilitation and inhibition (therapeutic
handling).34 In contrast, EE approaches
deliberately minimize handling to promote active child-generated muscle
activation and movement. Interventions that included handling or positioning embedding into daily routines
were regarded as largely passive
interventions and were thus treated as
non-EE interventions from standard
care, on the basis that these treatment
ideas originated from NDT.
Types of Outcome Measures
Outcome measures of interest were
those that assessed progress in motor
skill acquisition at any time point after
intervention and as either a primary or
secondary measure. To improve homogeneity, meta-analysis was conducted using only data collected at time
points immediately at the end of the
intervention period.
Search Terms
The following Population, Intervention,
Comparison, Outcome search terms were
used: P = cerebral palsy OR neonatal
stroke OR intraventricular hemorrhage

OR brain injury OR hypoxic ischemic
encephalopathy OR newborn encephalopathy OR periventricular leukomalacia (PVL); I = environment OR enriched
environment OR enhanced environment OR home environment OR nurture
OR parenting OR parent training OR
parent coaching OR caregiving OR
shaping OR stimulation OR intensive
task practice; C = nil; O = motor development OR motor skills OR motor
learning OR motor outcome. Filters
applied during the searching were
“infants 0–23 months” and articles in
English. Abstracts from conferences
and dissertations were excluded. Additional hand searching was conducted
from reference lists and ﬁeld expert
recommendations.
Selection of Studies
Two authors (C.M. and I.N.) independently screened all titles and abstracts,
identiﬁed articles, and excluded irrelevant citations. Full-text articles of all
potentially relevant articles were
obtained and assessed for eligibility.
Ninety-ﬁve percent agreement was
reached; disagreement was resolved
through discussion and consensus. The
criteria for study exclusion are documented in Fig 2.
Data Extraction and Management
A data extraction tool based on the
Cochrane guidelines35 was used by 2
authors (C.M. and I.N.). The following
data were extracted: study design; inclusion and exclusion criteria; participant characteristics, including the
diagnosis of CP or “high risk of CP”;
number of participants; age and gender of participants; characteristics
of the intervention and comparison
interventions, including treatment approaches and duration, frequency, and
intensity of intervention; details of
cointerventions plus compliance with
treatment protocol; motor outcomes;
methods used to measure change in
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identiﬁed, and after inspecting the fulltext articles, 7 studies met full inclusion
criteria. Reasons for exclusion are
summarized in Fig 2.
Included Studies

FIGURE 2

Flow diagram. aArticles may have been excluded for failing to meet .1 inclusion criterion.

motor function; mean scores and SDs
of outcomes; and direction of effect for
motor outcome. We contacted authors
of included studies when there was
incomplete reporting of data. All
authors contacted were able to provide
the missing data requested.

The methodological quality of the included studies was assessed by using
the Cochrane risk of bias recommendations from the Cochrane Handbook for Systematic Reviews of
Interventions35 and is summarized in
Table 2.

Nordic Cochrane Centre, The Cochrane
Collaboration, 2012). The I2 statistic
was used to quantify the heterogeneity
of outcomes and informed decisions
about whether to pool data. Metaanalyses were conducted by using
a random-effects model to conservatively account for the data heterogeneity. The mean differences in motor
outcomes were pooled for each study
to provide a summary estimate of the
effectiveness of EE interventions. For all
continuous outcomes with different
units, effects were expressed as standardized mean differences and 95%
conﬁdence intervals.

Analyses

RESULTS

Meta-analysis was conducted for the
studies that were clinically homogeneous. Data were analyzed by using
Review Manager 5 (RevMan; Computer
program Version 5.1. Copenhagen: The

The electronic searches, citation
tracking, and reference list searches
elicited 226 references after 9 duplicates were removed. After screening
titles and abstracts, 16 studies were

Quality of Studies and Risk of Bias

PEDIATRICS Volume 132, Number 3, September 2013

Across the 7 included studies there
were a total of 328 participants
(Table 1). Three studies36–38 investigated the effects of EE interventions
(as per our deﬁnition) on very young
hospitalized infants with brain injuries
and at high risk of CP and followed
their progress post discharge. The
remaining 4 studies39–42 investigated
EE interventions (as per our deﬁnition)
in children older than 1 year with
a conﬁrmed diagnosis of CP. The features of EE interventions varied considerably among the studies. Six
studies provided part of the EE intervention via parent training or
coaching. This included ways of interacting with their infant,36–38 strategies
for modifying the physical environment
for motor task practice, and providing
frequent opportunities for task practice.39,40,42 Only 1 study did not actively
train parents but encouraged them to
“use newly acquired skills when the
therapist was not present.”41p306
Methodological Quality and Risk of
Bias in Included Studies
The methodological quality and risk of
bias in the 7 included studies were
variable, with a tendency for the more
recent studies to be of the highest
quality and at the lowest risk of bias
(Table 2). Three studies used adequate
methods for generating the randomization sequence but 4 were unclear.
Three studies used adequate methods
to conceal allocation. Blinding of participants and therapists was not possible in any of the studies because of
the “hands-on” and thus visible nature
of the intervention. Five of the studies
used assessors who were blinded to
group allocation and 4 studies had
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36

100% CP

79M; 49F

Age: 12-71 mo
(34% #2)a

100% high
risk CP
n = 128

Ohgi et al38
(2004)

100% highrisk CP

100% highrisk CP
n = 23
Age; 0 mo
17M; 6F

18M; 19F

Social enrichment: Training
parent-infant interaction
Sensory enrichment; auditory/
tactile/visual/Vestibular

Intensive, customized, and
variable task practice

Motor enrichment: Changing
the environment to enable
goal attainment
Parent coaching in problem
solving child movement
difﬁculties

Motor enrichment: Training
parent in various stimulation
activities for motor learning

Cognitive enrichment:
CAMS program

Enrichment Used

RCT
Social enrichment: Training
Aim: Facilitate infant development
parent-infant interaction
Gp1 = Enrichment via training of
mother-infant interaction +
handling and developmental support
using NDT principles
Gp 2 = Standard care

Aim: Reduce incidence of
handicap
Gp1 = Enrichment via
multisensory stimuli +
standard care
Gp 2 = Standard care

Aim: Improve performance on
functional tasks and mobility
and increase participation
in everyday tasks
Gp 1 = context-focused therapy
(therapeutic intervention
aimed at task 6 enriching
environment)
Gp 2 = child-focused therapy
(therapeutic intervention
aimed at child only; may
include intensive task
practice)
RCT

RCT

Aim: Enhance cognitive and
sensorimotor development
Gp1 = Enriched intensive
stimulation using CAMS
(Curriculum and
Monitoring System)
Gp 2 = Standard care

Age: 0 mo

38M; 24F

RCT

Design and Intervention

n = 62

Participants

Nelson et al37 n = 37
(2001)
Age: 0 mo

Law et al39
(2011)

Badr et al
(2006)

Study

TABLE 1 Summary of Included Studies

Neonatal Behavioral
Assessment Scale
certiﬁed examiner

Research assistant,
then parent

Physiotherapist or
occupational therapist

Nurse

Provider

Motor: Bayley PDI
Other: Bayley MDI;
NBAS; STAI; LCC

Other: Bayley MDI; Dyadic
Mutuality Code; NCAFS

Motor: Bayley PDI

Other: APCP; FES

Motor: GMFM, PEDI,
joint ROM

Other: Bayley MDI;
NCAFS; NCATS; PSI

Motor: Bayley PDI

Outcome Measures

No signiﬁcant difference between groups
on motor outcomes at 6 mo

No signiﬁcant difference between groups
on Bayley at 12 mo. Confounded by
.25% attrition rate. Best predictor of
motor outcome was presence of PVL

No signiﬁcant difference between groups.
Both groups improved equally on the
PEDI and GMFM

No difference between groups,
Bayley PDI fell in both groups.
Confounded by 30% attrition rate.
NOTE: Data reanalyzed in 2009,
showing signiﬁcant difference
between groups favoring enrichment

Results
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Aim: Promote cognitive and
motor development

Gp1 = Enriched intensive
stimulation using
learningames (cognitive,
sensory, language and motor
activities) for 6 mo followed
by 6 mo NDT
Gp 2 = Standard care (12 mo NDT)
RCT

Aim: Improvement in motor
function of affected arm
Gp1 = Enriched intensive task
practice via shaping with
constraint
Gp 2 = Standard care
(conventional PT/OT)
RCT

Aim: Improve performance in
ADL tasks
Gp 1 = Enriched intensive task
practice, mCIMT plus home
program
Gp 2 = Enriched Intensive OT plus
home education program

Age: 12–19 mo

36M;12 F

Age: 7–96 mo

Age: 19–94 mo
(34% #2)a
27M; 23F

100% CP

13M; 5F
100% CP
n = 50

(50% #2)

100% CP
n = 18

RCT

Design and Intervention

n = 48

Participants

Motor enrichment: Training
parent in various stimulation
activities for motor learning
Intensive, customized task
practice

Motor enrichment: Intensive,
customized and variable
task practice

Cognitive/social enrichment:
Training parent in various
stimulation activities
Motor enrichment: Changing
the environment to enable
goal attainment
Intensive, customized and
variable task practice

Enrichment Used

Occupational
therapist

Occupational therapist,
physiotherapist or
PT assistant

Child development
specialist

Provider

Other: COPM; GAS

Motor: AHA; PMAL-R

Motor: EBS,
PMAL, TAUT

Other: Bayley MDI;
Vineland

Motor: Bayley PDI

Outcome Measures

No signiﬁcant difference between groups.
Motor outcomes improved equally in
both groups

Signiﬁcant difference between the groups
favoring enrichment
Note: Cochrane review in 2007
details QUEST scores on this
group not reported in the
article

Signiﬁcant difference between
the groups favoring enrichment
at both 6 and 12 mo

Results

AHA, Assisting Hand Assessment; APCP, Assessment of Preschool Children’s Participation; COPM, Canadian Occupational Performance Measure; EBS, Emerging Behaviors Scale; FES, Family Empowerment Scale; GAS, Goal Attainment Scaling; GMFM, Gross
Motor Function Measure; Gp 1, experimental group, Gp 2, control group; LCC, Lack of Conﬁdence in Caregiving; mCIMT, modiﬁed Constraint-Induced Movement Therapy; NBAS, Neurobehavioral Assessment Scale; NCAFS, Nursing Child Assessment Feeding
Scale; NCATS, Nursing Child Assessment Teaching Scale; PMAL, Pediatric Motor Activity Log; PMAL-R, Pediatric Motor Activity Log Revised; PSI, Parenting Stress Index; STAI, State Trait Anxiety Inventory; TAUT, Toddler Arm Use Test.
a Conﬁrmed with author.

Wallen et al42
(2011)

Taub et al41
(2004)

Palmer et al
(1988)

Study

TABLE 1 Continued
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TABLE 2 Cochrane Risk of Bias Assessment
Study

1

2

3

4

5

6

7

Badr et al36 (2006)
Law et al39 (2011)
Nelson et al37 (2001)
Ohgi et al38 (2004)
Palmer et al40 (1988)
Taub et al41 (2004)
Wallen et al42 (2011)

?
+
?
+
?
?
+

?
+
?
—
?
+
+

—
—
—
—
—
—
—

+
+
—
+
+
—
+

—
+
—
+
+
—
+

+
+
+
+
+
—
+

—
+
+
+
+
—
+

The Cochrane Risk of Bias assessment domains addressed are the following: (1) random sequence generation; (2) allocation
concealment; (3)blinding of participants and personnel; (4) blinding of outcome assessment; (5) incomplete outcome data;
(6) selective reporting; (7) other bias. +, low risk of bias; —, high risk of bias; ?, unclear.

adequate follow-up. Only 1 study selectively reported outcomes and 5
studies were free of other bias because
they provided full statistical reporting.
Effects of Interventions on Motor
Outcomes
Five of 7 included studies compared an
EE intervention with standard care and
were clinically homogeneous for metaanalysis (ie, compared EE with standard
care, and used the Bayley Psychomotor
Developmental Index [PDI] [4/5] trials).
Standard care was not clearly described in terms of the treatment
approaches in use or the intensity of
intervention provided. Two of the 7
studies compared 2 different types of EE
interventions (as per our deﬁnition)
head to head.39,42 In the study by Law
et al,39 both the context-focused group
and the child-focused group enlisted
intensive task practice as an EE feature.
What differentiated the groups was
that the context-focused intervention
also included parent training and environmental adaptations to promote
functional skill attainment. Likewise,
Wallen et al42 compared modiﬁed
constraint-induced movement therapy
(CIMT) with an intensive occupational
therapy approach in which both groups
received intensive task practice and
parent training aimed at EE.
The 5 studies that compared EE with
standard care were included in the
meta-analysis. Data imputed into the
analyses were motor outcomes captured at the immediate cessation of
e742
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treatment. Motor outcome data were
pooled from 4 studies using the Bayley
PDI43 and 1 study using the Quality of
Upper Extremity Skills Test (QUEST).44
For the study by Nelson et al,37 only the
values reported on infants with a central nervous system injury were included within the meta-analyses, which
was possible because these ﬁgures
were reported separately from infants
without central nervous system injury.
Data from the 6-month point were used
from the Palmer et al40 study because
infants in the experimental group received the enrichment intervention
only during the ﬁrst 6 months and then
after this they were prescribed maintenance NDT for the next 6 months.
QUEST values for the Taub et al41 trial
were used, as this was the only motor
outcome measure used in this trial for
which appropriate psychometrics
were available. These values were retrieved from the Cochrane Review by
Hoare et al.45 When combined, the 5
studies included a total of 150 participants. The standard mean difference
was 0.39 (95% conﬁdence interval
0.05–0.72; I2 = 3%; P = .02), indicating a small positive effect favoring

enrichment over standard care (Fig 3:
forest plot).

DISCUSSION
The aim of this systematic review was to
determine the effect of EE intervention
programs on the motor outcomes of
infants who were 2 years and younger
with a high risk or diagnosis of CP,
compared with standard care. This is
the ﬁrst systematic review and metaanalysis that has attempted to deﬁne
and measure the effect of EE on motor
development of infants with CP. Previous systematic reviews have focused
more broadly on motor and cognitive
outcomes in preterm populations27 or
those at risk for a broader range of
developmental disorders.46,47 In these
previous studies, favorable cognitive
outcomes programs have been consistently demonstrated for a range of
early-intervention programs, but motor outcomes rarely improve. Five
studies with sufﬁcient homogeneity for
meta-analysis were found, which indicated good-quality evidence for
a very small but favorable beneﬁt from
enrichment interventions in improving
motor outcomes for infants with CP.
The studies were all RCTs (ie, high levels of evidence, of medium-high quality,
and varying levels of risk of bias). The
entire body of evidence for EE improving motor outcomes in infants with
CP was graded as moderate quality
(ie, further research is likely to have an
important impact on our conﬁdence in
the estimate of effect and may change
the estimate).48 Nevertheless, our study
makes a new and unique contribution to

FIGURE 3
Forest plot.
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the literature by highlighting ways to
improve motor outcomes at an early
age. Unfortunately, it was not possible
to draw conclusions about the contributions of the varying components of
EE because of the high levels of intervention and participant heterogeneity among the studies. The studies
varied in severity of motor impairment,
initial degree of risk for CP, the type of EE
used, the intervention duration, the involvement of parents, and the motor
assessments used. The meta-analysis
appears, however, to indicate that enrichment is beneﬁcial, despite differences in child attributes and “favorable”
parent characteristics, as conceivably
any differences would have been distributed evenly across EE and non-EE
groups owing to randomization.
The 2 studies that commenced with
newborns were unable to demonstrate
favorable motor outcomes for the experimental groups. Although reasons
were explored in each publication, we
also concluded that these studies were
inadvertently underpowered because
only a small proportion of participants
ultimately ended up with a CP diagnosis.
In other words, because most of the
participants in both groups were
healthy or mildly affected, intervention
would be unlikely to affect their results.
Infants who have normal or milder
motor impairments will unmistakably
score better on norm-referenced tools,
such as the Bayley PDI, than will infants
with CP. Potentially grouping motorimpaired infants with those whose delay is simply related to prematurity
does not allow identiﬁcation of aspects
of the interventions that may have been
effective for the different diagnoses. In
addition, it has been suggested in
earlier reviews that norm-referenced
tools, such as the Bayley PDI, may not
be sensitive enough to measure
change in infants with CP.46 The 3 infant
studies used different inclusion criteria for deﬁning risk of CP, which is likely
PEDIATRICS Volume 132, Number 3, September 2013

to further explain the nil ﬁndings. For
example, Badr et al36 curiously excluded a subgroup of infants with the
highest risk for CP (eg, Grade IV intraventricular hemorrhage with PVL),
but the remaining study group still had
some risk factors for CP.
Not surprisingly, only a small percentage of infants were then diagnosed with
CP at follow-up. Nelson et al37 reported
a ﬁnal CP diagnostic rate of 44% to 67%,
dissolving the study power. None of the
studies included infants younger than
12 months who had not been sick in the
neonatal period. This is an interesting
ﬁnding, and supports the authors’ experience that almost half of infants at
risk for CP are not being referred for
therapy services until closer to their
ﬁrst birthday.28 Another identiﬁed limitation in 2 of the infant studies (Nelson
et al,37 Ohgi et al38), was that the
authors ceased intervention before, or
at 6 months of age, before the average
age at which CP is commonly diagnosed. It is therefore unclear whether
ongoing intervention of different types
(ie, EE versus no EE) would have
changed the results, as the complexity
of motor demands increases over time
and children with CP tend to fall farther
and farther behind.
Several studies had to be excluded from
this review, because they did not meet
the inclusion criteria of a sample at high
risk of CP; most notably, an RCT that
compared the parent coaching intervention “Coping with and Caring for
Infants with Special Needs” (COPCA),
with standard care. In the COPCA study,
there were no differences between the
groups with respect to motor outcomes, which should have perhaps
been expected given that ,25% of
participants were eventually diagnosed with CP. Thus, for the most part,
authors were comparing healthy
infants with healthy infants. Post hoc
analysis of infants with CP revealed
a positive correlation between PEDI

scores and elements of the COPCA approach.49,50
In the subsequent years since many of
these clinical trials have been conducted, the ﬁeld has learned a great
deal more about how to precisely
identify infants who are most at risk for
CP. It is now possible to identify those
infants at risk for CP with a high degree
of accuracy using the General Movements Assessment plus imaging.51,52
Abnormal general movements (“absent ﬁdgety”) at 3 months corrected
age predicts CP with a sensitivity of
$92% (speciﬁcity $82%).53 In light of
our study ﬁndings, using best practice
tools to identify those infants at risk for
CP and to tease them apart from those
at risk for general delay is very important, as EE interventions can be
speciﬁcally targeted at motor development if this is expected to be
impaired. Also, earlier intervention instituted at a time of greater brain
growth and plasticity is likely to be
associated with a stronger beneﬁcial
effect.
Of the 4 studies that included infants
with a conﬁrmed CP diagnosis, the severity of the motor impairment varied,
which is known to be a covariate for
explaining study ﬁndings.54 Only 1 study
(Law et al39) included children from all
Gross Motor Function Classiﬁcation
System (GMFCS) levels. The Taub et al41
and Wallen et al42 studies included only
children with hemiplegia (usually
GMFCS I–II) and Palmer et al40 applied
their enrichment intervention to a subgroup of children with diplegic CP. Although the Palmer et al40 study
predates the invention of GMFCS, it is
clear from the description of the participants that almost all infants had
motor skills that fall into GMFCS I to III
categories (ie, were certain to be ambulatory). Broadly speaking, the interventions described in these 4 studies
all involved motor task practice customized to the child, delivered by
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a professional (therapist or teacher)
and reinforced by tailored home practice. Interestingly, these 4 of the 7
studies were the studies that showed
a positive trend favoring EE.
The study by Law et al39 that compared 2
different EE interventions head-to-head
found both approaches were equally
effective. Law et al’s39 ﬁndings are
consistent with other studies of functional therapy or task-based training EE
approaches known to be effective in
older children.55,56 In line with the International Classiﬁcation of Functioning, Disability, and Health, functional
therapy or task-based training EE
approaches deliberately consider the
impact of the environmental context in
the design and implementation of
therapy. The difference with Law
et al’s39 context-focused study is that 2
novel approaches are compared:
“hands off and hands on.” In a typical
clinical situation it is unlikely that only
child-focused (“hands on”) or contextfocused therapy (“hands off”) would be
provided. A combination of strategies
that target both the child and the context is more likely. Our review did not
locate any studies that used these
functional motor learning, goal-driven,
and environmentally enriching approaches for infants with little or no
motor repertoire. This remains a gap
in literature, warranting further study.
Wallen et al42 and Taub et al41 used
different models of CIMT as a form of EE
(as per our deﬁnition). It is the motorlearning strategies, or shaping, that cooccur with use of a constraint that

make this approach motor-speciﬁc
enrichment. The 2 studies used quite
different approaches with variations in
intensity and the type of constraint
used. However, both experimental
groups offered a similar total amount
of intervention (mean 119 hours) but
over different durations (3 weeks or 10
weeks). Although the study by Taub
et al41 demonstrated impressive motor
outcomes for the constraint group,
a subsequent Cochrane review outlines
substantial sources of bias in this
study.45 In contrast, both groups in the
Wallen et al42 study used an EE approach in which the experimental
group constraint was the “added extra.” Motor outcomes improved in both
groups. It may be that the consistent
motor-learning/task-practice approach
is the key component of these studies.

and features of enrichment, using extensive hand searching and using
search terms indicative of the early
intervention ﬁeld. In particular, opportunities for motor task practice were
included within the deﬁnition of EE, as it
seems evident that for infants to develop motor skills, opportunities must
be provided within their learning environment. However, other deﬁnitions
of EE may single out EE from task
practice opportunities. Future studies
should therefore be careful to detail
the approaches and strategies in use,
the frequency and intensity of intervention of all groups, and account
for the effect of cointerventions. In
particular, the breakdown of the approach and the extent of parent involvement should be speciﬁed to
advance our understanding of human
EE.

Limitations of This Review
Some of the included studies in this
review did not provide adequate
descriptions of standard care interventions, resulting in the possibility that
enrichment activities were indeed part
of these comparison groups, which
would ultimately dissolve statistical
power. It is, however, our experience
that standard care for young infants is
typically a “wait-and-see” approach,
which mostly involves active monitoring of the infant over the ﬁrst 12
months. It is also possible that because
of the deﬁnition of EE used, intervention
studies that actually offered enrichment were omitted. This confounder
was minimized by clearly deﬁning EE

CONCLUSIONS
Enrichment interventions to improve
motor outcomes in infants at high risk
of CP appear promising. Therefore,
more high-quality, low-bias, largesample, longitudinal RCTs that examine the effects of motor task practice
with deliberate attention to environmental enrichment via appropriate
parent training and a variety of stimulating opportunities for learning are
urgently needed. Researchers also
need to use the best available evidence to accurately identify those at
the highest risk of CP for inclusion in
these trials to ensure adequate study
power.
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N. Sensitivity and specificity of General Movements Assessment for
diagnostic accuracy of detecting cerebral palsy early in an Australian context.
(Accepted for publication in Journal of Paediatrics & Child Health 2015)
Our literature review (Study 1) demonstrated the depth and quality of
evidence available for predicting CP in high-risk infants when the right
assessment tools are used at the right time. We established a network of trained
general movements (GMs) assessors who continue to meet biannually to
share cases and maintain inter-observer reliability. In Study 3, five sites
collaborated to assess whether our network could detect CP using the
General Movements Assessment with sensitivity and specificity rates similar
to published European standards. Using Standards for the Reporting of
Diagnostic Accuracy studies (STARD) criteria, we assessed our diagnostic
accuracy in a high-risk group that included both preterm and term infants.
Our results were similar to rates previously published, confirming we were
detecting CP accurately from this high-risk group of infants. Furthermore,
we confirmed we could accurately detect the “right” infants for early
intervention trials, which is vital to advance the evidence base in this field.
The establishment of the GMs rater network and the confirmation of
diagnostic accuracy served to “set the scene” for the recruitment of infants to
clinical trials (Studies 5 and 6).
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ABSTRACT!
!

AIM(
To!calculate!the!sensitivity!and!specificity!of!the!General!Movements!Assessment!
(GMA)!for!estimating!diagnostic!accuracy!in!detecting!cerebral!palsy!(CP)!in!an!
Australian!context!by!a!newly!established!NSW!rater!network.
!
METHODS(
A!prospective!longitudinal!cross\sectional!study!was!conducted.!The!GMA!was!
blind\rated!from!conventional!video!by!two!independent!certified!raters,!blinded!to!
medical!history.!A!third!rater!resolved!disagreements.!High\risk!population!
screening!for!CP!using!the!GMA!during!the!fidgety!period!(12\20!weeks)!was!carried!
out!in!four!neonatal!intensive!care!units!and!one!CP!service!over!a!30\month!period!
(2012\2013).!Participants(were!259!high\risk!infants.!Sensitivity!and!specificity!
values!were!calculated!with!true!positives!defined!as!a!confirmed!diagnosis!of!CP!
from!a!medical!doctor.!
!
RESULTS!!
Of!the!259!infants!assessed,!one\year!follow\up!data!was!available!for!187.!Of!
these,!n=48!had!absent!fidgety!(high!risk!for!CP),!n=138!had!normal!fidgety!(low!risk!
for!CP),!and!n=!1!had!abnormal!fidgety!(high!risk!for!a!neurological!disorder).!Of!the!
48!with!absent!fidgety!movements,!39!had!received!a!diagnosis!of!CP!by!18!months!
and!another!6!had!an!abnormal!outcome.!Of!the!n!=138!normal!fidgety!cases,!n=99!
cases!had!a!normal!outcome,!n=!38!had!an!abnormal!outcome!but!not!CP,!and!n=1!
had!CP.!For!detecting!CP,!we!had!a!sensitivity!of!98%!and!specificity!of!94%.!!
!
CONCLUSION!!
GMA!was!feasible!in!an!Australian!context!and!accurately!identified!CP!with!a!
sensitivity!and!specificity!comparable!to!European!standards!and!published!
neuroimaging!data.!!

KEY!WORDS: general!movements!assessment,!cerebral!palsy,!infants!
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Introduction!
!
Cerebral!palsy!(CP)!is!defined!as!a!group!of!disorders!of!movement!and!posture!that!
results!from!a!lesion!to!the!developing!brain(1)!and!is!the!most!common!physical!
disability!of!childhood.!Early!detection!of!CP!is!important!as!it!allows!referral!to!
early!interventions!aimed!at!maximising!motor!and!cognitive!outcomes!in!children!
and!providing!support!to!families!(2,!3).!
!
Data!from!the!Australian!Cerebral!Palsy!Register!shows!that!the!average!age!for!
diagnosis!of!CP!is!17!months!although!the!range!varies!from!a!few!weeks!to!4!years!
of!age!(I.!Novak,!unpubl!data,!2014).!About!half!of!all!children!diagnosed!with!CP!
have!identifiable!markers!that!enable!them!to!be!labelled!“at!risk”!during!the!
neonatal!period,!e.g.!prematurity!or!neonatal!encephalopathy!(2).!These!infants!are!
typically!cared!for!in!neonatal!intensive!care!units!(NICUs)!and!are!often!enrolled!in!
follow\up!programs!to!ascertain!their!long\term!outcome.!These!programs!follow!
protocols!to!monitor!infants!for!evidence!of!developmental!delay!or!disabilities,!
referring!for!early!intervention!once!signs!become!apparent.!
!
Recent!systematic!reviews!have!demonstrated!that!in!fact!CP!can!reliably!be!
detected!as!early!as!3!months!post!term!age!using!Prechtl’s!Qualitative!Assessment!
of!General!Movements!Assessment!(GMA)!and!Medical!Resonance!Imaging!(MRI)!
(4,5\6).!The!GMA!was!developed!by!Professor!Heinz!Prechtl!in!the!early!1990s!and!is!
an!assessment!of!the!spontaneous!movement!patterns![“general!movements”!
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(GMs)]!of!young!infants(7,8).!Two!periods!of!GMs!are!described;!the!“writhing!
period”!from!preterm!until!6\9!weeks!post!term!age,!and!“fidgety!period”!from!9\20!
weeks!post!term!age(9).!Normal!GMs!are!shown!to!have!a!high!correlation!with!a!
normal!outcome,!while!abnormal!GMs,!in!particular!absent!fidgety!GMs!(F\),!are!
highly!predictive!of!CP!(sensitivity!as!high!as!98%!and!specificity!91%,(6)).!Thus!the!
GMA!is!considered!the!reference!standard!for!early!detection!of!CP.!Validity!of!the!
tool!is!established(9)!and!inter\rater!reliability!of!the!GMA!has!been!repeatedly!
demonstrated(9\11).!Importantly,!a!number!of!studies!have!demonstrated!that!the!
predictive!validity!of!the!GMA!is!superior!to!neuroimaging!(6),!while!the!
combination!of!abnormal!GMA!and!white!matter!injury!evident!on!MRI!has!been!
shown!to!be!100%!predictive!of!an!outcome!of!CP!in!a!cohort!of!preterm!infants!
(13).!Studies!in!infants!with!Hypoxic!Ischaemic!Encephalopathy!(HIE)!showed!a!high!
correlation!between!abnormal!GMs!and!lesions!of!the!basal!ganglia!and!
thalamus(12).!!
!
Despite!the!compelling!psychometric!data,!implementation!of!GMA!in!clinical!
practice!outside!of!Europe!has!been!ad!hoc!and!is!a!“know\do”!evidence!to!practice!
gap.!Systematic!reviews!on!the!predictive!validity!of!the!GMA!have!proposed!that!
the!lack!of!non\European!data,!especially!outside!the!expert!group!(General!
Movements!Trust),!is!a!potential!limitation!to!the!generalizability!of!findings!and!
possible!explanation!for!the!know\do!gap(5).!Use!of!the!GMA!has!been!growing!in!
Australia!in!the!last!7\8!years.!Spittle!and!colleagues!from!Melbourne!Australia!have!
demonstrated!sensitivity!and!specificity!results!similar!to!European!rates!in!very!
preterm!children.!In!addition,!their!work!has!demonstrated!important!associations!
4

between!neuroimaging!findings!and!the!GMA!in!predicting!later!
neurodevelopmental!outcomes!(13\15).!These!important!studies!have!focused!on!
preterm!infants,!a!population!that!make!up!about!30%!of!all!CP!(2).!To!date!little!
published!data!exists!on!the!diagnostic!accuracy!of!the!GMA!for!a!more!
heterogeneous!clinical!population!of!high\risk!infants!in!an!Australian!context.!In!
2011,!a!knowledge!translation!program!to!close!the!GMA!know\do!gap!was!
implemented!in!New!South!Wales!!(NSW)!Australia.!!First,!European!trainers!were!
brought!to!Australia!to!remove!the!barrier!of!needing!overseas!rater!training.!
Second,!educational!scholarships!were!provided!to!remove!the!costs!of!obtaining!
rater!training.!Third,!a!new!rater!network!was!established!in!NSW!for!the!purpose!of!
providing!peer\to\peer!support!for!maintaining!GMA!scoring!reliability!and!
troubleshooting!any!difficulties!embedding!the!GMA!in!clinical!practice.!Network!
meetings!are!held!twice!a!year!and!trained!assessors!from!all!participating!centres!
present!cases!for!blind!scoring!to!help!maintain!inter\rater!reliability.!Between!
network!meetings,!de\identified!videos!are!shared!for!blind!scoring!purposes!to!
arbitrate!any!discrepancies.!
!
The! aim! of! this! study! was! to! calculate! the! sensitivity! and! specificity! of! the! GMA! for!
diagnostic! accuracy! of! detecting! CP! at! 3\5! months! of! age! in! high\risk! infants,! in! an!
Australian!context!when!scored!by!the!NSW!rater!network.!

Methods)
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)
Participants!
Inclusion!criteria:!(1)!All!infants!included!were!those!prospectively!enrolled!in!follow!–up!
clinics! and! screened! using! the! GMA! from! the! study! sites:! 4! NICUs! in! NSW! Australia!
(Westmead! Hospital,! the! Children’s! Hospital! at! Westmead,! John! Hunter! Children’s!
Hospital! and! Royal! Prince! Alfred! Hospital)! and! the! Cerebral! Palsy! Alliance! (CPA);! (2)! All!
infants! were! designated! high\risk! of! poor! neurodevelopmental! outcome! based! on! their!
medical!history!and!/or!neuroimaging!by!at!least!one!member!of!their!treating!team.!This!
included! infants! admitted! to! NICUs! post! surgery! or! with! neurological! risk! factors! (eg.!
severe! intraventricular! haemorrhage,! periventricular! leukomalacia,! neonatal! stroke),!
hypoxic!ischaemic!encephalopathy!(stage!II\III),!or!due!to!prematurity!(ie.!<29!weeks,!one!
unit!enrolled!<32!weeks);!or!infants!referred!to!CPA!with!motor!delay!or!neurological!signs!
suggestive! of! CP.! Recruitment! via! voluntary! participation! was! offered! to! all! infants!
meeting! the! inclusion! criteria,! unless! there! was! a! competing! concurrent! study! in! which!
case! they! were! offered! enrolment! to! both! studies,! with! researchers! respecting! the!
parent’s!choices.!Exclusion!criteria:!Nil.!!
!
Methodology!
High\risk!population!screening!for!CP!was!conducted!at!study!sites,!predominantly!in!the!
NICU!follow\up!clinic!over!a!30\month!period,!resulting!in!a!prospective!longitudinal!and!
cross\sectional! study.! The! CPA! received! referrals! from! concerned! parents! and!
professionals!in!the!community!to!screen!infants!for!signs!of!CP.!!
!
Instrument:!General!Movements!Assessment!
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Infants!were!assessed!during!the!fidgety!movement!period!at!the!developmental!follow\
up!clinic!or!in!the!family!home.!Since!GMs!in!the!fidgety!period!are!the!most!predictive!for!
a! later! diagnosis! of! CP,! our! outcome! of! interest,! we! focused! on! results! from! this! GMA!
period.!GMAs!for!259!infants!were!collected!on!conventional!video!following!the!protocol!
outlined!by!Einspieler!et.al!(9).!!
All! study! sites! used! certified! GM! assessors! to! score! the! videos! blinded! to! medical! and!
clinical!history.!Although!all!sites!had!certified!blind!raters!there!was!a!number!of!minor!
pragmatic! practice! variations! across! the! study! sites! in! relation! to! the! processes! for!
arranging! the! scoring.! Despite! uniformity! being! preferable,! in! the! clinical! setting! local!
variations! was! deemed! allowable! as! the! greater! knowledge! translation! goal! was! for! as!
many!raters!as!possible!to!be!using!the!GMA!and!all!study!sites!to!develop!feasible!and!
acceptable! local! processes! that! led! to! routine! GMA! use.! For! instance,! one! service! had! a!
number!of!raters!who!scored!independently!and!were!blinded,!another!had!two!raters!but!
only!one!blinded,!and!the!other!services!had!two!blinded!raters.!A!third!rater,!unaware!of!
medical!and!clinical!history!and!part!of!the!GM!Network,!resolved!disagreements!for!any!
case! at! any! site.! There! were! no! scoring! accuracy! differences! between! the! study! sites,!
despite!the!differing!processes.!!
!
Neurodevelopmental!Outcome!
Infants!were!followed!to!12!\24!months!post\term!age.!True!positives!were!defined!as!a!
confirmed! diagnosis! of! CP! from! a! medical! doctor.! The! diagnosis! was! typically! given! at! a!
follow! up! time! point! by! a! developmental! paediatrician! or! neonatologist! based! on!
neurological! examination,! clinical! history,! and! developmental! motor! assessment.! For!
infants!not!diagnosed!with!CP!an!abnormal!outcome!was!defined!as!having!scores!on!one!
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or!more!domains!of!the!BSID\III!(14)!greater!than!1!standard!deviation!below!the!mean!at!
follow\up.! If! the! only! delay! on! the! BSID\III! was! in! the! domain! of! language,! the! outcome!
was! not! coded! as! abnormal,! given! these! children! can! go! on! to! have! a! normal! outcome!
despite!delayed!speech!and!language!(16).!
Ethics!
Ethics!approval!was!obtained!from!all!study!sites,!with!The!Royal!Prince!Alfred!
Hospital!Human!Research!Ethics!Committee!as!the!lead!committee!and!site!specific!
approval!from!all!other!participating!institutions.!Parental!consent!was!previously!
obtained!from!families!at!the!point!of!GMA.!The!accompanying!history!data!was!
abstracted!from!medical!records.!
Statistical!Analysis!
This!was!a!prospective!study;!with!data!analysis!planned!a!priori!to!data!collection.!
Study!design!and!data!analysis!were!reported!in!accordance!with!the!STARD!
checklist!for!reporting!of!studies!of!diagnostic!accuracy.!Neurodevelopmental!
outcome!data!was!compared!with!GMA!results!from!the!fidgety!period.!Statistical!
analysis!was!completed!using!SPSS!using!conventional!sensitivity!and!specificity!
calculation!methods.!Confidence!intervals!were!calculated!for!sensitivity!and!
specificity!for!predicting!an!outcome!of!CP!and!for!any!abnormal!outcome.!!
Results))
Participants!
Data!were!collected!on!all!infants!recruited!and!screened!between!2011\2013,!although!
some! study! sites! did! not! collect! data! for! the! full! study! period! while! awaiting! Ethics!
Clearance.!Infants!were!all!between!10\20!weeks!post!term!age!at!the!time!of!their!GMA!
fidgety!assessment!and!within!2!weeks!of!their!first!or!second!birthday!at!their!one!or!two!
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year! aged! follow! up.! The! most! common! reason! for! a! GMA! was! prematurity! followed! by!
neonatal!encephalopathy.!
Complete! one\year! follow\up! data! were! available! for! 187! infants.! Partial! data! were!
available! for! another! 72! infants! who! had! not! yet! reached! 12\24! months! or! were! lost! to!
follow! up! (n=62)! and! for! n=10! whose! GMA! was! not! able! to! be! scored.! Reasons! for!
conducting!GMA!are!presented!in!Figure!1.!
Figure!1:!Reasons!for!conducting!General!Movements!Assessment!(%)!

!
!
!
!
Quality!of!GMs!
Data!were!analysed!when!both!the!fidgety!GMA!and!12\month!outcomes!were!available,!
all! other! cases! were! treated! as! missing! and! excluded! from! the! analysis.! Of! the! 187!
complete!cases,!n=138!were!scored!as!normal!fidgety!(F+)!i.e.!low\risk!for!CP,!n=48!were!
scored! as! absent! fidgety! (F\)! i.e.! high\risk! of! CP,! and! n=1! were! scored! abnormal! fidgety!
(AF)!i.e.!high\risk!for!a!neurological!disorder.!No!adverse!events!were!reported!as!a!result!
of!testing.!
!

9

!
Neurological(Outcome(
At! one\year! follow\up,! of! the! n=187! cases:! 102! children! had! a! normal! outcome! and! 40!
children!had!a!diagnosis!of!CP.!A!further!45!children!had!an!abnormal!outcome!(not!CP)!
(Table!1).!
Table!1:!GMA!Fidgety!Results!and!12!Month!Outcome!Results!

GMA)result)
Type!of!Fidgety!

12)month)outcome)
Normal!

CP!

Abnormal!

Normal)

n=138!

!n=99!

n=1!

n=38!

)[F+])

(74%)!

(72%)!

(<1%)!

(28%)!

n=1!!

n=0!!

n=0!!

n=1!!

[AF])

(<1%)!

(0%)!

(0%)!

(100%)!

Absent))

n=48!

n=3!!

n=39!!

n=6!!

[FP])

(26%)!

(6%)!

(81%)!

(13%)!

Abnormal)

!!!!!!!!!!!!!!!!NB:!Shading!indicates!the!predicted!outcome!from!GMA!

!
First,!in!the!n=138!with!F+!movements!there!were!n=99!with!a!normal!outcome,!n=1!later!
diagnosed!with!CP,!and!n=38!with!a!neurodevelopmental!delay!other!than!CP.!Abnormal!
neurodevelopmental! outcomes! that! were! not! CP! included;! n=1! with! Prader\Willi!
syndrome,! n=2! with! hearing! impairments! and! n=35! with! global! developmental! delay,!
including!n=1!suspected!autism.!The!infants!with!global!developmental!delay!ranged!from!
mild!motor!and/or!cognitive!delay!at!12!months!to!significant!delays!in!both!the!cognitive!
and!motor!domains,!as!scored!on!the!BSID\III.!
!
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Second,! in! the! n=48! with! F\! movements,! n=39! infants! were! diagnosed! with! CP! by! 12\18!
months.!Of!the!n=9!with!F\!and!not!diagnosed!with!CP!all!had!a!suspected!or!confirmed!
diagnosis! of! an! abnormal! outcome,! including:! n=1! had! a! genetic! disorder;! n=1! had! a!
mitochondrial! disorder;! n=1! was! recovering! from! meningitis;! n=3! had! moderate\severe!
global! developmental! delay;! and! n=3! had! suspected! CP! at! 12! months,! but! had! not! yet!
been!formally!diagnosed!but!were!undergoing!monitoring!for!a!diagnosis!of!CP!(coded!as!
normal!outcomes!however!at!12!months).!!
!
Third,! the! n=1! with! AF! movements! had! a! motor! delay! at! 12! months! >! 1! SD! below! the!
mean.!
!
Sensitivity(and(specificity(((
Sensitivity!and!specificity!scores!were!calculated!for!predicting!CP!and!for!predicting!
an! abnormal! outcome.! Sensitivity! for! detecting! CP! was! 98%! (95%CI:! 86.79\99.58)!
and! specificity! 94%! (95%CI:! 88.69\97.16).! Sensitivity! for! detecting! any! abnormal!
outcome!with!abnormal!or!absent!fidgety!GMs!was!54%!(95%CI:!42.66\64.98)!and!
specificity!97%!(95%CI:!91.63\99.36).!
!
The!mean!age!of!CP!diagnosis!for!children!identified!at!high!risk!of!CP!by!the!NSW!GMA!
rater!network!was!8.5!months!(SD=4!months).!All!infants!identified!as!high!risk!of!CP!by!F\!
GMs!at!3\4!months!were!referred!to!early!intervention!services.!The!child!later!diagnosed!
with!CP!but!with!normal!fidgety!movements!was!also!referred!for!early!intervention!due!
to!concerns!about!motor!development!that!were!identified!at!follow\up!from!tests!other!
than!the!GMA.!
11

Discussion)
The! GMA! has! consistently! been! shown! to! be! a! sensitive! method! for! early! detection! of!
adverse!neurodevelopmental!outcomes!especially!CP.!Although!clinical!use!has!generally!
been! lacking! outside! the! European! context,! this! study! confirmed! that! the! GMA! had!
excellent!sensitivity!and!specificity!to!predict!infants!who!would!later!be!diagnosed!with!
CP! as! well! as! those! with! normal! outcomes.! Our! results! are! comparable! to! previous!
Australian! and! European! studies! demonstrating! that! the! reliability! of! the! GMA! can! be!
replicated!in!different!parts!of!the!world.!!
In!the!clinical!setting,!making!a!diagnosis!of!CP!utilises!a!combination!of!robust,!evidence\
based!tools!including!neuroimaging,!neurological!and!standardised!motor!testing!(2).!The!
GMA!is!a!highly!predictive,!non\invasive!assessment!that!would!be!a!valuable!tool!to!add!
to!the!diagnostic!work\up.!Results!of!this!study!suggest!that!one!benefit!of!early!detection!
using!GMA!was!that!diagnosis!occurred!earlier,!on!average!at!8.5\months!compared!to!the!
Australian!CP!Register!convention!of!17\months.!Previous!Australian!studies!of!preterm!
infants!have!followed!infants!until!four!years!and!demonstrated!the!value!of!the!GMA!in!
predicting!adverse!neurodevelopmental!outcomes!(15).!The!current!study!builds!on!this!
work!with!a!broader!group!of!high\risk!infants,!indicating!very!early!identification!of!
infants!at!the!highest!risk!of!motor!impairment!is!possible!and!clinicians!can!be!confident!
in!referring!those!most!in!need!of!early!intervention!in!the!first!few!months!of!life.!!Clinical!
application!of!the!GMA!is!useful!to!build!a!clinical!profile!of!high\risk!infants!over!time.!It!
allows!early!entry!of!infants!into!targeted!treatment!programmes!and!enrolment!into!
intervention!studies!during!the!period!of!greatest!neuroplastic!change.!!
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All!study!infants!designated!“high!risk!of!CP”!on!the!basis!of!F\!GMs!were!referred!for!early!
intervention.! Unless! there! were! very! clear! markers! such! as! severe! MRI! findings,! a!
definitive! diagnosis! was! not! given! at! this! time,! due! to! diagnostician\preferred! practices!
(2).! Importantly,! our! high! sensitivity! rates! confirm! that! parents! were! not! “worried!
unnecessarily”,!given!that!almost!all!the!infants!with!F\!movements!were!found!to!have!an!
abnormal!outcome.!
The!high!rate!of!abnormal!outcomes!found!in!this!study!is!consistent!with!previous!studies!
reporting!outcomes!in!this!high\risk!population!(18\20).!We!defined!“abnormal”!as!a!delay!
in!at!least!one!developmental!domain!of!the!BSID\III,!which!is!the!commonly!used!criteria!
in!some!follow\up!services,!although!some!services!prefer!to!define!an!abnormal!outcome!
as!one!where!at!least!2!domains!of!the!BSID!are!>!1!SD!below!the!mean.!In!our!analysis,!
only! delays! in! language! alone! were! not! counted! as! abnormal! due! to! the! high! level! of!
variability! in! the! emergence! of! these! skills! and! high! prevalence! of! early! language! delays!
that! resolve! (17).! Not! surprisingly,! the! GMA! did! not! detect! infants! with! developmental!
delay,! highlighting! the! importance! of! using! complementary! assessments! when! following!
high\risk! infants.! Detecting! a! probable! CP! outcome! versus! one! of! mild! developmental!
delay!is!important!as!it!allows!referral!for!diagnosis\specific!intervention!(21).!
The! GMA! has! now! been! embedded! in! clinical! practice! across! NICU! follow\up! services! in!
NSW,! Australia.! Use! of! the! GM! Rater! Network! has! provided! support! for! use! of! this! tool!
and!for!the!accuracy!of!results.!To!accommodate!timing!of!peak!fidgety!period,!a!number!
of! services! have! brought! forward! their! initial! follow\up! clinic! visit! to! 3! months! of! age!
rather! than! the! conventional! 4! months! of! age,! in! order! to! capture! the! GMs! of! at\risk!
infants!during!the!ideal!fidgety!period.!
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It! is! recommended! that! the! following! high\risk! groups! of! infants! be! screened! using! the!
GMA;! preterm! (including! late! preterm),! all! with! neonatal! encephalopathy,! cardiac! and!
surgical! infants,! those! with! stroke! and! neurological! signs! such! as! seizures,! growth!
restriction!and!those!with!birth!defects!(22).!
!
Limitations)
There! are! several! limitations! related! to! our! study.! First,! as! has! been! noted! in! previous!
publications! sampling! is! a! potential! source! of! bias! (23).! All! infants! in! this! study! were!
already! considered! at! high! risk! of! adverse! neurodevelopmental! outcome.! Within! our!
group!the!level!of!risk!for!CP!specifically!was!variable.!For!example,!the!sample!included!
term!infants!with!HIE!(very!high!risk!for!CP)!and!those!with!congenital!heart!defects,!very!
preterm! and! late! preterm! infants.! In! addition,! cases! were! recruited! for! the! most! part!
sequentially;!however!some!cases!were!excluded!as!they!were!recruited!to!other!studies,!
and!some!study!sites!did!not!collect!data!for!the!full!study!period!owing!to!the!differing!
timelines!for!study!approval!from!Ethics.!
Second,!outcome!data!was!mostly!only!at!12!months!and!it!is!known!that!milder!forms!of!
CP!may!only!be!diagnosed!later!in!childhood!when!the!diagnostician!is!sure!that!the!motor!
impairment! is! permanent.! Indeed! n=3! infants! were! suspected! to! have! a! mild! CP! due! to!
tone! abnormalities! but! had! not! yet! been! formally! diagnosed! but! were! being! closely!
monitored!by!allied!health!practitioners!who!suspected!they!had!CP.!Potentially!the!rate!
of! CP! therefore! has! been! under! identified! in! this! sample,! and! that! the! sensitivity! of! the!
GMA!might!have!been!even!higher.!Future!studies!should!report!2\year!outcomes!in!this!
high\risk! cohort,! as! has! been! done! previously! in! very! preterm! groups! (15).! Third,!
additional!analysis!of!sensitivity!and!specificity!of!GMs!in!the!earlier!writhing!period!might!
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lead!to!the!development!of!effective!very!early!interventions!that!could!be!applied!in!the!
NICU!within!first!2\3!months!of!life!closest!to!the!timing!of!the!brain!injury.!Fourth,!sex!of!
participants!was!deliberately!not!recorded!so!as!to!protect!the!anonymity!of!children!with!
an! absent! fidgety! score! from! small! study! sites,! where! the! n\value! was! below! the!
conventional!n=4!cut\off!for!anonymity.!The!accuracy!of!GMs!is!not!however!known!to!be!
affected!by!gender!and!therefore!this!is!unlikely!to!have!influenced!the!results.!Finally,!as!
previously! outlined,! the! practice! variation! between! sites! in! terms! of! number! of! blinded!
GMs!scorers!is!a!further!limitation!of!the!study.!
Conclusion)
The!GMA!is!an!accurate,!important!and!feasible!assessment!tool.!It!is!non\invasive!
and!therefore!should!be!used!regularly!in!the!NICU!environment!and!in!follow\up!
programmes!for!early!identification!of!infants!at!the!highest!risk!of!CP.!It!is!clinically!
feasible!to!use!and!has!excellent!predictive!validity!when!used!by!certified!
Australian!assessors.!Early!detection!of!CP!is!possible!and!implementation!of!
screening!high\risk!infants!will!allow!those!identified!timely!access!to!intervention!
services!that!aim!to!optimise!their!developmental!outcomes.!In!conclusion,!we!
recommend!that!the!GMA!be!widely!adopted!into!clinical!practice,!to!close!the!
know\do!gap!about!late!diagnosis!of!CP,!which!is!potentially!harmful!to!infants.!
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Chapter 5| Study 4 GAME (Goals-Activity-Motor Enrichment)
PROTOCOL
PUBLICATION
Morgan C, Novak I, Dale RC , Guzzetta A, Badawi N. GAME (Goals Activity - Motor Enrichment): protocol of a single blind randomised
controlled trial of motor training, parent education and environmental
enrichment for infants at high risk of cerebral palsy. BMC Neurology. 2014;
14:(203).
Our systematic review (Study 2) revealed firstly the paucity of early
intervention trials that accurately identified infants with CP in the first year
of life, and secondly, that those interventions that were effective in this
population were based on motor learning principles including enrichment of
the learning environment.
We developed a novel early intervention programme we labelled GAME
(Goals – Activity - Motor Enrichment) that focused on intensive motor
training, co-delivered by therapists and parents in an enriched home
environment.
This methods paper describes the GAME protocol for the randomised trials
that followed (Studies 5 and 6).
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STUDY PROTOCOL
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GAME (Goals - Activity - Motor Enrichment):
protocol of a single blind randomised controlled
trial of motor training, parent education and
environmental enrichment for infants at high
risk of cerebral palsy
Catherine Morgan1,2*, Iona Novak1,2, Russell C Dale3, Andrea Guzzetta4 and Nadia Badawi5
Abstract
Background: Cerebral palsy is the most common physical disability of childhood and early detection is possible
using evidence based assessments. Systematic reviews indicate early intervention trials rarely demonstrate efficacy
for improving motor outcomes but environmental enrichment interventions appear promising. This study is built
on a previous pilot study and has been designed to assess the effectiveness of a goal - oriented motor training and
enrichment intervention programme, “GAME”, on the motor outcomes of infants at very high risk of cerebral palsy
(CP) compared with standard community based care.
Methods/design: A two group, single blind randomised controlled trial (n = 30) will be conducted. Eligible infants
are those diagnosed with CP or designated “at high risk of CP” on the basis of the General Movements Assessment and/
or abnormal neuroimaging. A physiotherapist and occupational therapist will deliver home-based GAME intervention at
least fortnightly until the infant’s first birthday. The intervention aims to optimize motor function and engage parents in
developmental activities aimed at enriching the home learning environment. Primary endpoint measures will be taken
16 weeks after intervention commences with the secondary endpoint at 12 months and 24 months corrected age. The
primary outcome measure will be the Peabody Developmental Motor Scale second edition. Secondary outcomes
measures include the Gross Motor Function Measure, Bayley Scales of Infant and Toddler Development, Affordances in
the Home Environment for Motor Development – Infant Scale, and the Canadian Occupational Performance Measure.
Parent well-being will be monitored using the Depression Anxiety and Stress Scale.
Discussion: This paper presents the background, design and intervention protocol of a randomised trial of a goal driven,
motor learning approach with customised environmental interventions and parental education for young infants at high
risk of cerebral palsy.
Trial registration: This trial is registered on the Australian New Zealand Clinical Trial register: ACTRN12611000572965.
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Background
Cerebral palsy (CP) is the most common physical disability of childhood with a prevalence of 2.1/1000 live births
[1]. Late diagnosis, conservative “wait and see” monitoring
and late referral to early intervention is the prevailing
norm for two main reasons. First, because only half of infants with CP have clearly identifiable risks in the newborn
period, for example prematurity or neonatal encephalopathy (NE) [2], and second, because not all infants with prematurity or NE will go on to have CP. Wait and see
monitoring can mean brain injured infants do not always
receive intervention in the most crucial period of brain development [2]. Furthermore children with CP reach approximately 90% of their gross motor potential by age 5
(or younger for more severely impaired), but for 40% of
this critical window the ultimate severity of their condition
is largely unknown [3], however severity itself is a likely
predictor of responsivity to early intervention. The field
of neuroscience has repeatedly demonstrated the plasticity of the infant brain and persistence of neurogenesis and
activity- dependent plasticity are two of the basic mechanisms at work [4]. Intervention for infants with brain injuries aims to optimise these neuroplastic mechanisms.
In recent years, research into the predictive validity of
Prechtl’s Qualitative Assessment of General Movements
(GMs) has allowed earlier diagnosis of high risk of CP to
be reliably made at 3 months of age [5,6]. GMs is now
the gold standard tool for early diagnosis of CP because of
higher specificity and sensitivity than other traditional
tests such as neurological examinations, cranial ultrasound
and MRI [7]. For the preterm population, the combination
of GMs and evidence of white matter injury on MRI predicts CP at 3 months with 100% accuracy [6].
Early intervention and early enrichment

Early intervention (EI) studies have typically not used this
combination of assessment tools to recruit homogenous
samples of infants at high risk of CP. Rather heterogeneous infants are included in EI studies and labelled “high
risk” because they were preterm, display delayed development or had complex social issues [8]. In many of these
studies the proportion of children who actually go on to
be diagnosed with CP are relatively small resulting in
underpowered type II trials for CP. As a result it is virtually impossible to ascertain the effects of EI on the motor
outcomes of infants with CP. Most systematic reviews
conclude that EI approaches currently in use for CP do
not have any effect on motor outcomes greater than what
would be expected as a result of maturation [9,10]. It is
important to note, however, that evidence for the effectiveness of general EI to improve cognition is well established
for the more heterogeneous “high risk” groups [11].
It remains to be determined whether intervention approaches that are goal-oriented and involve active motor
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training [12,13] currently used in older children with CP
are actually applicable to infants with a small emergent
motor repertoire. In addition, what “active ingredients”
from EI approaches are vital to maximise developmental
outcomes?
Environmental enrichment (EE) has been proven to
enhance neuroplasticity and promote memory and
motor function in animal studies [14] but the effect in
humans is less understood. In animal studies, an EE is
defined as one that facilitates enhanced cognitive, motor
and sensory stimulation. Although there is no agreed parameters for enrichment, these animal housing conditions typically include high levels of complexity and
variability with arrangement of toys, platforms and tunnels being changed every few days to promote motor
learning and memory. The motor opportunities afforded
by EE are a critical success factor.
Translating these ideas into the human context is
complex. Much more is known about the detrimental
impact of deprivation (under-enrichment) on child development than is known about what constitutes enrichment for infants raised in “expected environments” [15].
Thus a continuum of enrichment is implied, but has not
been well explained in terms of the type or amount of
enrichment required for children who are not typically
developing. One recent systematic review [8] has demonstrated a small positive effect on motor outcomes for
infants at high risk of CP when the utilised interventions
are based on principles of environmental enrichment.
The enhanced plasticity mechanisms present in the infant brain allow it to be more strongly influenced by the
environment than adult brains, so furthering our understanding of what constitutes enrichment for brain injured babies is important [16,17].
In children with CP the key environmental factors which
influence motor development are yet to be determined,
however clinical and neuroscience do provide a clear rationale for the urgent need for the development of EI programmes that focus on EE strategies to improve motor
outcomes in these children [18]. Ulrich’s [19] recent review discusses the opportunities for the development of
early intervention programs which link neuroscience with
clinical science and states in her summary, “A growing
body of basic and clinical science results suggest we are
missing the boat on opportunities for infants with motor
disabilities if we do not develop more empirically based
protocols to use very early in life in order to optimize
developmental outcomes” [19], p10.
We have developed such a protocol, “GAME”, based
upon the principles of motor learning and widely accepted EI frameworks including family centred practice
[20] and the ecological framework [21]. Data from our
recent pilot randomised controlled trial RCT (n = 13) indicates that GAME, a goal-oriented, intensive motor
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training programme that actively involves parents and
includes EE strategies, could be effective in advancing
the motor trajectories of infants at high risk of CP [22].
After 12 weeks, GAME intervention infants (n = 6) had
an 8.05 point advantage on the Total Motor Quotient of
the Peabody Developmental Motor Scales – second edition
compared to infants who received standard care therapy
(n = 7). Although small, the pilot study confirmed feasibility
of recruitment and randomisation procedures, and enabled
confirmation of outcome measures and the sample size required for a larger RCT of GAME intervention. This proposed study will address this gap in the literature.
Objective

The aim of this study is to evaluate whether a goal oriented, intensive motor training programme with EE
strategies (GAME) is more effective than current standard care practices in influencing the early motor development of infants at high risk of CP.

Methods
A single blind RCT with 2 parallel groups will be conducted to evaluate the efficacy of GAME compared to
standard care. The outcomes of this trial are the infant’s
motor function after 16 weeks of intervention and at 12
and 24 months corrected age, home enrichment, parent
perception of and satisfaction with their child’s performance and parental well - being.
We hypothesise that:
1. Infants diagnosed with CP or at risk of CP that
receive GAME intervention will have higher short
term (after 16 weeks of intervention) Peabody
Developmental Motor Scale (PDMS II) scores than
infants that receive standard care
2. Infants diagnosed with CP or at risk of CP that
receive GAME intervention will have higher long
term (at 1 year of age) scores on the PDMS II scores
than infants that receive standard care.
3. Infants diagnosed with CP or at risk of CP that
receive GAME intervention will have higher Gross
Motor Function Measure (GMFM) scores than
infants that receive standard care at 1 year of age.
4. Infants who have received GAME intervention will
have sustained higher PDMS –II scores long term
(at 24 months) compared with infants who have
received standard care.
Study sample and recruitment

Thirty infants will be recruited from their treating institution, community physician or local therapist. The infants will be recruited in and around Sydney, NSW
Australia. Seven NICUs and the Cerebral Palsy Alliance
will actively recruiting to this study although infants
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may be referred from any source. Study sites are listed
in the Appendix.
All parents of eligible infants will be informed about the
study only after they have had discussions with their medical team regarding the high risk status of their child, or a
confirmed diagnosis of CP. Families will be given a site
specific information sheet regarding the purpose and design of the study and have opportunity to speak with investigators before consenting to the study. Parents who do
not wish to consent to the study will be offered standard
community based therapy.
After consent is obtained, prior to randomisation, the
investigators will visit the family at home to complete all
baseline assessments and collect demographic and perinatal data. MRI and medical data will be obtained from
the infant’s medical record.
The Human Research and Ethics Committees of the
Sydney Children’s Hospital Network (SCHN), Cerebral
Palsy Alliance (CPA) and the University of Notre Dame
Australia (UNDA) have approved this study. The experimental design including time points and outcome measures
are depicted in the CONSORT [23] flowchart (Figure 1).
Inclusion criteria

Infants aged between 3 and 6 months (corrected age) with a
diagnosis of CP or at high risk of CP are eligible for the
study. Infants referred between 9–18 weeks post term age
(PTA) will be screened using the General Movements Assessment (GMs). At least 2 certified assessors blinded to the
infant’s history will score the GMs videos. Infants with abnormal general movements (absent fidgety) are eligible for
enrolment, ie 95% high risk of CP. Where assessors disagree,
a third blinded assessor will be required to assess the video.
Infants over 18 weeks corrected age up to 6 months of
age, outside the window of reliable GMs assessment,
will be included on the basis of a confirmed CP diagnosis and/or abnormal neuroimaging as described by
Krageloh-Mann [24].
Imaging commonly associated with CP include:
1.
2.
3.
4.
5.

Periventricular Leucomalacia (PVL) and cystic PVL
Intracranial Haemorrhage
Periventricular infarction
Lesions of the basal ganglia and thalamus
Unilateral parenchymal injury eg middle cerebral
artery infarction
6. Cortical malformation
A pediatric neurologist blinded to group allocation will
confirm MRI features.
Exclusion criteria

Infants otherwise eligible but with severe genetic abnormalities, or not discharged from hospital, or residing in
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Figure 1 Consort flow chart.

remote areas not accessible to the research team will not
be eligible for the study.
Sample size

The planned study sample size (n = 30; 15 per group) has
been estimated from a power calculation based on our
pilot data using motor composite scores of the PDMS-2,
with an alpha value of 5% and power of 80%, using a minimal clinically important difference of 10%, accounting for
a 20% dropout rate.

Randomization process

After informed consent and baseline measures are taken,
an officer not connected with the study will randomise
participants at a separate location using a pre-prepared
random assignment schedule stored within 30 concealed
opaque envelopes generated using computer generated
random numbers. The Primary Investigator will be informed by the independent randomisation officer of group
allocation and will inform parents. Twins will be randomised together due to the nature of the intervention.
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Blinding arrangements

The independent assessors will be blinded to group allocation and will carry out all assessments after randomisation. Assessments of the child’s movement for the
primary outcome measure and GMFM-66, will be completed via scoring from video. Other secondary outcome
measure assessments will be conducted over the phone, via
home visit or parent self report, as per the test and clinical
conventions. Research Assistants from the Cerebral Palsy
Alliance Research Institute and trained physiotherapists
and/or occupational therapists will score the measures as
the blind assessors.
It is not possible for either the participating families or
those conducting the intervention to be blinded in this
trial due to the nature of the intervention.
Intervention
Therapists

Investigators CM, an experienced physiotherapist and IN,
an experienced occupational therapist are the primary
therapists providing the GAME intervention to maximise
fidelity of the intervention. If a speech pathologist or family support worker is required based on identified family
goals this will be provided. Infants in the standard care
group will receive services from local therapists according
to the centre’s protocol. Typically in Sydney this would include physiotherapists and/or occupational therapists.
Some sites offer a multidisciplinary team approach while
others a keyworker model with a primary therapist.
Interventions

GAME is a therapy intervention based on contemporary motor theory. This intervention approach has been
previously described in a small pilot RCT that tested
the feasibility of GAME [22]. GAME intervention consists of three components: goal-oriented intensive
motor training, parent education, and strategies to enrich the child’s motor learning environment. Although
described as distinct aspects of GAME, these components are fully integrated into therapy sessions with
the emphasis on any particular component varying
from session to session.
Game part 1

Goal-oriented intensive motor training Families collaborate with the therapists to determine a set of goals
for their child’s development [25]. Typically the goals
would relate to motor development but might also
include health related concerns known to affect development such as sleeping and feeding. The therapist plays
an important role in helping parents set realistic and
appropriately time framed goals. As goals are attained
the family and therapist work together to develop new
goals. These parent identified goal areas are targeted for
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practice during therapy sessions and built into a home
programme (HP).
The motor learning component of the intervention is
based on the principles of motor learning and dynamic
systems theory [26,27]. Therapist assessment of the relative
contributions of weakness, selective motor control and altered tone to difficulties in goal achievement are discussed
with the family and solutions are identified and tried [28].
Parents are encouraged to use their knowledge of their
child’s play preferences to elicit self-generated motor activity. Minimal manual guidance is provided when required
and withdrawn as soon as the child has the idea of the
movement or begins to demonstrate the ability to recruit a
successful muscle action or sequence. Parents are coached
in understanding “missing components” of the desired action and problem solve with the therapists ways of simplifying the task to enable at least part task attainment.
Motor tasks are scaffolded, so that the infant can always actively complete at least a part of the task [29]. As
performance improves, the motor challenge is increased
by altering the task or environment to encourage problem solving. Manual assistance is reduced or withdrawn
as soon as the infant demonstrates self-initiated progress
with the task; ensuring self-generated motor activity is
promoted in all practice sessions. Once a motor skill is
learned, variability of practice is introduced to increase
the complexity and generalizability of the skill [30]. Early
weightbearing and sit to stand from the parents’ lap are
routinely included for each infant even if standing is not
identified as a specific goal. Rehabilitation research in
older children and adults with brain injuries suggest that
functional weight bearing exercises can both improve
motor control and provide strength training [26]. Given
that the expected impairments of CP include weakness
and reduced selective motor control, early activation of
muscles of the lower limb using both concentric and eccentric exercise could enhance the development of upright
mobility. Similarly, practice of reaching and grasping a variety of objects is also a standard part of motor training for
all infants in order to expose the infants who are expected
to be delayed, to a variety of objects to advance grasp and
reach behaviours [31]. Modified constraint induced movement therapy and/or bimanual training is used when
asymmetrical hand function is evident.
Practice schedules are discussed and designed based on
family time constraints. A written HP, illustrated with photographs and related to parent identified goals, weightbearing and reach and grasp is provided. The HP describes
parenting strategies, environmental enrichments and childactivities as per published guidelines on effective home programmes [32]. Activities in the HP are organised into those
in which the carer plays an active role and those where
practice can be “set up” for the infant to carry-out independently. The HP is updated as goals are attained.
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Game part 2

Parent education Parent education is known to be an important component of early intervention that is grounded
in family centred practice [33]. Since most of the infant’s active practice opportunities are provided in the child’ daily
routines, parent education is vital [34]. In GAME intervention, parents are coached to identify their child’s voluntary
attempts to move and self-regulate, plus understand the
usual trajectory of emergent motor skills and how to stimulate progress. Parents are trained in simple motor task analysis and coached in appropriate strategies to enhance their
child’s development both at a specific goal level and in general early learning and development principles. Parents are
taught to optimise the best use of their infants’ “awake”
time and the naturally occurring opportunities for learning.
Learning optimisation includes both parent-directed and
structured practice of desired motor tasks, where the parent
role is integral to the child’s learning (e.g. creating repetitions) and constructing opportunities for independent play
(e.g. playing alone with motor enriching toys set up for the
child). Parents are encouraged to both observe the therapist
eliciting a motor behaviour from the baby and to attempt it
themselves. Specific feedback, in a warm and supportive
context, is given to parents to enable them to tease out why
some attempts were successful for the baby and others weren’t. As new motor skills emerge parents are coached in
strategies to increase the challenge of the task; for example
removal of support or the introduction of more complex
toys. The importance of allowing trial and error during
practice is discussed and parents are encouraged to devise
their own activities to enhance goal attainment. Prognostic
information is given when possible as well as evidence
based information regarding sleeping, feeding and responsive parenting.
Game part 3

Environmental enrichment It is clear that many aspects of a child’s environment influence his or her motor,
cognitive and social-emotional outcomes. Parental responsivity, a variety of daily experiences, equipment use and
the structure of the physical space are all known to influence child development [35-37]. In GAME, all visits are
conducted within the family’s home and deliberate attention is paid to aspects of the home environment to enhance developmental outcomes. This enrichment includes
assistance in setting up motor enriched play environments
to promote child self-generated movements, exploration
and task success. This includes instruction in careful toy
selection “matched” to the desired motor task, plus physical set up of areas for practicing and repeating activities
related to the identified goal areas, weightbearing, and
reaching and grasping tasks. Conventional baby equipment (e.g. highchairs, toys) already purchased by the family is used wherever possible. The whole environment for
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motor learning is taken into account and therefore intervention may also include: (a) evidence-based early
learning stimulation and role modelling to enhance cognitive and language development (e.g. reading books to
children, limiting passive television watching); (b) optimising sleep hygiene; and (c) feeding interventions (e.g.
anti-reflux medications) to ensure adequate caloric nutrition and pain-free backdrops for learning. The importance of variable daily experiences for infants is
deliberately addressed and support given when parents
articulate difficulty leaving the house. Siblings and extended family members are also actively encouraged to
take part in the HP and therapy sessions to promote:
family knowledge; family acceptance; family wellbeing;
repetition of learning opportunities; and provide a natural source of varied social interaction for the infant.
Parent well-being is openly discussed and support given
to parents to access appropriate services when required.
Home visits from the GAME treating therapists are offered weekly initially and then frequency of intervention
negotiated with each family around their preferences,
availability and family resources required to carry out
the intervention with fidelity. Visits are approximately
60 to 90 minutes duration.
Standard care

“Standard care” (SC) describes the current follow-up and/
or therapeutic interventions used when an infant deemed
at high risk of CP is discharged from hospital in New South
Wales Australia. It is not possible to standardise the frequency, intensity or type of interventions received in the
SC group. Approaches used are varied and might include
neurodevelopmental therapy, the developmental skills approach, group therapy or motor learning approaches reflective of the current EI literature base. Most therapists
include parent education on positioning and handling and
suggested home activities within the therapy programme.
In the pilot study, SC therapy was offered approximately
monthly but ranged from fortnightly to 3 monthly. In order
to monitor the mode, frequency and intensity of intervention received by those in the standard care group as compared to the GAME group, all parents will be asked to keep
a “log book” so that these relevant parameters can be compared between the groups. Similarly since the actual interventions provided in SC are likely to vary between services,
history taking will include information gathering regarding
the type of interventions used.
Outcome measures and procedures
Peabody Developmental Motor Scales -Second edition
(PDMS-2)

The PDMS-2 [38] is the primary outcome measure in
this trial and is a frequently used assessment of motor
skills. This test is standardised and normed for children
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aged from birth to 6 years and has been validated for
use as a discriminative measure. Two studies have demonstrated that it is responsive to change in the CP population for both infants [39] and toddlers [40]. It has
demonstrated concurrent validity with the GMFM [41]
and the Bayley [42]. PDMS-2 assessments will be obtained at baseline, 16 weeks after therapy has commenced and at 12 months and 2 years. Assessments will
be blind scored from video.
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and social-emotional development of infants and toddlers
aged 0–3. It consists of a number of developmental play
tasks that can be completed at the child’s home and videoed for scoring by blind raters. Alternatively infants enrolled in follow up programmes from recruitment sites may
be assessed by staff blinded to group allocation at their 1year clinic appointment. Infants will be assessed on the
BSID-III at 12 months and 2 years.
Statistical methods

Gross Motor Function Measure (GMFM)

The GMFM [43] is a criterion-referenced tool that is
widely accepted as the gold standard for gross motor assessment in children with CP. There are a total of 5 dimensions measured including rolling, sitting, creeping,
standing and walking. Infants will be videoed during the
assessment and blind raters will score from the video
using the appropriate manual. The GMFM- 66 will be
used in this study at the secondary endpoint, (12 months)
and at the 2-year follow up.

Analysis will be conducted on an intention-to-treat basis
using SPSS and reported according to the CONSORT
statement. Descriptive statistics (frequencies, means and
95% CIs) will be used to describe the sample at baseline
and data from each outcome measure used will be summarised for both treatment groups. Between-group differences following intervention will be analysed using
multiple regression to determine whether group allocation predicts outcome. MRI classification, SES and comorbidities including vision impairment and epilepsy
will be considered as covariates in the analysis.

Canadian Occupational Performance Measure (COPM)

The COPM [44] is an individualised criterion referenced
measure of performance of a self-selected range of activities. Functional problem areas are identified, prioritised
and rated for performance and satisfaction via a semistructured interview. The COPM will be used to prioritise
goals and measure change in performance and satisfaction. The COPM will be used at baseline, 16 weeks after
therapy has commenced and at 12 months. Data will be
collected via face to face or phone interview by independent raters.
Affordances in the Home Environment for Motor
Development-Infant Scale (AHEMD-IS)

The AHEMD-IS [45] is a measure of the quality and
quantity of motor enrichment opportunities available to
a child within the home environment. This tool has
demonstrated validity and reliability in the toddler format. Data is collected via a parent self report on a standardised questionnaire. A total raw score is calculated.
This measure will be taken at baseline and at 12 months.
Depression, Anxiety and Stress Scale-21 (DASS)

The DASS-21 [46] is an adult self-report designed to
measure the emotional states of depression, anxiety and
stress. It is a 21-item questionnaire and will be used to
measure parent emotional well-being at baseline, before
randomisation and at all time points thereafter.
Bayley Scales of Infant and Toddler Development Third
Edition (BSID-III)

The BSID-III [47] is a standardised and norm referenced
assessment, which measures the cognitive, motor, language

Discussion
This paper outlines the design and background for a single blind RCT comparing a novel intervention “GAME”
with standard care to improve the motor outcomes of
infants at high risk of CP.
Appendix
Study Sites

1.
2.
3.
4.
5.
6.
7.

Cerebral Palsy Alliance, NSW Australia
Sydney Childrens Hospital Network, NSW Australia
Royal Prince Alfred Hospital, NSW Australia
Westmead Hospital, NSW Australia
Royal North Shore Hospital, NSW Australia
Liverpool Hospital, NSW Australia
Royal Women’s Hospital, NSW Australia
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CP: Cerebral palsy; GMs: General movements; EI: Early intervention;
EE: Environmental enrichment; GAME: Goals-Activity-Motor-Enrichment;
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Edition; GMFM: Gross Motor Function Measure; COPM: Canadian
Occupational Performance Measure; BSID-III: Bayley Scales of Infant and
Toddler Development- 3rd Edition; AHEMD-IS: Affordances in the Home
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Chapter 6| Study 5 PILOT STUDY
PUBLICATION
Morgan C, Novak I, Dale RC, Badawi N. Optimising motor learning in
infants at high risk of cerebral palsy: a pilot study. BMC Pediatrics. 2015;
15(1): 30.
This paper provides the results of a pilot study of the effectiveness of
GAME intervention when compared to standard care. The pilot study
tested both the feasibility of the processes involved in recruiting such
young infants to a randomised trial, as well as the acceptability of GAME
to parents. Importantly the 12-week pilot study allowed us to conduct a
power analysis for the larger and longer planned RCT (study 6), and
evaluate the suitability of our chosen outcome measures in this young
population.
We found that the intervention was acceptable to parents and
recruitment sources, with no study dropouts or adverse events occurring.
The pilot study results demonstrated significant between-group
differences in favour of GAME on one of the secondary measures – the
Peabody Developmental Motor Scale. These findings enabled us to make
minor adjustments to inclusion criteria and choice of measures for Study
6.
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Optimising motor learning in infants at high risk
of cerebral palsy: a pilot study
Catherine Morgan1,2*, Iona Novak1,2, Russell C Dale3 and Nadia Badawi4
Abstract
Background: The average age for the diagnosis of cerebral palsy (CP) is 19 months. Recent neuroplasticity literature
suggests that intensive, task-specific intervention ought to commence as early as possible and in an enriched
environment, during the critical period of neural development. Active motor interventions are effective in some
populations, however the effects of active motor interventions on the motor outcomes of infants with CP have not
been researched thoroughly, but pilot work is promising. The aim of this study was to determine the short- term
effects of “GAME”; a new and novel goal-oriented activity-based, environmental enrichment therapy programme
on the motor development of infants at high risk of CP and test study procedures for a randomized controlled
trial (RCT).
Methods: Pragmatic 2-group pilot RCT to assess motor outcomes, goal attainment, parent well-being and home
environment quality, after 12-weeks of GAME intervention versus standard care. GAME included: creation of
movement environments to elicit motor behaviours; parent training in motor learning and task analysis; frequent
practice of motor tasks using a programme that was individualised to the child, was varied and focused on
self-initiated movement. Data were analyzed using multiple regression.
Results: Thirteen infants were consented, randomised, treated and completed the study. At study conclusion, the
GAME group (n = 6) demonstrated an advantage in Total Motor Quotient of 8.05 points on the Peabody Developmental
Motor Scale-2 (PDMS-2) compared to the standard care group (n = 7) (p < .001). No significant differences existed
between groups on any other measure.
Conclusions: GAME appears to offer a promising and feasible new motor intervention for CP, with favourable
short-term motor outcomes. A pressing need exists for an adequately powered RCT with long-term end points, to
determine if GAME may advance these children’s motor trajectory.
Keywords: Cerebral palsy, Infant, Environmental enrichment, Motor skill

Background
Late diagnosis is the norm for children with cerebral
palsy (CP) since very few diagnostic biomarkers exists;
only half are unwell in the neonatal period [1]; and neuroimaging does not accurately predict severity except in
severe cases. This most often leads to a “wait and see”
approach, where brain injured babies are monitored but
not referred for rehabilitation until marked developmental delay is evident. Formal diagnosis of CP is made on
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1
School of Medicine, University Of Notre Dame Australia, Darlinghurst, NSW,
Australia
2
Cerebral Palsy Alliance Research Institute, University of Notre Dame
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average at 19 months and can be as late as 4 years for
those mildly affected, usually after failed motor milestones, or the emergence of clinical signs such as spasticity or involuntary movements. Identifying infants at
very high risk of CP early and discriminating them from
those with other diagnoses could lead to the provision of
more specific, timely and evidence-based CP rehabilitative therapies in the critical period of brain development
[1]. Current thinking is that these diagnostic-specific interventions should be applied very early rather than delivering general early intervention (EI), in an effort to
optimise outcomes and limit maladaptive plasticity [2,3].
A consequence of the lack of a definitive CP biomarker
and late diagnosis is that only a handful of EI clinical trials
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exist where all participants actually have CP or are at very
high risk of CP. Rather, most EI trials comprise of heterogeneous “at risk” populations, including many infants who
go on to have normal outcomes, resulting in underpowered trials that do not tell us much about effect of EI in
CP [4]. Studies specifically recruiting infants with brain injuries in the newborn period have typically not accurately
identified infants who will later go on to be diagnosed
with CP and disconcertingly, rarely have the study interventions resulted in motor improvements [5]. Prechtl’s
qualitative assessment of general movements (GMs) is
the most predictive assessment tool to detect infants, as
young as 3 months who have the highest risk of CP,
however it is rarely used when recruiting infants to
intervention studies [6]. A further confounder in CP
intervention studies is the heterogeneity of the condition, creating wide distributions of baseline and change
scores making it difficult to detect change and identify
best responders and non-responders.
As evidence of the benefits of Environmental Enrichment (referred to as EE from now on) on brain recovery
grows [2,5], the focus of CP rehabilitation in older children has shifted towards approaches that emphasise
goal-oriented activity-based therapy [7], and frequent
task practice with deliberate creation of optimal environments for motor learning. These approaches, based on
motor learning principles do not focus on passive interventions such as stretching, or the normalisation of
movement like traditional Neurodevelopmental Therapy
(NDT), but rather on task practicability and environmental context [8,9]. Improvements in motor behaviour
depend upon intentional goal directed practice where
the therapist is a “change agent” setting the stage for
learning and facilitating the child’s exploration of effective movement solutions [10,11]. Examples of proven effective interventions utilising motor learning principles
include constraint induced movement therapy and bimanual therapy. Typically these interventions are offered
to children with CP from 2 years of age. Recently, a systematic review and meta-analysis of infants at high risk of
CP, showed a small but significant effect of EE interventions
on motor outcomes [5], suggesting that diagnostic-specific
interventions including EE lead to better outcomes for infants. There remains a significant gap in our understanding
of how the motor learning approaches effective in older
children with CP can be applied to infants with a very limited motor repertoire. In addition, parent education is
known to be an important component of early intervention [12] and since most of the infant’s active practice opportunities are provided within daily routines, parent
education and coaching is crucial in order for the necessary practice to take place [13]. We therefore developed a
new infant intervention approach: “Goals, Activity and
Motor Enrichment” (GAME) that utilized motor learning
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principles, goal-oriented activity-based therapy, parent
education and EE strategies.
The aim of our study was to determine the short-term
effects of GAME intervention on the motor development of 3–5 month old infants at very high risk of CP,
and to test study procedures in preparation for a Randomised Controlled Trial (RCT). We hypothesized that infants in the GAME intervention group would have
higher goal attainment and Peabody Developmental
Motor Scale-2 (PDMS-2) scores after 12 weeks of intervention than infants receiving Standard Care (referred to
as SC from now on).

Methods
A pragmatic 2-group pilot RCT was used to explore the
feasibility and effects of 12 weeks of GAME (Goals –Activity –Motor –Enrichment) intervention in infants at
high risk of CP. GAME intervention is a home-based
motor learning approach that aims to advance motor
skills of infants and young children via motor task practice, parent education and environmental enrichment.
The study also aimed to test the acceptability of randomisation procedures and the intervention to families
and referring institutions, and to check outcome measure sensitivity and determine likely effect sizes.
Study rationale

This study is both an RCT and a feasibility study [14].
We conducted and reported the pilot/feasibility study as
an RCT because: 1) we wanted to test whether the randomisation procedure itself was acceptable to referring
institutions and parents and therefore it was important
to test whether or not it was feasible to recruit participants to an RCT. Since the GMs was new in our locality
we were unsure that once the label “high risk of CP” was
given to infants whether referral institutions were likely
to promote a study where there was equal chance the infant would get a therapy program from a “CP specific”
service vs general pediatric therapy programs, which are
varied in type and intensity. Moreover, we wanted to see
if parents “dropped out” of the study if they were randomised to SC; 2) The intervention was not previously described and we wanted to test the feasibility of both
carrying out the intervention and its’ acceptability to
parents; 3) The dearth of available outcome measures
that are criterion-referenced for infants with disabilities
is well established. As Goal Attainment Scaling (GAS) is
widely used in toddlers and children with CP we wanted
to test whether this was useful with infants who are yet
to meet their motor potential; 4) We wanted to test statistical procedures. CP is a heterogeneous condition and
the GMs assessment does not predict severity. We expected therefore to recruit infants across the severity
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levels and for this reason used regression to enable us to
account for differing motor ability affecting outcome.
Participants

Thirteen infants were recruited from 6 Neonatal Intensive
Care Units (NICUs) in the Sydney Children’s Hospital
Network (SCHN) and from the Cerebral Palsy Alliance,
Australia. Infants 3–5 months of age were eligible for enrolment if parental consent was obtained and they had an
abnormal GMs assessment score between 11–18 weeks
post term age. Since “absent fidgety” GMs are the most
predictive of a future diagnosis of CP, we used results from
this period [6] rather than the earlier “writhing” period.
GMs assessments were scored by at least 2 certified GMs
assessors blinded to the infant’s history. No official diagnosis by a medical professional was made at enrolment, rather, parents were counselled about the results of the
GMs meaning their baby was at very high risk for CP.
Infants were excluded if oxygen dependent, still an inpatient, or lived in a remote location precluding home
visits from investigators.
Procedures

Ethics approval was obtained from the University of
Notre Dame Australia, Cerebral Palsy Alliance and the
SCHN. After eligibility was determined, informed written consent was obtained and baseline measures taken.
Infants were randomised to either the GAME or SC
groups using sequentially numbered opaque sealed envelopes. The randomisation sequence was computer
generated by an independent officer and group allocation was managed off-site. Intervention was carried out
for 12 weeks as per the trial protocol for the 2-groups.
Measures were taken at baseline within the child’s home
and were repeated at the primary end-point, after 12 weeks
of intervention.
Intervention

GAME: All GAME interventions were provided by the
investigators (CM and IN) and carried out within the
home environment. GAME has been described elsewhere [15] but always consisted of three components:
goal oriented activity-based motor training, parent education, and strategies to enrich the child’s learning
environment.
1. Goal-oriented intensive motor training – parent
identified goal areas were targeted for practice
during the therapy session and after further
assessment, a home program (HP), which was a
detailed goal focussed activity based home practice
plan was devised [16]. The therapist scaffolded all
motor tasks, so that the infant could always actively
complete at least a part of the task. As performance
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improved, the challenge was increased by altering
the task or environment to a new and appropriate
level of difficulty. Manual assistance was provided by
the therapist and parent only when necessary for
safety or to give the infant the “idea” of the movement.
Manual assistance was reduced or withdrawn as soon
as the infant demonstrated self-initiated progress with
the task; ensuring self-generated motor activity was the
focus of all practice. Once a motor skill was learned,
variability of practice was introduced to increase the
complexity and generalizability of the skill. Early
weightbearing and sit to stand from the parents’ lap
were part of each HP even if standing was not
identified as a specific goal. Rehabilitation research in
older children and adults with brain injuries suggest
that functional weight bearing exercises can both
improve motor control and provide strength training
[17]. Given that the expected impairments of CP
include weakness and reduced selective motor control,
early activation of muscles of the lower limb using
both concentric and eccentric exercise could enhance
the development of upright mobility. Similarly,
practice of reaching and grasping a variety of objects
was a standard part of motor training for all infants in
order to expose the infants who are expected to be
delayed, to a variety of objects to advance grasp and
reach behaviours [18].
The written HP was related to parent identified goals,
weightbearing and reach and grasp. The HP included
photographs, describing parenting strategies, environmental enrichments and child-activities as per published guidelines on effective home programmes [16].
Activities in the HP were organised into those in
which the carer played an active role and those where
practice could be “set up” for the infant to carry-out
independently. The HP was updated once during the
12-week period.
2. Parent Education: Parents were coached to identify
their child’s voluntary attempts to move and
self-regulate, plus understand the usual trajectory of
emergent motor skills and how to stimulate
progress. Parents were trained in simple motor task
analysis and coached in appropriate strategies to
enhance their child’s development both at a specific
goal level and in general early learning and
development principles. Parents were taught to
optimise the best use of their infants’ awake time and
the naturally occurring opportunities for learning.
Learning optimisation included both parent-directed
and structured practice of desired motor tasks, where
the parent role was integral to the child’s learning (e.g.
creating repetitions) and constructing opportunities
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for independent play (e.g. playing alone with motor
enriching toys set up for the child). Parents were
encouraged to both observe the therapist eliciting a
motor behaviour from the baby and to attempt it
themselves. Specific feedback was given to parents to
enable them to tease out why some attempts were
successful for the baby and others weren’t. As new
motor skills emerged parents were coached in
strategies to increase the challenge of the task; for
example remove support or introduce a more complex
toy. The importance of allowing trial and error during
practice was discussed and parents were encouraged
to devise their own activities to enhance goal
attainment.

3. Environmental Enrichment – Parents were
encouraged and assisted to set up motor enriched
play environments to promote child self-generated
movements, exploration and task success. This
included instruction in careful toy selection
“matched” to the desired motor task, plus physical
set up of areas for practicing and repeating activities
related to the identified goal areas, weightbearing, and
reaching and grasping tasks. Conventional baby
equipment (e.g. highchairs, toys) already purchased
by the family was used wherever possible. The
whole environment for motor learning was taken
into account and therefore intervention also included:
(a) evidence-based early learning stimulation and
role modelling to enhance cognitive and language
development (e.g. reading books to children, limiting
passive television watching); (b) optimising sleep
hygiene, for example assisting with implementing sleep
routines; and (c) feeding interventions (e.g. anti-reflux
medications) to ensure adequate caloric nutrition and
pain-free backdrops for learning. The importance of
variable daily experiences for infants was deliberately
addressed and support given when parents articulated
difficulty leaving the house. Siblings and extended family members were also actively encouraged to take part
in the HP and therapy sessions to promote: family
knowledge; family acceptance; family wellbeing;
repetition of learning opportunities; and provide a
natural source of varied social interaction for the
infant.
Intervention was customised for the child’s motor
ability, the family enrichment style, and parent goals.
Therapist visits were weekly initially and then frequency was negotiated with each family around their
preferences, availability and parental skill level to carry
out GAME with fidelity. Visits typically lasted for 60 to
90 minutes.
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Standard Care: Therapy intervention for infants at
high risk of CP is available in New South Wales (NSW)
free of charge, upon medical referral but varies enormously with no gold-standard guidelines in existence.
Prior to study commencement, a survey was conducted
amongst the study recruiting sites, revealing that the intensity of SC therapy was an average of 14-hours in the
first year of life, spread typically over fortnightly or
monthly appointments. Not all NICU recruitment sites
offered ongoing intervention and referred infants to
community-based organisations. The content of SC typically involved physical guidance to facilitate normal
movement patterns and parental advice on positioning
and handling. As no employer guidelines exist the choice
of therapy approach is decided by the treating therapist
and might have included NDT, motor learning, the
developmental skills approach or a combination of approaches. For study purposes the SC offered to the control group was outside the investigators control both in
terms of type of therapy and intensity of therapy, but
was however representative of SC. Infants randomised to
SC were referred to the provider by the centre referring
the infants to the study. Infants received SC from either
a hospital (n = 2), a community-based health centre (n = 3),
or a Not-For-Profit Organisation (n = 2).
Outcome measurement

The primary outcome measure was Goal Attainment
Scaling (GAS), an individualised criterion-referenced
measure of goal performance. Goals are set, with five
possible outcomes specified for each goal. Composite
T-scores are calculated for multiple goals and change
over time is quantified using change scores and using
conventional procedures recommended in literature [19].
We treated GAS scores as a continuous variable rather
than ordinal although both approaches are used in the
field and disagreement exists [19]. GAS is useful in CP rehabilitation for detecting incremental change in functional
abilities that might not be detected on norm-referenced
tools such as the Bayley Scales of Infant and Toddler Development [20]. GAS is widely used and recommended in
childhood CP research because it is valid, reliable and responsive [19]. The use of GAS to measure outcomes in infants with CP has been validated [21] but never used in
RCTs of infants under 12 months of age with limited
motor repertoires and thus sensitivity is untested for this
younger population. We therefore wanted to test the usefulness and applicability of GAS in very young infants
across a broad spectrum of motor ability. We used GAS
because we wanted to capture incremental change in performance. At the initial appointment after consent had
been obtained, parent identified functional developmental
goals for their child from interview. These were formulated
into individual goal scales prior to the commencement of
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therapy with the baseline level set by the investigators on
the basis of an initial assessment of ability of the identified
goal and confirmed by parent interview. GAS banks have
been recommended in literature as a way of improving
rigour. We used GAS banks wherever possible but individualised the goals as per the tool conventions when banks
did not exist. For example, if the same baseline ability was
evident for different participants for a specific goal the same
GAS levels from a bank were used. As per test developer
conventions parents were encouraged to identify 3 to a
maximum of 5 goals for the 12-week period. Assessors
were blinded to group allocation and scored the infant’s 12week GAS performance from video.
Canadian Occupational Performance Measure (COPM)

The COPM is an individualised, criterion referenced tool
measuring perceived change in infant performance and
parental satisfaction with performance over time on
family priorities. The COPM is widely used in CP research and is valid, reliable and responsive [8,22]. During
a semi-structured interview parents identified a number
of areas that they would like to focus on with their baby
during the study period. The standard 10-point scale
was used to rate the infant’s performance and their own
satisfaction with the infant’s performance on the identified focus areas. This was repeated after 12-weeks by a
blinded assessor. An improvement of two or more
points is regarded as clinically significant [22].
Peabody Developmental Motor Scales - Second edition
(PDMS-2)

The PDMS-2 [23] is standardised norm-referenced tool,
which is valid, reliable, and widely accepted. A total of 5
sub-scales are assessed including reflexes, locomotion,
stationary, grasp and visual motor integration. A total
motor quotient (TMQ) is calculated with a mean of 100
and SD of 15. Responsivity has been established for infants for the original version [24] and for toddlers with
CP for the PDMS-2 [25]. The PDMS-2 was selected preferentially over the gold standard Gross Motor Function
Measure (GMFM) because it evaluates fine motor skills
that are targeted in many early intervention programmes.
Home Observation Measurement of the Environment
(HOME) - infant-toddler version

The HOME [26-28] is a reliable, valid standardised
measure of the quality and quantity of parent and home
environmental stimulation and support available, scored
from parent interview and direct observations. Sub-scales
include parent responsivity, the availability of learning materials and variety of stimulation. The infant – toddler version is suitable for ages 0–3 [26]. Higher total HOME
scores indicate a more enriched environment with 45 being the highest possible score.
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Depression, Anxiety and Stress Scale (DASS-21)

The DASS-21 [29] is a mental health self-report measure
of the emotional states of depression, anxiety and stress.
The DASS-21 is psychometrically sound and is useful
tool in the postnatal period for assessing psychological
risks [29]. The primary caregiving parent completed the
DASS 21 at baseline and study completion.
Logbooks

All families were asked to complete a logbook of the
number and length of therapy sessions received over the
12-week study period. Families also documented the
amount of time they spent carrying out therapist recommendations in the home environment. Parents who
chose to access additional therapist-provided intervention documented the number of extra sessions.
Statistical analysis

Parent and infant characteristics and baseline measure
mean scores were compared using independent t-tests,
to ensure baseline equivalence of groups. Linear regression
was used (where baseline scores were entered as covariates)
to test the effect of providing GAME intervention compared to SC, on the infant’s goal attainment and motor
performance, the home environment and the parent’s
mental health. We chose to use linear regression over
traditional t-tests as CP is known to be a heterogeneous
condition and we expected to recruit infants across the severity spectrum leading to a wide variety of baseline scores
and large standard deviations in both groups. Linear regression allowed us to treat baseline scores as a covariate.
Severity could not reliably be imputed as a covariate in
this short duration, small sample study, although this
would be highly desirable, because 42% of infants change
severity levels on the gold standard scale under 2-years of
age [30]. Post-hoc analysis of the effect of total therapy
dose (therapist delivered intervention plus parent delivered home program practice) in hours on the outcome
was also conducted because there was insufficient power
to use intensity of therapy as a covariate in the regression.
Analyses were conducted on the basis of intention to treat.
Missing values were imputed as last observation carried
forward. Results were presented as between group differences with 95% confidence intervals.
Effect size was computed using Cohen’s d. Commonly
used criteria specify that a value below 0.2 is regarded as
no effect, a value of 0.2–0.5 is a small effect, a value of
0.5–0.8 is a medium-sized effect and a value above 0.8 is
a large effect [31].

Results
Thirteen infants from twelve families, mean age 17.6 weeks
(SD =3.9), corrected for prematurity, and at very high
risk of CP were recruited between September 2011 and
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September 2012 (Table 1). Six infants were randomised
to the GAME and seven to SC. Twins were randomised
into the same group, as it would be impossible for parents to operationalize two different treatment approaches without intervention contamination. The flow
of participants through the study is summarised in
Figure 1. Adherence to study protocols was excellent
with no dropouts. Participant characteristics are summarised in Table 1. Groups were equivalent at baseline
on infant and parent characteristics. All child outcome
data was normally distributed at both baseline and
follow-up, therefore meeting the assumption for parametric statistics. The only exception to this was the
HOME follow-up data, which was skewed right (kurtosis of 3.24) indicating ceiling effects on the measure.
Primary outcome at the primary end-point – GAS at
12 weeks

Primary and secondary outcomes are presented in Table 2.
After 12-weeks of intervention, both groups improved.
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The mean change score for GAME intervention was 38.67
(SD = 7.63) and 28.28 (SD = 18.33) for the SC group but
with no statistically significant between-group differences
and wide variation about the SC mean. Infants in both
groups achieved the expected motor outcomes for
parent-identified therapist-set goal scales (Table 2), improving 2 SDs from baseline on GAS T-Scores (GAS
mean T-score = 50, SD = 10, with a T-Score 40–60 indicating achievement as expected). Parents usually identified 4–5 motor goals for their infants including rolling
(77%), sitting (54%), reaching in prone (54%) and grasping toys (54%). One parent identified a non-motor goal
(improved sleeping).
Secondary outcome measures

PDMS-2: After 12 weeks of intervention, the infant’s
motor abilities were assessed using the PDMS-2. Statistically significant between group differences were found in
the Total Motor Quotient (TMQ) PDMS-2 scores, conferring an 8.05 point advantage to the GAME intervention

Table 1 Baseline characteristics of participants
Characteristic

GAME (n = 6)

Standard care (n = 7)

p value

Gestational age, mean (SD), weeks

35.50 (5.21)

33.57 (7.76)

0.61

Age at baseline, mean (SD), weeks (corrected for prematurity)

17.83 (4.17)

17.43 (3.95)

0.86

Sex: M/F

5/1

6/1

-

Birthweight, (kg)

2.85 (1.19)

2.40 (1.40)

0.54

Mother

33.00 (3.34)

33.43 (5.0)

0.86

Father

39.17 (5.12)

38.43 (2.64)

0.76

GAS T-score, mean (SD)

21.50 (1.22)

22.43 (0.96)

0.47

COPM Performance score, mean (SD)

3.03 (1.01)

3.19 (0.58)

0.42

COPM Satisfaction score, mean (SD)

4.26 (0.89)

4.81 (1.31)

0.36

80.17 (8.98)

81.29 (9.20)

0.83

Parent age, years

PDMS-2
Total Motor Quotient
Total Motor Standard Score, mean (SD)

35.67 (6.56)

36.43 (6.88)

0.87

HOME – IT score, mean (SD)

33.83 (3.66)

29.00 (8.08)

0.06

DASS 21 score, mean (SD)

19.67 (8.71)

24.57 (23.96)

0.16

Risk for CP*
• Premature
<28 weeks

n = 1/6

n = 3/7

-

>28 - < 37 weeks

n = 1/6

n = 0/7

-

• HIE

n = 2/6

n = 3/7

-

• Multiple Birth

n = 2/6

n = 0/7

-

• Hydrocephaly

n = 0/6

n = 1/7

Absent Fidgety General Movements Score (12–16 weeks PTA)

n = 6/6

n = 7/7

-

Diagnosis of CP between 5-12months

n = 4/6

n = 6/7

-

*Primary risk factor - some participants had >1 risk factor. GAS = Goal Attainment Scaling; COPM = Canadian Occupational Performance Measure; PDMS-2 = Peabody
Developmental Motor Scales – second edition; HOME = Home Observation Measurement of the Environment; DASS 21 = Depression, Anxiety, Stress Scales short
(21 item) version; HIE = Hypoxic Ischaemic Encephalopathy; PTA = post term age.
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Assessed for
eligibility
(n = 15)
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Excluded n=2
Did not meet inclusion
criteria (n=2)

Randomised (n=13)

Allocated to
experimental group
(n=6)
Received allocated
intervention (n=6)

Allocated to
standard care group
(n=7)
Received allocated
intervention (n=7)

Lost to follow up
(n=0)

Lost to follow up
(n=0)

Analysed (n=6)

Analysed (n=7)

Figure 1 Flow of participants.

group (95% CI 3.88-12.27; p < 0.001). This represents just
over 0.5 of a SD on the PDMS-2, which is probably clinically significant based on Wang’s calculation for toddlers
[25], but since no data on clinically meaningful change exists
in infancy we cannot be certain. The total composite motor
scores are also provided in Table 2 but the primary analysis
was conducted on the TMQ because it is regarded as the
most psychometrically robust estimation of motor ability.
We calculated sensitivity to change coefficients using
Cohen’s effect size, to assist with interpretation of the results. The Cohen’s effect size for the GAME group was
0.5, which is considered a small to moderate effect size,
while the SC group was −0.4, which Cohen defines as
trivial since the change is <0.2.
COPM: COPM performance and satisfaction scores
improved in both groups with no between-group statistical differences.
HOME: Scores on the HOME improved in both
groups however there were no statistically significant between group differences.

DASS 21: DASS 21 scores were calculated for 12
mothers and 1 father, with no between-group statistical
differences found. Mean DASS 21 scores dropped in the
GAME group by 13.67 points (SD = 11.83) but were
stable in the SC group with an endpoint mean of 26.00
(SD = 28.75). The large SD in the SC group is explained
by the scores of one parent who had a pre-existing severe mental health condition.
Logbook: Adherence to the GAME study protocol was
high for all families. All GAME parents completed the
logbook indicating HP and therapy time. All families in
the SC group recorded therapy visits however 2/7 did
not record HP time. These were the only missing values
in the analysis and were coded as missing. Seven of the
13 infants were formally diagnosed with CP during the
study period. Another 3 were formally diagnosed by
12 months and the developmental outcome of another 3
is unknown (2 in GAME group and 1 in SC). No information was collected about the type or severity levels of
those diagnosed in this small pilot study.
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Table 2 Primary and secondary outcome measures with estimates of effect (between group differences and 95%
confidence intervals)
Outcome
Time
Point

Group
Measure

GAME (n = 6)

SC (n = 7)

Mean (SD)

Mean (SD)

Estimate of effect
(95% CI)

p-value

Infant goal achievement on motor tasks:
Baseline

GAS T-Score

21.50 (1.22)

22.43 (0.98)

-

-

12-weeks

GAS T-Score

60.17 (6.62)

50.71 (18.33)

7.37 (−12.71, 27.45)

0.43

Parent perception of infant motor performanceBaseline

COPM Performance

3.03 (1.01)

3.19 (0.58)

-

-

12-weeks

COPM Performance

7.24 (1.11)

6.58 (2.10)

0.72 (−1.49, 2.92)

0.49

Baseline

COPM Satisfaction

4.26 (0.89)

4.81 (1.31)

-

-

12-weeks

COPM Satisfaction

7.42 (1.05)

7.49 (2.56)

0.13 (−2.54, 2.79)

0. 92

Parent enrichment style
Baseline

HOME Score

33.83 (3.66)

29.00 (8.08)

-

-

12-weeks

HOME Score

39.83 (2.14)

36.43 (6.90)

−0.13 (−3.48, 3.22)

0.93

Infant motor development
Baseline

PDMS-2 TMQ

80.17 (8.98)

81.29 (9.20)

12-weeks

PDMS-2 TMQ

84.67 (10.21)

77.71 (8.85)

8.05 (3.88-12.23)

<0.00*

Baseline

PDMS-2 Total motor SS

35.67 (6.56)

36.43 (6.88)

-

-

12-weeks

PDMS-2 Total motor SS

38.83 (7.44)

33.86 (6.44)

5.72 (2.88, 8.56)

.001*

Baseline

DASS 21 Total

19.67 (8.71)

24.57 (23.96)

-

-

12-weeks

DASS 21 Total

13.67(11.83)

26.00 (28.75)

−7.49 (−24.86, 9.89)

0.36

Parent well being

GAS = Goal Attainment Scaling; COPM = Canadian Occupational Performance Measure; PDMS-2 TMQ = Peabody Developmental Motor Scales – second edition
Total Motor Quotient; PDMS-2 total motor SS = Peabody Developmental Motor Scales – second edition total motor standard score; HOME = Home Observation
Measurement of the Environment; DASS 21 = Depression, Anxiety, Stress Scales short (21 item) version.
*Indicates statistically significant.

Post-hoc analysis of the dose of therapy found a significant difference between groups in both the number
of hours of therapy and the numbers of hours HP time.
Infants in the GAME group received an average of 9.93
(range 7.5-15 hours) hours of therapy, which was almost
three times higher than the 3.49 hours (range 1–6 hours)
received by the SC group (p < 0.00). Parents in the
GAME group also spent more time carrying out the HP.
The mean total dose of therapy (therapy plus HP) was
140.58 hours (SD 23.3) for GAME, and 54.17 hours (SD
32.62) for SC.

Discussion
We hypothesised that GAME infants would have higher
GAS scores than SC infants. Mean GAS score for the
GAME group was a full GAS T-Score SD higher than
that of the SC group. Statistical significance was not
reached but this was not expected in this feasibility RCT
which was underpowered to detect change, leading to a
probable type II error. Interestingly goal achievement
was higher and more homogenous in the GAME group
whereas great variation was evident in SC scores, perhaps indicating GAME was more goal-focused - an issue

that could be further examined in future studies. We
also noted that therapists found it difficult to predict the
rate of infant’s motor development at baseline given the
limited motor repertoire at enrolment age and the lack
of a robust severity measure for infants. Prior to intervention when goals were set, parents had difficulty predicting their baby’s rate of development and their
knowledge of what was “normal” varied. For example
some parents did not know when a child would normally sit or walk. Parents were taught information in the
parent education component of GAME but at baseline
knowledge of milestone attainment affected levels of
parental concern and GAS prediction accuracy. Although GAS has been shown to be an effective measure
of motor change for infants [20,21] it might be more
useful for documenting incremental change rather than
standard milestone acquisition within clinical trials. We
concluded that whilst GAS is sensitive in older children,
the parent and therapist inaccuracy of predicting infant
motor outcomes substantially affected sensitivity and
therefore we would not recommend using GAS as a primary outcome in our own future GAME studies with
infants.
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Although this study was a small pilot randomised trial
the secondary findings suggest that 12 weeks of GAME
intervention might have a beneficial effect on the developmental motor outcomes of infants at high risk of CP.
There have been no publications on the PDMS-2 about
how much change is required in terms of motor quotients or raw score points to be regarded as clinically
meaningful in this very young population. However,
Wang et al. suggested a change of more than 9 raw score
points on the PDMS −2 may be clinically significant [25]
amongst toddlers. Our data exceeded the 9 points for all
participants but was even greater for the GAME group,
however this is a period of rapid motor development so
greater change is expected, limiting interpretation of our
results. While infants in both groups demonstrated improvements in terms of goal attainment, TMQ scores at
12 weeks on the PDMS-2 were significantly better in the
GAME group. This difference could be the result of intensity alone or possibly a result of both the type and intensity of the intervention, as GAME parents engaged in
more practice at home than did SC parents. Although
the PDMS-2 motor gain is pleasing in this study, children with a permanent physical disability like CP usually
fall further behind peers as developmental motor expectations increase. We would therefore expect that for a
study of longer duration, the TMQ would drop in children with CP even if raw scores continued to increase.
The small-moderate effect size we found in this pilot
therefore needs to be confirmed in a larger sample of
children over a longer period of time.
The lack of significant between-group differences on
the subjective COPM was surprising given that the
GAME groups scored better on the PDMS-2. This result
might indicate that parents of infants at high risk of CP
are pleased with any noticeable improvement or with
natural developmental gains, and do not expect age appropriate performance or do not know what motor skills
are considered “normal” at various time points. Most
parents expressed a general goal for their child to “develop normally” although they were not sure what developmental milestones they should precisely expect. Even
though the COPM and GAS scores did not demonstrate
significant differences, we found the goal-oriented approach framed by these tools assisted parents to be more
specific in identifying concerns, thus enabling focussed
HP practice.
Environmental enrichment as measured by HOME
scores demonstrated gains in both groups but there were
no significant between-group differences. Notably ceiling
effects existed, with 9/13 participants having higher than
average baseline scores. Previous HOME studies have
confirmed this ceiling effect [32]. It should be noted that
the baseline HOME scores of the SC displayed a higher
degree of variance than the GAME group due to 3
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families with scores below the published mean of 31 (26)
and only 1 in the GAME group. However after 12 weeks
only one family in the SC group still scored below the
mean. Future GAME studies should endeavour to explore the use of other measures of EE that might be
more sensitive to change.
DASS 21 scores between groups were comparable at
baseline and after intervention. At baseline, 23% of parents (all mothers) had abnormal depression scores but
after intervention this had dropped to 15%. Miller at al
[29] reported a DASS 21 depression rate of 19% in primiparous mothers, so our result was not surprising as
mothers in the study experienced additional stressors in
the newborn period. At baseline 31% of parents (all
mothers) had symptoms of anxiety and this had reduced
to 15% after 12 weeks of intervention. Our sample’s
baseline anxiety rate was higher than previously reported
rate of 13% in new mothers. Premature birth and exposure to intense medical environments such as Neonatal
Intensive Care Units are known risk factors for adverse
psychological symptoms in mothers [33]. Adaptation to
the diagnosis of CP is another known stress point and
families participating our study were at risk of poor
emotional health because of these factors. Evaluating
parent wellbeing in studies of infants at high risk of CP
is important as parental depression and anxiety can
affect parent-infant attachment [33], negatively influence
child cognition [34] and might impact the mother’s ability to carry-out HPs.
Feasibility of the trial

We found GAME was both feasible to carry out and acceptable to parents and referrers, with no dropouts,
minimal missing data, and only n = 1 parent declining to
enrol. Ten of 12 families completed the logbook of HP
and two forgot, but were able to estimate data. Although
some described the logbook as tedious, it provided invaluable information about dose of practice.
GAME intervention fidelity was maintained as the
same therapists provided intervention for each infant in
the GAME group. Intensity of SC intervention was variable and little information was available about the type
of SC intervention. Future studies should attempt to describe the content of SC more specifically.
The pilot study enabled us to confirm outcome measures for a planned larger RCT and calculate the sample
size required with PDMS-2 as the primary outcome
measure.
Limitations

There were several limitations to this pilot study. First,
the small sample size gives rise to the possibility that the
absence of GAS, COPM and HOME differences could
be type II errors arising from low statistical power.
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Second, the study period was relatively short and infants
were only 6–8 months old at the primary endpoint. It is
therefore not clear whether the advantage observed in
the GAME group would have been maintained long-term,
particularly since at one-year of age the more demanding
motor tasks of upright ambulation is the developmental
norm. Third, as previously discussed, it is possible that the
higher PDMS-2 GAME scores might have been solely attributable to the dose of therapy rather than GAME intervention. Dose of therapy will be entered as a covariate in
the planned larger trial, however GAME intervention itself
may in fact lead to greater parental participation in home
practice as parent education is regarded as a key component of the intervention. Fourth, since SC is variable, areas
of overlap in approach could well have existed creating
contamination between the groups. Fifth, the lack of
evaluator blinding across some measures may have unintentionally led to observer bias.
A larger blinded, RCT of infants from 3 months to
one year is required to investigate whether the benefits
of GAME confers a similar result to this pilot long-term.
We did not find GAS the most appropriate primary
measure to use in an RCT with young infants, and
recommend a suite of measures including both a norm
referenced tool complemented by criterion referenced
measures capable of detecting incremental motor change,
such as the COPM and GMFM. Future studies with larger
sample sizes should also treat severity of motor impairment and dose as covariates in the analyses.

Conclusions
This pragmatic pilot study compared 12 weeks of goaloriented, activity-based, motor training centred on parentelicited goals (“GAME”) to SC in infants at high risk of
CP. While infants in both groups attained their goals,
GAME infants had higher scores on a standardised assessment of motor ability, providing preliminary promising
evidence of efficacy of GAME. Parent reported improvement in COPM performance and satisfaction and home
enrichment scores improved in both groups. Mothers
tended to report higher depression and anxiety scores
than mothers without infants with a disability, indicating
parental well-being is important to monitor. The recruitment processes and intervention was clinically feasible to
do and acceptable to all families.
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ABSTRACT
BACKGROUND: Cerebral palsy (CP) is caused by a lesion in the developing
infant brain. Recent neuroplasticity literature suggests that intensive, taskspecific intervention ought to commence as early as possible during the critical
period of neural development.
OBJECTIVE: To determine whether “GAME”, a motor learning, environmental
enrichment intervention, is effective for improving motor skills in infants at high
risk of CP.
METHOD: Single blind randomised controlled trial of GAME versus standard
care. Primary outcome was motor skills on the Peabody Developmental Motor
Scales-2 (PDMS-2). Secondary outcomes included Canadian Occupational
Performance Measure (COPM), Bayley Scales of Infant and Toddler
Development (BSID-III) and Gross Motor Function Measure-66 (GMFM-66).
Outcome assessors were masked to group allocation and data analyzed with
multiple regression.
RESULTS: Of n=30 3-6 month old infants enrolled, all received the assigned
intervention until 16 weeks post enrolment. At 12 months of age, n=26
completed assessments. At both time points there were significant between
group differences in raw scores on the PDMS-2 in favour of GAME (p <. 03)
and at 12 months on the total motor quotient (p < .05). Significant between
group differences also favored GAME participants in the composite scores of
the cognitive and motor scales of the BSID-3 and satisfaction scores on the
COPM at 12 months.
CONCLUSION: GAME intervention appears to result in advanced motor and
cognitive outcomes when compared with standard care. Further research is
needed to evaluate whether these gains have any impact on severity of CP in
the long term.

Trial registration
This trial is registered on the Australian New Zealand Clinical Trial register:
ACTRN12611000572965
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Introduction

Cerebral palsy (CP), the most common physical disability of childhood, occurs
because of a lesion in the developing brain1. The lesions associated with an
eventual diagnosis of CP usually occur during the prenatal or perinatal period. A
small percentage acquires their injury after the neonatal period and account for
approximately 5.6% of CP2. Since the brain injury of CP occurs early it is
important to develop evidence based rehabilitation protocols that enhance the
neuroplasticity mechanisms at work in the developing brain 3. Many effective
rehabilitation interventions for older children with CP exist4, but most have not
been trialled early with infants because recruitment is difficult, since the
diagnosis typically occurs after 18 months of age. Consequently although early
intervention is endorsed for high-risk infants, the efficacy for infants with CP is
not yet firmly established 5. Early intervention research in the form of clinical
trials for infants is burgeoning 6-8 with new knowledge expected in the coming
years.
We developed an early intervention programme, GAME (Goals Activity Motor
Enrichment) 9 that was first tested in a small pilot study (n=13) 10 with promising
results in improving motor outcomes of GAME participants when compared to
standard care. Our earlier pilot also established feasibility of procedures for
recruitment and randomisation. The aim of this phase 2 study was to determine
whether GAME intervention improved motor outcomes and parent perception
and satisfaction with motor performance after 16 weeks of intervention, and at
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12 months when compared with SC. We hypothesized that infants randomised
to GAME would have superior motor skills at both time points.
METHODS
Participants
Infants were included if they were corrected age 3-4 months and: scored as
“absent fidgety” on General Movements Assessment (GMA); OR were aged 5-6
months with a CP diagnosis OR had abnormal neuroimaging such that a CP
diagnosis was considered extremely likely. Infants were excluded if they were
inpatients, had medical conditions that precluded active involvement in therapy
or lived in a remote location not accessible for home visits by the research
team.
Study timeline and protocol
Infants were recruited from 6 participating Sydney hospitals with Neonatal
Intensive Care Units (NICUs) and the Cerebral Palsy Alliance between
February 2013 and June 2014. The study received ethical approval by the
Sydney Children’s Hospital Network, the University of Notre Dame Australia and
the Cerebral Palsy Alliance human research ethics committees. Once eligibility
was determined, parental consent was obtained and all baseline assessments
and demographic data were collected.
Motor severity is a known predictor of responsiveness to intervention. Due to
the young age of the participants, the Gross Motor Function Classification Scale
(GMFCS) could not to be used to reliably rate the severity of motor
impairment11. We therefore needed to use the best clinically available severity
predictor which is neuroimaging blind-scored by a paediatric neurologist and
paediatric radiologist to estimate severity of the brain injury. Neuroimaging was
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not available for n=2 and only cranial ultrasound was available for n=3. A score
form was created from best available literature12-14. When multiple images were
available, the series closest to term equivalent age was used for preterm infants
and closest to day 7 for infants with hypoxic ischaemic encephalopathy.
Severity results were ordinally coded as: 0 = normal OR unlikely to have CP;
1=likely to have ambulant CP (e.g. focal vascular insults); and 2= likely to have
non-ambulant CP, (e.g. significant basal ganglia/thalamus lesions or diffuse
brain injury). When neuroimaging data was not available it was coded as
“missing”.
An officer not connected with the study randomised participants at a separate
location. The Primary Investigator was informed of group allocation and then
informed parents. The allocation sequence was computer generated and
assignments concealed using sequentially numbered opaque envelopes. No
stratification was used in terms of gestational age, or type or severity of brain
injury.
Intervention
Infants randomised to standard care either continued with pre-existing therapy
arrangements or were referred to a local intervention site by their referring
institution. Appendix 2 contains a checklist of intervention content for both
GAME and standard care as recommended by the Tidier Guidelines15.
GAME Intervention
GAME is an acronym for Goals, Activity and Motor Enrichment. The intervention
is based on the principles of active motor learning, family centred care, parent
coaching and environmental enrichment. Refer to Appendix 2 for a detailed
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description. The intervention was offered at least fortnightly until the infants first
birthday (corrected age).
Standard Care Intervention
“Standard care” (SC) describes the current follow-up and/or therapeutic
interventions used when an infant at high risk of CP is discharged from hospital.
It is not possible to standardise the frequency, intensity or type of interventions
received in the SC group. Therapeutic approaches used and modes and
intensity of delivery are varied. Appendix 2 contains information about SC in this
study.
Outcome Measures
The primary outcome was motor skills as measured by the Peabody
Developmental Motor Scales -Second edition (PDMS-2), a norm referenced
assessment of gross and fine motor skills in children 0-6 years. Results are
expressed as raw scores, standard scores and total motor quotient (TMQ),
which is regarded as the best estimator of motor ability. The PDMS-2 has been
validated as a discriminative measure and two studies have demonstrated its’
responsivity to change in infants and toddlers with CP16-17. PDMS-2
assessments were obtained at baseline, 16 weeks after therapy had
commenced and at 12 months corrected age. Two highly experienced
assessors (one physiotherapist and one occupational therapist) who were
blinded to group allocation scored the PDMS-2 assessments from video. High
inter-rater reliability has previously been established for this tool18.
Secondary outcomes included the Canadian Occupational Performance
Measure (COPM)

19

, an individualised criterion-referenced measure of

performance and satisfaction with performance of a parent-selected range of
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activities. The COPM was used at baseline to prioritise parent goals for their
baby’s development and assess parent’s perception of their infants’
performance on identified goals and their own satisfaction with the infants
current ability. After 16 weeks of intervention the COPM was rescored and new
priority areas identified. At 12 months the second COPM was rescored. Two
blinded assessors scored all COPMs post enrolment via telephone call.
Motor and cognitive skills were assessed using the Bayley Scales of Infant and
Toddler Development – Third Edition (BSID-III) and motor function using the
Gross Motor Function Measure (GMFM-66) 20. These measures were taken at
12 months only and scored by blinded assessors.
Enrichment of the home environment was assessed with the Affordances in the
Home Environment for Motor Development – Infant Scale (AHEMD-IS) 21.
AHEMD-IS identifies opportunities available within the home to promote motor
development, including characteristics of the indoor and outdoor environment
and the presence of a range of toys and equipment. This tool is a validated,
parent self report however sensitivity to change has not been established22.
Total score possible for infants younger than 11 months is 66 while from 12
months possible total score is 93, to account for the expected increase in
available learning materials. To compare change from baseline to follow-up at
12 months we compared percentages of total score, as per test developer
recommendations (personal communication).
The Depression, Anxiety and Stress Scales – 21 (DASS-21) 23 is an adult selfreport designed to measure the emotional states of depression, anxiety and
stress. It is a 21-item questionnaire and was used to measure parent mental
health at baseline, 16 weeks after randomization and at the 12-month time

!

7!

!
point. Lower scores are associated with more normal levels of depression,
stress and anxiety.

Sample size estimation
The study sample size was estimated from a power calculation based on our
earlier published pilot data using motor composite scores of the PDMS-2. We
considered a clinical meaningful difference between the groups to be at least 5
standard score points (0.5 of a standard deviation). With an alpha value of 5%
and power of 80%, using a minimal clinically important difference of 10% and
accounting for a 20% dropout rate, we estimated the sample size required to be
n=30; 15 per group.
Statistical Analysis
Analysis was carried out using SPSS and reported according to the CONSORT
statement. Descriptive statistics (frequencies, means and 95% CIs) were used
to describe the sample at baseline. Random missing data was imputed as last
observation carried forward. Where there were no results available due to
dropouts, only the data available were analysed so as not to introduce new
biases. Between-group differences for child outcomes were analysed using
multiple regression to determine whether group allocation predicted outcome.
As infants were too young to accurately use GMFCS as a motor severity
variable, a blunt neuroimaging +/- vision impairment severity variable was used
as a covariate within the regression analysis. The severity variable was the
aforementioned imaging ordinal score, plus a weighting point of +1 if the infant
had severe vision impairment (i.e. consistently visually unresponsive to a
moving toy stimulus; but motorically responsive to the same stimulus if an
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auditory cue was paired to the stimulus), since vision impairment is a known
confounder of motor development. Outcomes on the COPM were analysed
using linear regression without the severity covariate. Parent mental health
scores and home environment scores were compared with independent t-tests.

RESULTS
Thirty infants from twenty-nine families were recruited between February 2013
and June 2014 and randomised to GAME (n=15) or SC (n=15). Mean age at
enrolment was 17.9 weeks (SD 5.31). There was one set of twins randomised
to SC and two infants who were twins randomised to GAME. The flow of
participants is summarised in Figure 1. Adherence to study protocols was
excellent until the 16-week time point with no dropouts and all participants
receiving intervention as per protocol.
Between the 16-week primary endpoint and 12 month follow-up, 4 infants
dropped out of the study, all from GAME group. Reasons for drop out included:
relocation overseas or interstate for increased family support (n=3 of 4) and
experimental stem cell treatment (n= 1 of 4). Data was analysed for all infants
remaining in the study at 12 months, n=11 in GAME and n=15 in SC. In the 12month analysis, missing data could not have substantially biased the secondary
results because there was only after treatment BSID-III and GMFM-66 data,
plus baseline and severity covariates were available for all individuals and
included in all analyses24.
Participant characteristics are summarised in Table 1. Groups were equivalent
at baseline on infant characteristics, except for age at enrolment where the
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GAME infants were about 4 weeks younger by chance. Social risk was
classified as “high” or “low” based on previously used criteria 25.There were no
significant between group differences on child motor function (table 2) at
baseline. Parent mental health scores were different at baseline with GAME
parents having higher rates of depression, but no between group differences on
the other sub-scales or total score.

Child Outcomes
Primary and secondary outcomes for GAME and SC infants are presented in
table 2.
Primary Outcome 16 weeks after enrolment
After 16 weeks of intervention, no statistically significant between group
differences were found on the TMQ but GAME participants were 0.5 of a SD
better off. Significant between group differences were found in change in raw
scores in favour of GAME.
Primary outcome 12 months corrected age
Statistically significant between-group differences were found at 12 months on
both the PDMS-2 TMQ and raw scores favouring GAME. Confirmatory,
significant between-group differences were evident on the other motor
measures, the GMFM-66, BSID-III composite motor scores (B= 15.23; 95% CI
1.21, 29.25; p<. 04), and BSID-III fine motor standard scores alone, all
favouring GAME. No significant differences existed for the BSID-III gross motor
scale alone. In addition, mean BSID-III cognition scores were significantly
higher for GAME at 12 months.
COPM

!

10!

!
After 16 weeks of intervention both groups showed clinically meaningful change
on the performance scale of the COPM. Significant between group differences
were found in favour of GAME; mean change 3.55 (1.92) compared to 2.58
(2.21) for SC. There were no statistically significant differences between the
groups in change scores on the satisfaction scale (GAME: 1.62 [SD 3.22] and
SC: 2.00 [SD 1.78]).
At 12 months parent perception of their infant’s movement skills did not
significantly differ between the groups, despite only the GAME groups’ COPM
improvements reaching clinically significant thresholds of >2 points
(performance change scores: GAME 2.57 [2.44]; and SC 1.09 [1.06]). Parents
of infants in GAME did however have higher rates of satisfaction with their
child’s improvements (satisfaction change scores: GAME 2.66 [2.68] and SC
0.39 [1.17]).
Child Diagnostic Outcomes
Appendix 1 contains diagnostic outcome data for all 30 infants. At 12 months of
age n=25 (83%) had received a diagnosis of CP including 3 of the 4 who had
dropped out of the study. A further two infants were globally delayed, two were
undiagnosed but displaying neurological abnormalities such as motor
asymmetry and the developmental outcome of one infant was unknown. Of the
3 children with either no imaging or normal imaging, n=2 had mild diplegia and
n=1 had monoplegia and cognitive delay at 12 months.

Parent and environment outcomes
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Between-group differences on the AHEMD-IS scores at 12 months were non
significant. DASS 21 scores were compared at 12 months and no statistically
significant differences existed between the groups in total DASS 21 score or in
any of the subscales (Table 3). Mean values for both groups dropped to more
normal values between the 16-week time point and 12 months.
Dose of intervention
Complete logbooks were kept by 10 GAME families and 7 SC families and were
collected at 12 months. Hours of face- to-face therapy could be ascertained for
all families, however total dose could only be calculated for those with
completed logbooks. Infants in GAME received a mean of 21.91 (SD 4.25)
hours of therapy (median 22 hours) over the study period and SC 14.82 (SD
12.89) hours (median 13 hours). Parents in GAME reported they spent a mean
of 47.70 (23.30) minutes per day (median 54 mins) carrying out the home
programme while SC parents spent 42.29 (35.87) minutes (median 30 mins).
The total dose of therapy for GAME infants from enrolment until 12 months was
216.00 (87.26) hours and for SC infants 164.29 (98.79) hours. There were no
statistically significant differences in dose of therapy over the entire study period
(p =. 27), however there was a trend towards more intensive face-to-face
intervention for GAME participants (p =. 09).
DISCUSSION
GAME intervention appears to lead to improved short and medium term motor
outcomes when compared with a similar dose of SC. This is evidenced both in
the norm referenced measures (PDMS-2 and BSID-III) as well as the criterion
referenced GMFM-66. GAME appears to offer a new and positive benefit to
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developing the motor skills of infants with CP, which is the first clinical trial data
in CP to suggest this, since Palmer’s seminal work in the 1980s.
The PDMS-2 TMQ scores were not statistically significant after 16 weeks,
despite an estimate of effect of 7.5 favouring GAME, probably with the effect
washed out due to large variances in both groups. At baseline, the TMQ
variance was 0.5 of a SD for both groups, but increased to >1.0 SD by 16weeks, indicating: (a) infants were of heterogeneous severities with varying
capacities to respond to intervention; and (b) that norm referenced
assessments might overestimate ability at younger ages, when infants have a
more limited motor repertoire. At baseline, mean PDMS-2 TMQ scores for both
groups were “below average”, but after 16 weeks had dropped further into the
“poor" range for both groups, despite receiving intervention. At 12 months the
TMQ had dropped further again, into the “very poor” range for SC participants.
This finding was not unexpected. Infants with CP continue to develop and “gain”
raw score points over time, but are not expected to perform within the “normal
range” but rather fall further behind peers over time. GAME appeared
protective, that is, GAME participants did not fall as far behind.
The great majority of our sample had bilateral brain injuries albeit of varying
severities, whereas in the CP population one third typically have unilateral
injuries with milder motor disabilities26. In addition during the study period it
became clear that 8 of 30 (27%) had severe vision impairments (4 per group),
which exceeds the CP population norm of 10% 2. Vision impairment is a known
contributor to delayed motor development27 and in children with CP is a
predictor of non-ambulation28. These sampling errors meant that our study
sample was “more severely affected” than a representative CP “population
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sample”. In practice this may have meant our recruited sample might have been
lower responders than a more representative CP population sample.
Given the unexpectedly high number of infants with severe vision impairments
that were recruited to this study we would recommend formal visual function
assessments be completed early (at around 3 months) 29 to allow appropriate
supports and intervention to be put in place.
After intervention, cognitive scores as measured by the BSID-III were superior
for GAME infants, which we hypothesise could be a result of the environmental
enrichment component built into GAME intervention. A recent meta-analysis
demonstrated that in vulnerable families home visiting had a small positive
mean effect on child cognitive outcomes30. The consistency of home visiting in
GAME allowed specific exchanges and information sharing to take place
concerning customisation of play space, toys and play routines to enrich the
infant’s learning environment. Measuring cognitive outcomes by motor
manipulation of cognitive test items in infants with CP is complex and may have
dampened our ability to detect cognitive change. Many items are dependent on
age appropriate hand motor function and most widely used tools are not
validated or sensitive to change in children with CP31. A recent study of 4-5 year
olds with CP showed that almost 40% of participants were unable to complete
enough items to score a complete IQ test due to difficulties with items requiring
verbal ability and accurate fine motor performance (for example, pointing) 32. It
is likely that infants in this study with poor hand function may have scored lower
than their actual ability. Measuring cognition accurately in children with severe
forms of CP is an area requiring urgent research.
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The high number of infants diagnosed with CP by 12 months (n=25; 83%)
demonstrated the feasibility and accuracy of recruiting young infants with CP to
clinical trials using Prechtl’s General Movements Assessment (GMA) 33. To our
knowledge this is the first study published in literature to recruit a sample of
young infants (<6 months) where over 80% had CP. The 2 infants not
diagnosed with CP but whom had severe global delay (all domains <2 SDs
below the mean) had absent fidgety movements at 12-16 weeks but nonspecific changes on neuroimaging. The combination of term equivalent MRI and
GMA at fidgety age is recommended to most accurately identify infants with the
highest risk of CP, as neuroimaging alone is less sensitive34. Two infants in this
study were performing within the normal range on the PDMS-2 and the BSID-III
at 12 months although they both had persisting mild asymmetries and one had
spastic catches bilaterally at the ankle. Another infant who had also scored in
the normal range on the norm referenced tests, was predicted from imaging not
to have CP was nevertheless diagnosed with mild spastic diplegia at 12
months. Defining clinical diagnostic criteria for this group of mildly affected
infants is difficult and, in the absence of obvious activity limitations that are
required for a diagnosis of CP1, clinicians are understandably reluctant to use
the CP label. It is also a possibility that early motor intervention may have
optimised the outcomes of these infants.
Parent satisfaction with and perception of their infant’s performance on
identified goals was clinically important at 12 months only in GAME but only
significantly different from SC in satisfaction scores of the COPM. Interestingly
this was different to results at the 16-week time point when performance scores
were significantly higher for GAME families. Perhaps parent education about
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CP in the GAME group led to parents being more realistic about their child’s
motor skills at 12 months.
Measuring home enrichment is complex and we attempted to do this by using a
new scale, the AHEMD-IS. Although not statistically significant, mean scores in
the GAME group increased as a percentage of total possible score over the
study period. This may indicate that parents in this group were more likely to
provide a wider variety of learning materials to match motor challenge as their
child developed. A limitation of the AHEMD-IS is the focus on the physical
home environment and variety of motor stimulation; it does not account for
opportunities in other environments that the infant is exposed to. In addition, the
scale does not capture parental responsiveness, a known contributor to child
developmental outcomes35. Future studies of GAME should include measures
of parental responsiveness as well as more responsive measures of the
physical environment.
Professional mental health support was offered to all mothers with abnormal
DASS-21 anxiety or depression scores at any time point. Parent mental health
remained stable over the course of the study, with the mean score for
depression in the “mildly abnormal” range both at baseline and after 16 weeks
for mothers in GAME and in the normal range for SC. Although by 12 months
mean scores for all subscales were in the normal range, approximately 20% of
mothers were scoring in the moderate to severe range for depression and/or
anxiety. This finding highlights the importance of the availability of evidence
based parent support programmes for parents of infants newly diagnosed with
disabilities36. In addition, two thirds of the sample was considered to be at high
social risk plus one third were from families where English was not the first
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language spoken at home. The combination of high social risk and higher than
average levels of depression and anxiety amongst these mothers, highlights the
vulnerability of families with young infants at high risk of CP and other
disabilities. EI programmes should include family support options that assist
parents in their role and provide strategies to support their mental health and
enhance their well-being.
Previous CP trials in older children have shown that high-dose motor-learning
based therapy leads to better results than low-dose motor-learning therapy,
causing experts to hypothesise that many therapy interventions studied to date
might be under-dosed. Interestingly, in older children, when two effective motorlearning interventions are compared head-to-head at the same high-dose,
similar patient outcomes result. Recent systematic reviews have therefore
identified that in addition to type of therapy mattering (effective versus
ineffective) also the intensity of the therapy is important for treatment success37.
In our GAME study, the dose of intervention was not statistically significant
between the groups, due to the large variation within each group, however the
median values clearly demonstrate that most GAME participants received a
higher number of therapy sessions and most GAME parents engaged in more
home practice. It is therefore likely that both the higher dose of intervention as
well as characteristics of GAME contributed to the gains achieved in the GAME
group.
Limitations
The study has a small sample size, but despite this we observed betweengroup differences. We estimated sample size on an earlier pilot study in which
no infant had visual impairment. In this study the spread of severity was
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considerably wider as evidenced by the confidence intervals in the primary
outcome at follow up. In addition the n=4 dropout, all from the intervention
group might have influenced the final results. A further limitation is the
incomplete information about the intervention content of the SC group. As
expected there was substantial variety in intensity, mode and type of therapy
offered. Motor task practice and the provision of a home program were common
elements across both groups. Future studies should endeavour to identify the
specific elements of GAME that led to the demonstrated benefits. Finally, we
used a novel severity variable to account for the variation in brain injury in our
sample. This has not been previously tested however in this study it predicted
outcome accurately 75% of the time which proved more accurate than the most
recognised severity tool, GMFCS, which is 58% in this age group38.
CONCLUSION
Our study suggests that 6-9 months of GAME, a clinically feasible intervention,
is more effective than SC to advance the motor function of infants at high risk of
CP. Furthermore using the GMA to recruit very young infants with CP to clinical
trials is possible. GAME is a promising new early intervention for infants. We
therefore recommend a larger and longer well-powered RCT of GAME
intervention be conducted with more finely tuned exclusion and inclusion criteria
to establish characteristics of responders and non-responders and to define the
minimum dose required.
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Figure 1: Flow of participants
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TABLE 1. Characteristics of Participants
INFANT CHARACTERISTICS
AGE

Enrolment corrected age (weeks) mean (SD)

SEX
CP RISK
FACTORS

Male, n (%)
Birth weight (kg), mean (SD)
Multiple births, n (%)
Hypoxic Ischaemic Encephalopathy, n (%)
Birth gestational age (weeks), mean (SD)
• < 28 weeks, n (%)
• 28-31 weeks, n (%)
• 32-36 weeks, n (%)
• > 36 weeks, n (%)
GMs Absent fidgety, n (%)
GMs not assessed, n (%)
Neuroimaging available, n (%)
MRI
• CUS only
• No imaging
Neuroimaging results, n (%)

CP
DETECTION

GAME n=15
15.73 (4.76)
8 (53)
2.31 (1.02)
2 (13)
4 (27)
34.27(5.27)
1(6)
4(27)
2(13)
8(53)
15 (100)
0

SC n=15
20.07
(5.08)*
9 (60)
2.65 (1.12)
2 (13)
2 (13)
35.27 (5.09)
1(6)
3(20)
2(13)
9(60)
13(87)
2 (13)

13 (87)
1 (6)
1 (6)

12 (80)
2 (13)
1 (6)

0
1(6)
13(87)

1 (6)
3(20)
10(67)

4(27)
4 (27)

2(13)
1 (6)

4 (27)
2 (13)
1 (6)

7 (47)
4 (27)
1 (6)

4(27)
0
1(6)
0
5 (33)

3(20)
1(6)
1(6)
1(6)
3 (20)

33.73 (4.73)
10 (67)

31.07 (7.11)
6 (40)

7 (47)
9 (60)

3 (20)
11 (73)

(MRI or CUS – term equivalent age)

• Normal
• Unilateral injury
• Bilateral injury
CP
SEVERITY
SCORES
(predicted by
blind scoring
of imaging)

Associated
impairments
n (%)

• 3=non-ambulant CP +VI
• 2 = non-ambulant CP no VI OR
ambulant CP + VI
• 1 = ambulant CP no VI OR VI alone
• 0 = no CP and no VI
• Missing (ie no imaging available)
•
•
•
•
•

Severe cerebral vision impairment (CVI)
Severe ROP (Grade 3)
Epilepsy (uncontrolled)
Hearing Impairment
Microcephaly (>3 SD below mean)

FAMILY CHARACTERISTICS
SOCIAL
RISK

Maternal age; mean (SD)
Mother’s education beyond secondary school,
n (%)
Primary language not English, n (%)
High social risk, n (%)

* p<.05; CP severity score based on neonatal imaging and visual function; VI=vision impairment (either
severe ROP or diagnosed severe cerebral vision impairment [CVI]); *=Statistically significant
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Table 2: Outcomes at baseline, after 16 weeks and at 12 months
Outcome
Time Point Measure
Baseline
16-weeks
12-months
Baseline
16-weeks
12 -months

Baseline
16-weeks
16-week
new
12-months
Baseline
16-weeks
16-week
new
12-months
12-months
12-months
12-months
12-months
Baseline
12-months

PDMS-2
Raw
PDMS -2
Raw
PDMS-2
Raw
PDMS-2
TMQ
PDMS-2
TMQ
PDMS-2
TMQ

Group
GAME (n=15)
SC (n=15)
Mean (SD)
Mean (SD)
INFANT MOTOR DEVELOPMENT

Estimate of
Effect
(95% CI)

pvalue

33.60(13.71)

41.93 (16.49)

-

.14

73.20(36.40)

77.20 (44.25)

20.71 (1.66,39.76)

.03*

124.64(55.98)

107.93 (51.11)

51.58 (26.64,76.52)

.01*

84.87 (7.89)

82.93 (7.92)

-

.51

79.13(16.11)

71.93 (16.02)

7.58 (-1.37, 16.52)

.09

72.64(17.75)

67.339 (16.12)

8.29 (0.13, 16.45)

.05*

PARENT PERCEPTION OF INFANT MOTOR PERFORMANCECOPM
3.05 (1.09)
3.19 (0.58)
Performance
COPM
6.53 (2.08)
5.94 (2.56)
1.86 (0.58, 3.14)
Performance
COPM
3.75 (1.48)
3.45 (1.15)
Performance
COPM
6.64 (2.55)
4.54 (2.82)
1.61 (0.11, 3.34)
performance
COPM
5.18 (2.24)
4.40 (1.64)
Satisfaction
COPM
6.80 (2.37)
6.19 (2.80)
0.35 (-1.35, 2.13)
Satisfaction
COPM
4.05 (1.89)
4.78 (2.51)
Satisfaction
COPM
7.00 (2.45)
5.18 (2.82)
2.14 (0.40, 3.89)
Satisfaction
INFANT MOTOR FUNCTION
GMFM-66
34.97 (13.42)
32.51 (9.99)
7.96 (0.00, 15.96)
INFANT DEVELOPMENT
BSID-III
Cognition
6.27 (4.69)
4.40 (4.09)
3.85 (0.39,7.31)
BSID-III
Fine motor
5.18 (3.66)
3.80 (3.41)
3.01 (0.32,5.71)
BSID-III
5.72 (2.88, 8.56)
Gross motor
3.36 (3.98)
3.00 (3.05)
HOME ENRICHMENT
AHEMD-IS
50.40 (14.08)
55.00 (11.83)
AHEMD-IS
55.09 (13.90)
53.60 (10.66)
2.30 (-10.88, 6.30)

PDMS-2= Peabody Developmental Motor Scales – Second edition; TMQ= total motor quotient;
COPM=Canadian Occupational Performance Measure; GMFM-66= Gross Motor Function Measure; BSID-III=
Bayley Scales of Infant and Toddler Development (expressed as standard scores); AHEMD-IS= Affordances
in the Home Environment for Motor Development Infant Scale (expressed as percentage of total possible
score). *=Statistically significant
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.41
.01*
.53
.07
.28
.08
.53
.02*
.05*
.03*
.03*
.12
.34
.59

!

Table 3. Parent mental health at Baseline, after 16 weeks and at 12 months
Measure
GAME Mean
SC Mean (SD)
p-value
(SD)
DASS-21 Total Score
Baseline
16 weeks
12 months
Depression SubScale
Baseline
16 weeks
12 months
Stress Sub-Scale
Baseline
16 weeks
12 months
Anxiety Sub-Scale
Baseline
16 weeks
12 months

29.60(21.26)
30.80 (24.92)
22.73 (21.06)

21.47(10.62)
21.20 (17.95)
19.20 (17.38)

.20
.24
.64

10.67 (7.55)
10.00 (7.67)
8.18 (7.13)

4.53 (3.89)
6.27 (5.70)
6.00 (7.13)

.01*
.14
.45

13.33 (9.58)
14.27 (10.28)
10.00 (10.51)

13.07 (5.60)
9.87 (6.65)
9.07 (6.50)

.93
.18
.78

5.60 (6.29)
6.53 (8.57)
4.55 (5.52)

3.87 (4.69)
5.07 (7.32)
4.13 (6.07)

.40
.62
.86

*=Statistically significant
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!!!!!!!!!APPENDIX!1:!PARTICIPANTS!and!OUTCOMES!at!12!months!
!
Infant
sex
1

Group

SC

CP risks
and
severity
coding
Preterm
<32 weeks

GMs

U
F-

Severity
Code= 3
HIE
IUGR

PR
F-

Severity
code=2
Preterm
<26 weeks

Extensive WMI
Bilateral PLIC
involvement
Pre-wallerian
degeneration

PR
F-

Bilateral Grade CP
III/IV IVH
R
Bilat cerebellar unilateral
haemorrhages

8 months

CLD

CS
F-

Severe
bilateral cPVL

CP
Bilateral
hypotonic

4 months

Microcephaly
Cognitive
delay

CS
F-

No imaging

CP
Mild
dyskinetic
unilateral

12 months

Cognitive
delay

U
F-

CUS
Bilateral
Periventricular
echogenicity
CUS
Periventricular
echogenicity

CP
Mild
spastic
bilateral
CP
Spastic
bilateral

12 months

12 months

ROP stage 3

U
U

Bilateral
thalamic
haemorrhages

CP
Dyskinetic
bilateral

10 months

Epilepsy
Cognitive
delay

CS
F-

Signal intensity
abnormalities
Bilateral PLIC
involvement

Global
delay

NA

Hearing
impairment
Cognitive
delay

F
2

GAME

F

3

GAME

M

M

Severity
code=2
Preterm
<30 weeks
Birth defect

5

GAME

Severity
code=2
Birth defect

GAME

Severity
code =
missing
Preterm

4

GAME

M
6
F
7
M

8
M
9

SC

SC

SC

Severity
code=0
Preterm
<26 weeks
Severity
code=1
CVA
Severity
code=1
Birth
defects

M
Severity
code=0

!

PR
F-

Imaging
Abnormalities
(regions
involved)
Bilateral GMI
Bilateral PLIC
involvement
Pre-wallerian
degeneration

Diagnosis

CP
Spastic
bilateral

CP
L
unilateral

Age
diagnosed

Other
impairments

6 months

CVI
Microcephaly
Cognitive
delay
Epilepsy
Gastrostomy

10 months

26!
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10

SC

HIE

PR
F-

BGT injury +
mild WMI
Bilateral PLIC
involvement

CP
Bilateral
Dyskinetic

8 months

GAME

Severity
code=2
HIE

PR
F-

BGT injury
Bilateral PLIC
involvement

Not
diagnosed

PR
F-

CUS
Bilateral Gr III
IVH
Bilateral
ventriculomeg
aly

Spastic
catches
present
both LLs,
otherwise
normal
Mild
asymmetr
y,
otherwise
normal

Preterm
< 30 wks

U
F-

WMI
Moderate
bilateral cPVL

CP
Spastic
Bilateral

6 months

SC

Severity
code=1
NNAS

U

Normal

5 months

Cognitive
delay

GAME

Severity
code=0
HIE

PR
F-

5 weeks

Severity
code=3
Birth
defects

Severe
bilateral BGT
and WMI

CP
Mild
spastic
bilateral
CP
Bilateral
dyskinetic

Epilepsy
CVI
Gastrostomy

PR
F-

Unknown

Severity
code=0
Birth
defects

Mild vermian
hypoplasia
Enlarged
fourth ventricle

PR
F-

Maldevelopme
nt:
Reduced
sulcation
Abnormal
ventricular
shape
Grade IV L
IVH
cPVL (left)
L PLIC
involvement

CP
Bilateral

12 months

CVI
Microcephaly
Gastrostomy

CP
R
unilateral

12 months

R
hemianopia
Severe
feeding
issues

No imaging

CP
Mild
bilateral

12 months

M
11
F
12

Severity
code=1
SC

M

13
M

14
F
15
M
16

Preterm
Severity
code=0

GAME

GAME

F
17

SC

F
Severity
code=1
18

SC

Hydrocepha
lus

PR
F-

M
Severity
code=1
19
F

!

SC

Preterm
(<36 wks)
NNAS
Birth
defects

PR
F-

Not
diagnosed

Microcephaly
Failure to
thrive
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20

GAME

M

Severity
code=
missing
Preterm
Multiple
birth

CH
F-

Bilateral
arterial
infarction
Bilateral PLIC
involvement
Pre- wallerian
degeneration
Bilateral BGT
+ WMI

CP
Mild
bilateral

12 months

CP
Bilateral
dyskinetic

8 months

Bilateral GMI +
BGT
Bilateral PLIC
involvement
Bilateral
ventriculomeg
aly
Bilateral PLIC
involvement

CP
Bilateral
spastic

5 months

CP
Bilateral
spastic

10 months

U
F-

BGT + mild
WMI

12 months

CH
F-

Bilat GMI +
BGT
Severe
bilateral cPVL
Bilateral PLIC
involvement
L MCA infarct
including BGT
L PLIC
involvement
Pre-wallerian
degeneration
WMI + mild
BGT
Bilateral PLIC
involvement
Bilateral
extensive WMI
R IVH grade IV
R PLIC
involvement
Pre-wallerian
degeneration

CP
Mild
Bilateral
Spastic
CP
Bilateral
dystonic

CP
Unilateral
spastic

12 months

Global
delay

Not
diagnosed
by 12 mths

Cognitive
delay

CP
Bilateral

4 months

CVI
Microcephaly

CP

8 months

Severity
code=1
21
F
22

GAME

NE

GAME

Severity
code=2
Nil known

F
23

GAME

M

24
F
25

SC

GAME

F
26

28

Severity
code=1
HIE
Severity
code=1
Preterm
<30 weeks

CS
FN
F-

Severity
code=3
SC

M
27
M

Severity
code=3
Hydrocepha
lus
Birth
defects

U
F-

CVA

U
F-

Severity
code=1
SC

SC

M

Seizures
Severity
code=0
Preterm
<30 weeks
Multiple
birth

U
FCS
F-

Severity
code=3
29
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SC

Preterm

CS

R GMI +

4 months

CVI
Microcephaly

CVI
Microcephaly
Gastrostomy

28!

!
<30 weeks
Multiple
birth

F

30
M

GAME

Severity
code=1
Preterm
<36 weeks
Multiple
birth

F-

thalamus
R PLIC
involvement
Pre-wallerian
degeneration

L
unilateral

PR
F-

Severe
bilateral cPVL
Bilateral PLIC
involvement

CP
Bilateral
spastic

4 months

CVI
Microcephaly

Severity
code=3
GMs = general movements: U=unknown; PR= poor repertoire; CS= cramped
synchronised; CH= chaotic; N=normal; F- = absent fidgety. HIE = hypoxic ischaemic
encephalopathy; NE = neonatal encephalopathy; IUGR= intrauterine growth restriction;
cPVL = cystic periventricular leukomalacia; NNAS = neonatal abstinence syndrome;
CVA = cerebrovascular accident; CUS= cranial ultrasound; GMI= grey matter injury;
WMI=white matter injury; BGT= basal ganglia and thalamus abnormalities;
PLIC=posterior limb of internal capsule; MCA=middle cerebral artery infarction;
IVH=intraventricular haemorrhage; CVI=cerebral vision impairment; ROP = retinopathy
of prematurity; CLD = chronic lung disease
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'

who could not take weight well in supported standing by 10 months.

'

'

'

adequate support. Standing frames were provided to 2 infants with more severe motor impairments

was used or adapted. Customised foam inserts were sometimes used in highchairs to provide

In most instances infant equipment (baby seats, prams or highchairs) already owned by the family

materials already owned by families was utilised.

information re toy libraries, websites or shops to purchase additional materials. Wherever possible

family. Assistance was given to families who wanted to obtain specific toys for their child eg

A range of toys and learning materials were shown to the families and sometimes loaned to the

activities or how to “set up” play space for practice.

customised home programme containing activities and photographs of their child performing

needs. We did not use pre-written brochures or information sheets. Each family received a

All information relayed to families was customised to the parent’s goals and questions and the infants

WHAT

framework.

GAME is grounded in contemporary motor learning theory and is delivered in a family centred

WHY

BRIEF NAME
GAME (Goals, Activity, Motor Enrichment)

Item

TIDieR'checklist'
'

3.

2.

1.

number

Item

'

1

'

number)

'

(page or appendix

Primary paper

'

Protocol; Pilot

Protocol; Pilot

Protocol; Pilot

Other † (details)

Where located **

Information to include when describing an intervention and the location of the information

The TIDieR (Template for Intervention Description and Replication) Checklist*:

'

'

'

general information. Activity ideas were photographed. Programme updated as required

'

Home programme: Customised to infant; included range of activities related to each goal PLUS

coached in simple task analysis and in observation of movement principles.

as questions arose -discussions could be initiated by either parent or therapist. Parents were

Parent Education: General information about development, feeding, sleep, play and CP were given

were introduced as early as practicable.

soon as infant demonstrated emerging ability to maintain balance. Activities to encourage reaching

required AND supported floor sitting. The minimal amount of support was provided and reduced as

c) Sitting: supported sitting began straight away both using a reclining infant seat with supports as

with reaching

parent’s lap and as/if sitting balance progressed from a small foam block. This activity was integrated

b) Sit to stand: all infants practiced sit to stand activities with their parents. Initially this was from the

as tolerated. Parents were coached inappropriate activities for mCIMT as well as bimanual play.

sock was used to constrain the affected hand. Suggested intensity of practice was 20 mins per day

a) CIMT: infants with asymmetrical hand function were treated with modified CIMT from 6 months. A

Some examples of motor training:

Motor training was customised to the child in relation to assessment and parent identified goals.

and parent problem solved solutions together.

began with discussion of changes since last appointment or any difficulties with activities. Therapist

around parent questions and infant health status, behavioural state or routine. Typically sessions

education and environmental enrichment strategies were woven together. Sessions were modified

infant’s routine. Usually all elements of GAME were present in every session. Motor training, parent

Therapy sessions: The time for sessions was usually set by parent preference according to the

TIDieR'checklist'
'

4.

'

'

'

'

Protocol; Pilot

'

'

'

'

activity. Similarly if difficulties arose with feeding the infant was referred for further assessment.

As the infant developed adjustments were made to the programme to grade the challenge of the

TAILORING

minutes

enrolment and complexity of child and family. Length of sessions ranged from 30 minutes to 90

preferences of the family. Number of appointments ranged from 18 to 30 depending on age at

hours of therapy. Sessions were typically one hour in length but were customized to the situation and

in length of time in the study due to age of enrolment, we calculated both the mean and median of

preferences however no infant was offered therapy more than once per week. As there was variation

of the study period. GAME dose was deliberately customized to the family’s situation and

GAME was offered at least fortnightly however some infants received weekly sessions for a portion

WHEN and HOW MUCH

GAME was always provided at the family’s home.

WHERE

All intervention was provided face to face on an individual basis.

HOW

pediatric rehabilitation.

sessions provided GAME intervention. Both therapists had more than 20 years experience in

A physiotherapist and occupational therapist either together in a joint appointment or in individual

TIDieR'checklist'
'

9.

8.

7.

6.

5.

WHO PROVIDED

'

P5

P5

P5

P5

'

'

'

Protocol; pilot

Protocol; pilot

Protocol; pilot

Protocol; pilot

Protocol; pilot

range of home practice recorded

their infants at home but were asked to do as much as they felt they could manage. There was a big

were collected. Parents were not instructed how much to practice home programme activities with

week and 12 month timepoints and for these infants the dose was not calculated as no logbooks

did not receive the intended dose of therapy. Four infants dropped out of the study between the 16

One infant in GAME went overseas for 8 weeks for family reasons during the intervention period and

was not separately assessed

As the same therapist provided the intervention to all infants in the experimental group, fidelity

HOW WELL

and implementation of advice by vision specialists was integrated into the programme.

referred for further assessment. The environment was adapted to include tactile and auditory toys

A number of infants were noted to have severe visual impairment. When this occurred the infant was

MODIFICATIONS

P9

Protocol; pilot

TIDieR'checklist'
'

'

'

'

'

'

'

'

'

*'The'focus'of'TIDieR'is'on'reporting'details'of'the'intervention'elements'(and'where'relevant,'comparison'elements)'of'a'study.'Other'elements'and'methodological'features'of'
studies'are'covered'by'other'reporting'statements'and'checklists'and'have'not'been'duplicated'as'part'of'the'TIDieR'checklist.'When'a'randomised*trial'is'being'reported,'the'
TIDieR'checklist'should'be'used'in'conjunction'with'the'CONSORT'statement'(see'www.consortRstatement.org)'as'an'extension'of'Item*5*of*the*CONSORT*2010*Statement.*
When'a*clinical*trial'protocol'is'being'reported,'the'TIDieR'checklist'should'be'used'in'conjunction'with'the'SPIRIT'statement'as'an'extension'of'Item*11*of*the*SPIRIT*2013*
Statement'(see'www.spiritRstatement.org).'For'alternate'study'designs,'TIDieR'can'be'used'in'conjunction'with'the'appropriate'checklist'for'that'study'design'(see'
www.equatorRnetwork.org).''
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Therapy sessions: Typically therapists handled the infant for practicing motor skills or facilitating

infants received standing frames while 6 used therapy balls for practicing set activities

including Bumbo seats or an infant seat with tray. One third prescribed specialised seating. Four
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parents were told how long and how often to carry out the HP. Sometimes photographs were used to

All parents were given a home programme and for 1/3 this was provided in written format. Most
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Chapter 8 CONCLUSION
8.1 SUMMARY
The studies of this thesis make an innovative and important contribution to
the early intervention in CP field. Despite the limitations outlined at the end
of this chapter, GAME is a promising intervention for infants with CP and
their families. The results demonstrate the importance of early diagnosis
using the GMA, and the importance of testing of motor and cognitive
outcomes of infants with CP in well-powered early intervention trials.
The studies of this thesis have focussed on two problems and investigated
two solutions:
1. PROBLEM: Although the brain injury or lesion associated with CP
originates in infancy and is non-progressive, a clinical diagnosis of CP is not
usually given until the second year of life. Not identifying CP in infancy
delays access to possible neuro-rehabilitative interventions that have the
potential to harness neuroplastic mechanisms and optimise developmental
outcomes.
SOLUTION: High quality evidence exists that in fact CP can be detected
early in high risk infants if the right tools are used, namely the GMA and
appropriately timed MRI (Study 1). The subsequent research programme
confirmed that the GMA detects CP in 3-4 month old high-risk infants with
high levels of sensitivity and specificity in an Australian context, similar to
those published elsewhere and therefore is feasible (Study 3).
2. PROBLEM: There is a lack of empirical evidence that early intervention for
infants at high risk of CP has benefits for motor outcomes above that which
would have been expected from development. This problem in part flows
from the historical difficulties in identifying the “right” infants to recruit to
clinical trials. In addition, goal-oriented motor learning interventions known
to be effective in older children with CP had not previously been tested in
infants.
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SOLUTION: Our systematic review (Study 2) found that interventions that
include an environmental enrichment component have a small but positive
effect on motor outcomes in infants at high risk of /with CP. We therefore
next developed and tested an intervention (”GAME”), based on motor
learning and environmental enrichment principles, in infants at high risk of
CP, whom we recruited using the GMA or MRI (Studies 4-6). These two
small clinical trials demonstrated that GAME is feasible to deliver and can
advance the motor outcomes of infants with CP.
8.2 SYNTHESIS OF FINDINGS
8.2.1. Early identification of CP - major findings
a) The right infants, the right tools at the right time
The first two research questions (identified in Chapter 1 p ) asked if it was
possible to detect CP in the first months of life and if it was, then what the
most predictive tools were, and what was the feasibility of achieving this in
our local context (Studies 1 and 3).
Right infants: The use of the right tools at the right time is the most accurate
way of identifying those who are specifically at “high risk of CP” from those
of generic “high-risk”. More specific “high risk of CP” designation will
enable infants to be offered diagnostic specific intervention rather than
generalised developmental advice. For example, infants with unilateral
lesions predictive of hemiplegia might be offered very early CIMT, while
those with basal ganglia and thalamus lesions and thus at risk of severe
dyskinetic CP, could be offered very early access to technology.
In Study 1 we summarised the risk profile for CP using data from the
Australian Cerebral Palsy Register. The mean age of diagnosis of CP was 19
months. It was found that just over half of all children later diagnosed with
CP were considered high risk in the neonatal period and were NICU
patients. In this group a large proportion of infants were preterm, although
amongst the preterm population 10% or less actually go on to have CP.
Higher risk for CP exists for infants with neonatal encephalopathy,
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particularly those with moderate to severe HIE, even with the advent of
hypothermia (1).
Right tools at the right time: For infants in the high-risk group we have made
recommendations for finding the right infants using the right tools, based on
available evidence (Study 1). This includes the routine and systematic use of
sensitive assessment tools including the GMA, HINE and neuroimaging
(preferably MRI) within the NICU environment as well as GMA and HINE at
follow-up. Identified infants should be referred for early intervention to
promote development. These infants are at high risk of abnormal outcome on
the basis of abnormal GMs alone. In our sensitivity study (Study 3) only
three infants with abnormal fidgety movements had not received a definitive
diagnosis at 12 months but had received early intervention and were being
closely monitored due to mild neurological signs, such as asymmetry in
hand function. All of the others had received early intervention and either
had CP or another developmental disorder. This study confirmed that early
detection is feasible in our context.
b) Recruiting samples of infants with CP is possible
Considering that CP is such a heterogeneous condition, and that 15% have
normal MRIs, and that the GMA can also detect severe cognitive impairment,
it is unlikely that 100% accuracy in detecting CP is achievable in the first year
using even the best combination of tools. However, given that 50% of infants
that will later be diagnosed with CP were treated in NICUs, earlier detection
is achievable for many of these infants (2).
Prior to the targeted training of clinicians across all NICUs in NSW, only one
centre was using the GMA routinely. As a result of our knowledge
translation project (Study 3) that used tailored site-specific solutions to
embed the use of the GMA into practice, all centres now have at least two
trained staff and a number of centres have changed their follow-up schedule
to take advantage of the optimal window for GMA. This simple shift in
practice enabled accurate identification of infants suitable for enrolment into
the RCTs of this research program as well as earlier access to intervention for
other infants with identified delays.
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In the two RCTs we conducted (Studies 5 and 6), the GMA was used to
identify infants for recruitment to the trials. In the pilot study 85%were
referred from NICUs and 15% from the community. In the 12-week pilot
(Study 5) 77% of infants had a definitive diagnosis of CP before the primary
endpoint. The long-term outcome of the others is unknown. In the larger
RCT (Study 6) 83% had a definitive diagnosis by 12 months, 7% had severe
developmental delay, 7% had normal outcomes on standardised testing but
persisting mild asymmetries and 3% had dropped out prior to diagnosis. To
our knowledge of the published literature, these two studies have recruited
the highest percentage of infants with CP from such an early age. Future
studies might be able to improve further on this by adopting inclusion
criteria that specifies relevant MRI results and absent fidgety GMs at 3-4
months.
c) Use of clinical imaging in prognosis
Predicting CP from MRI is possible in many cases if the right timing,
equipment, sequences and scorers are used (3). In the preterm population,
MRI at term equivalent age has higher sensitivity for predicting CP than
earlier scans and is recommended for these infants for risk stratification (4-6).
For term born infants the picture is less clear, although in recent reviews
authors have confirmed the sensitivity of early (newborn) MRI post HIE and
neonatal stroke for predicting neurodevelopmental outcomes, including CP
(3, 7).
In our second RCT (Study 6) a pediatric neurologist and radiologist blind
scored clinical imaging and were 75% accurate in predicting a future
diagnosis of ambulant or non-ambulant CP (Appendix 1 of chapter 7). Of the
25% of cases where the outcome was not accurately predicted from imaging
alone, 7% was a scan quality issue (CUS) and 3% had a normal finding. A
further 7% were expected from imaging to be non-ambulant due to extensive
bilateral injuries but were clearly going to be ambulant by the 12-month
assessment. Only one infant predicted to have ambulant CP was not
diagnosed by 12 months. In essence, in our study, clinical imaging when
scored by experts, gave enough information to predict CP and therefore we
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conclude high quality imaging should be routinely included in the diagnostic
process.
Implications for policy, practice and research
1). A multidisciplinary approach to the diagnostic process is recommended.
Imaging experts, neonatologists and allied health practitioners are all
responsible for aspects of infant care and assessment. Parents of high-risk
infants need evidence-based information provided compassionately and in a
timely fashion with which they can begin the process of acceptance of their
child’s disability.
2). To most accurately make an early clinical diagnosis of CP both the GMA and
MRI are recommended to be used.
The combination of absent fidgety general movements and specific findings
on MRI are highly predictive of CP and we recommend counselling for
parents and prompt referral to early intervention programmes that offer
motor learning and cognitive enrichment approaches. In cases where only
general movements are abnormal but MRI findings are non-specific we
recommend a “high-risk of CP” designation be given and an explanation to
parents that a more formal diagnosis may be established in the future. Early
intervention should still be offered in this case.
Clinicians responsible for the care of high-risk infants ought to be equipped
with the most appropriate training to accurately identify the infants in their
care most in need of intervention post discharge. Currently the use of
neuroimaging appears “centre dependent”. MRI is more often used for
infants with HIE than preterm infants although well equipped centres might
use MRI in more instances. Cranial ultrasound is the imaging of choice in the
preterm population due to its clinical utility, however CUS has lower
sensitivity and when used alone misses a large proportion of infants with CP
(8-9). Routine use of the GMA within the NICU environment could identify
those at neurological risk thus enabling closer specific monitoring. In
particular, a trajectory of cramped synchronized general movements is a
marker for later diagnosis of spastic CP (10) and could prompt a medical
practitioner to request MRI. Infants with abnormal general movements ought
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to be followed up and monitored even if other results such as imaging and
early developmental testing are within the normal range. Further research to
establish and implement the use of scoring systems for MRI at an
international level is vital to further our understanding of causal pathways to
CP and to ensure researchers and clinicians are using the same “language”
when reporting neuroimaging findings.
3). Neonatologists, paediatric neurologists, paediatricians and allied health personnel
working with high-risk infants should receive basic training in the GMA.
Currently, training in the GMA is not regarded as essential, however given
the predictive validity of the assessment we recommend it be introduced.
The human resource burden of GMA scoring might be reduced in the future
by computerized scoring (13,14) as well as the development of smartphone
applications to enable parents to record a general movements video and
upload for scoring by certified assessors. Outcomes of these studies have the
potential to improve clinical utility of GMA and when these tools are
available should be seamlessly embedded into NICU and follow up
environments.
4). Standard neurological testing is an important part of the diagnostic process.
Standard neonatal follow up includes comprehensive developmental
assessment, typically using the BSID. Routine use of the HINE at follow up is
a suitable addition to this procedure. Recent publications regarding the BSID
have demonstrated poor predictive power for future cognitive and motor
delays (11-12) and so should not be relied on in isolation to determine an
infant’s neurodevelopmental status. We recommend the HINE be included
for the high risk population as cut off scores on this assessment can predict
CP at different time points with greater accuracy than other available tests.
No specialized training course is required to be able to use this assessment.
5). Identifying infants who are not regarded “high risk” in the neonatal period will
prove more difficult.
The causes of CP in the term born (“low risk”) group are still not well
understood and lack of knowledge regarding timing of the injuries
associated with CP is an ongoing problem. The “wait and see” approach is
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commonly applied in practice, often leading to delay in referral for
intervention and feelings of unresolved anxiety for parents (15). Another
problem for this group is that there are very few CP-specific predictive tests.
In infants older than six weeks an anaesthetic is usually required for MRI so
in the absence of clear neurological signs, MRI is not typically offered. The
atypical presence of primitive reflexes and muscle tone are considered basic
items for infant assessment but are not as sensitive for prediction of
neurodevelopmental outcome as the “quality and quantity of movement “
items in the HINE (16). Assessment of risk factors, neurological exam (HINE)
and standardized motor assessment and the use of the Ages and Stages
Questionnaire with three additional questions are recommended, as outlined
in Study 1. Further research is required to determine what combination of
these items are the most predictive of a future diagnosis in “low risk” infants
with motor delay.
In order to translate these recommendations into clinical practice we
recommend that International Clinical Guidelines for the early detection of
CP be developed and disseminated as a matter of urgency.

8.2.2. Early intervention for infants with CP – major findings
a) Infants with CP are an under-researched group
The last three research questions (Chapter 1 p ) were focused on the
effectiveness of using motor learning interventions for infants at high risk of
CP. In Study 2 we used systematic review methodology to summarise the
available evidence for the impact of environmental enrichment (EE) on the
motor outcomes of infants with CP or at high risk of CP. The paucity of trials
in this population was alarming with only seven RCTs retrieved from all
published literature. Only the studies that included relatively homogeneous
groups of infants with CP demonstrated between group differences in favour
of the EE intervention group. These studies also included child-active motor
training within the protocol.
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The search process for this review demonstrated that although there were
many intervention studies of preterm infants, very few of these studies
included infants with known brain injuries and studies that included them
had very low numbers with CP. In addition, interventions commonly
researched in the “at risk” populations are now shown ineffective (17-18),
while very few contemporary motor learning interventions have been tested
in infants. We concluded that very little is known about the effect of early
therapy intervention on infants at the highest risk of CP because despite
commonly held beliefs, they are an under-studied population. Our metaanalysis (Study 2) was able to demonstrate, however, a small but positive
effect for interventions that included environmental enrichment even though
the types of enrichment varied between the studies.
b) A motor-learning intervention, GAME is effective for infants with CP
The intervention package we developed and labelled GAME (Study 4) was
built upon published literature relating to goal and activity based therapy,
motor-learning principles, and environmental enrichment and delivered in
the context of family centred care. The protocol was first tested in a pilot
study (Study 5) and we found the intervention was acceptable to parents and
the recruitment processes were identifying the “right” infants. The second
larger and longer RCT (Study 6) used slightly expanded inclusion criteria
and some alternative outcome measures. Both of these studies demonstrated
that early motor learning interventions, delivered in an enriched home
environment and jointly applied by trained therapists and parents can
improve motor outcomes of infants with CP to a greater extent than usual
care. This is the first trial to demonstrate superior motor outcomes since
Palmer’s trial (19), and is therefore a new contribution to knowledge about
early intervention in CP.
Although there were elements of GAME and standard care (SC) that
overlapped, for example provision of home programmes, GAME was unique
in mode (100% home visits), content (active motor training focus versus
milestone attainment focus) and total dose (on average 52 hours more than
standard care in Study 6).
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c) Standard early intervention is variable in content and intensity
Studies 5 and 6 confirmed that early intervention services for infants at high
risk of CP in Sydney, Australia were extremely variable in mode, content and
dose. Our earlier survey of a number of NICU staff found that infants in this
category typically received about 14.2 hours of therapy during the first year
of life (Appendix 1 of Chapter 1). This figure was very close to the 14.82
hours of therapy received by infants in standard care in Study 6 but is a vast
contrast to the rehabilitation that adults with brain injuries receive. The
National Institute for Health and Care Excellence (NICE) adult stroke
guidelines (20) recommend a multidisciplinary team conduct assessments
and provide intervention for every domain affected for at least 45 minutes
per day, 5 days per week. If these guidelines were followed, an adult stroke
patient receiving the recommended dose of physiotherapy, occupational
therapy and speech pathology would receive in seven days the same amount
as infants with brain injuries typically receive in a whole year. In Study 6
33% of standard care infants received five hours or less of intervention over
the entire study period while 13% received more than 38 hours.
As well as variability in intensity, the content of standard care intervention
was also variable. Parents reported the use of therapy techniques from a
range of approaches including sensory integration and neurodevelopmental
therapy as well as motor learning. In general, therapy sessions targeted
milestone attainment and provided advice about positioning and handling.
Finally no child in standard care received all of their visits in a natural
environment. While 33% had some home visits, most therapy sessions were
conducted in clinical settings.
c) Very little is known about the motor trajectories of infants with CP
Our clinical trials recruited a heterogeneous group of infants, at various
levels of risk for CP but who nevertheless most often received a diagnosis of
CP. Some infants had standard motor scores in the low average or average
range at three months but were scoring in the “very poor” range at 12
months even with consistent therapy. Some included infants had very stable
scores over time, while others showed a slower decline. Since both natural
history and intervention studies in this age group of infants with CP are so
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few, an expected average rate of change in raw scores on most tests such as
the PDMS-2 has not been established nor could it be predicted. In other
words, Study 6 confirmed that predicting outcomes in infants with CP by
using norm referenced early motor assessments is imprecise. Criterion
referenced tests such as the GMFM are important for prognostication but are
not as useful for this purpose before two years. Suitable criterion referenced
assessments of the upper limb are available for infants with unilateral CP
(21) but not yet published for infants with bilateral upper limb involvement.
d) Associated impairments of infants make the first year difficult
Almost half of the participants in Study 6 had significant associated
impairments that adversely influenced their participation in therapy. The
most common associated impairment for infants was severe vision
impairment. Seven (23%) infants had severe cortical vision impairment and
one had severe retinopathy of prematurity. In most cases parents were not
aware at the time of discharge that their baby’s vision was a problem as they
had seen an ophthalmologist who had assessed the eyes as “normal”.
Delayed vision assessment meant that appropriate vision stimulation was
not provided until after six months of age in most cases.
In Study 6, 20% of the infants had severe feeding problems of which 80%
needed nasogastric or gastrostomy feeding by 12 months. In addition many
infants in both groups had gastro-oesophageal reflux that interfered with
sleep, play and required medication and/or specialist intervention. Sleep
was reported as difficult by almost all families whose baby also had a vision
impairment or severe reflux.
The cumulative effects of sensory impairment, inadequate nutrition, pain
and sleep deprivation appeared to further delay the development of these
infants. Very often these issues were dealt with by a wide range of health
professionals, across a range of services, resulting in a fragmented approach
to care.
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e) Parents are vulnerable, but are essential partners in early intervention
The early intervention protocol we used in Studies 5 and 6 involved training
parents to observe motor development and practice activities with their baby
to promote improvement in their motor skills. This was essential to
achieving an adequate “dose” of therapy as per motor learning principles.
Concurrently we monitored the mental health of these parents and found
that a proportion were experiencing higher than average levels of
depression, stress or anxiety that persisted to their child’s first birthday.
Managing the balance of educating and involving parents in carrying out
home programmes, while supporting their own emotional needs is
important to establish. Parents need information and practical and emotional
support while at the same time the development of a strong attachment with
their baby is essential. It is unknown if early intervention expectations help
or hinder mother-infant attachment, however all parents in our studies
expressed a desire to “do something” to help their child develop. Since
depression in mothers is a known contributor to poorer cognition in at-risk
children (22), taking care of the emotional health and well being of parents of
high-risk infants seems important.
Implications for policy, practice and research
1. More high quality research in early intervention for infants with CP is essential to
move the field forward.
The lack of early intervention evidence in infants and toddlers with CP is
alarming and has likely contributed to the high variability in practice evident
in standard care for these children. More research funding needs to be
urgently channelled into this area and researchers must collaborate in order
to organise well-powered clinical trials that will move the field forward.
Recruitment streams to early intervention CP trials have previously been
limited by identification of the “right” participants, but as we have shown
this does not need to be a problem.
We recommend a larger, RCT of GAME with a longer intervention period be
conducted with more finely tuned inclusion and exclusion criteria and longer
term follow up.
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2) Best practice clinical guidelines in early intervention are required
Health practitioners working in early intervention need up to date
information regarding the suitable content for infants with CP, and how this
might differ from intervention for children with global delay. Despite the
small amount of evidence available clinical practice guidelines ought to be
developed as a matter of urgency. When high level RCT evidence is not
available, guidelines ought to reflect what is known about motor learning
and dosing so that infants with brain injuries have the best chance to
optimise neuroplasticity during the critical period. Such a document would
give invaluable information to managers and policy makers regarding
appropriate resource allocation for these children
3. Prospective longitudinal data is urgently needed
In order to predict likely motor outcome earlier, a prospective longitudinal
study is required. Prospectively collecting data of the emerging motor skills
and musculoskeletal status of infants with/at high risk of CP will improve
our understanding of early developmental trajectories and potentially lead to
strategies to prevent secondary impairments such as contracture from
occurring.
4. Responsivity of available measurement tools should be established
Until more is known about the sensitivity to change of commonly used
assessments in the CP population, researchers will find it difficult to clearly
demonstrate an intervention effect above that which might solely be due to
development. Even CP specific assessments such as the GMFM-66 do not
have data concerning the amount of change that is regarded as “clinically
significant”. This is an important area requiring further research.
5. Early assessment and intervention for infants with CP should be holistic
Early intervention services for infants at high risk of CP ought to include
early and systematic assessment of vision, nutrition and feeding, sleep and
attend to parental wellbeing. Difficulties in any of these areas should be
immediately and comprehensively addressed so that infants and families can
focus on developing healthy attachment and promoting infant motor and
cognitive development. This holistic service will require a concerted and
deliberate effort on the part of the Department of Health and their
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community partners to collaborate more deliberately and effectively to
streamline waiting times for parents and remove barriers that lead to
delayed diagnosis and access to appropriate intervention.
The National Disability Insurance Agency currently have a unique
opportunity in Australia to provide appropriate funding packages to support
families to receive the right type and dose of therapy for infants at the right
time.

8.2.3 LIMITATIONS OF THE STUDIES
Our pragmatic trials (Studies 5 and 6) were confounded by the realities of
variable clinical practice. For example, since early intervention is universally
accepted as standard of care, conducting RCTs with a pure control group (ie
no intervention) was understandably regarded as unethical in our context.
Moreover parents should be free to seek co-interventions for their infant
according to their preferences, and this was the case in our RCTs (Studies 5
and 6). The effect of co-interventions was difficult to account for in our
pragmatic trials, however every effort was made to try and identify the
essential ingredients within the intervention protocols that differentiated
them from each other.
In future GAME and early intervention studies, a more detailed description
of the content of standard care would be ideal, but difficult to obtain as
clinicians are free to use their preferred approaches to therapy. In Study 6 we
used the Tidier guidelines to summarise the content of both interventions but
due to the great variability within the standard care group this had
limitations. Some overlap in content of standard care and GAME was
unavoidable. The fidelity of GAME was assured as the same therapists
delivered GAME intervention to all participants in the GAME group
however this makes replication of the study difficult. A knowledge
translation project is now required to train therapists in delivering GAME
intervention. Future GAME studies ought to involve other therapists trained
in GAME to minimise the potential bias of “therapist effect”.
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Studies 5 and 6 were also limited by the size of the samples we recruited.
Although our sample size was calculated on pilot data (Study 5), the
heterogeneity of CP meant that infants in the larger RCT (Study 6) were more
severely affected and therefore perhaps slower to respond to intervention
than a “typical” CP sample. In addition, since GMFCS level is not
determined by 12 months, the final motor function of these infants is unclear.
The motor measures we used in the studies are another limitation. As
previously described there is a paucity of outcome measures with
demonstrable sensitivity to change for infants with disabilities. We
attempted to use a known responsive primary outcome measure (Goal
Attainment Scaling) in the pilot work (Study 5) however found this
unsatisfactory due to the variability and unpredictability in the rate of
developmental change between the infants. The PDMS-2 was chosen as there
was some sensitivity data in CP, albeit in toddlers, and it measured hand
skills and mobility skills, both of which are commonly targeted in early
intervention programmes.
8.2.4 CONCLUSION
This unique series of studies has demonstrated that a novel intervention,
GAME improves the motor and cognitive abilities of infants with cerebral
palsy. We have shown that by using the right tools at the right time, the right
infants can be accurately identified and recruited to early intervention trials.
This programme of research suggests more is possible in the field of early
intervention for infants with CP and further research is warranted.
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AIM The aim of this study was to describe systematically the best available intervention
evidence for children with cerebral palsy (CP).
METHOD This study was a systematic review of systematic reviews. The following databases
were searched: CINAHL, Cochrane Library, DARE, EMBASE, Google Scholar MEDLINE,
OTSeeker, PEDro, PsycBITE, PsycINFO, and speechBITE. Two independent reviewers
determined whether studies met the inclusion criteria. These were that (1) the study was a
systematic review or the next best available; (2) it was a medical/allied health intervention;
and (3) that more than 25% of participants were children with CP. Interventions were coded
using the Oxford Levels of Evidence; GRADE; Evidence Alert Traffic Light; and the
International Classification of Function, Disability and Health.
RESULTS Overall, 166 articles met the inclusion criteria (74% systematic reviews) across 64
discrete interventions seeking 131 outcomes. Of the outcomes assessed, 16% (21 out of 131)
were graded ‘do it’ (green go); 58% (76 out of 131) ‘probably do it’ (yellow measure); 20% (26
out of 131) ‘probably do not do it’ (yellow measure); and 6% (8 out of 131) ‘do not do it’ (red
stop). Green interventions included anticonvulsants, bimanual training, botulinum toxin,
bisphosphonates, casting, constraint-induced movement therapy, context-focused therapy,
diazepam, fitness training, goal-directed training, hip surveillance, home programmes,
occupational therapy after botulinum toxin, pressure care, and selective dorsal rhizotomy.
Most (70%) evidence for intervention was lower level (yellow) while 6% was ineffective (red).
INTERPRETATION Evidence supports 15 green light interventions. All yellow light
interventions should be accompanied by a sensitive outcome measure to monitor progress
and red light interventions should be discontinued since alternatives exist.

Thirty to 40% of interventions have no reported evidencebased and, alarmingly, another 20% of interventions provided are ineffectual, unnecessary, or harmful.1 The gap
between research and practice has been well documented
in systematic reviews1 across multiple diagnoses, specialties, and countries. Surveys confirm that, unfortunately, the
research–practice gap occurs within the cerebral palsy (CP)
field to the same degree.2,3 This gap exists despite numerous systematic reviews providing guidance about what does
and does not work for children with CP. When clinicians
want to help, families expect effective interventions, and
the health system depends upon cost-effective services, the
provision of ineffectual interventions is illogical. In view
of this, why is there such variable uptake of best available
evidence within real clinical practice?
In the last decade, the CP evidence base has rapidly
expanded, providing clinicians and families with the
© 2013 Mac Keith Press

possibility of newer, safer, and more effective interventions.
Orthopaedic surgery and movement normalization were
once the mainstays of intervention, but localized antispasticity medications and motor learning interventions have
gained increased popularity.4,5 Thus, the sheer volume of
research published makes it hard for clinicians to keep up
to date.6 Systematic reviews seek to provide evidence summaries, but, in spite of this, clinicians find it difficult to
interpret review findings and stay abreast of these
syntheses.7 Furthermore, the introduction of new and
sometimes competing effective interventions increases the
complexity of clinical reasoning required by clinicians, who
are primarily motivated to improve outcomes for children.8
In the last 10 years, the field has adopted the World
Health Organization’s International Classification of Functioning, Disability and Health (ICF),9 which has redefined
the way clinicians understand CP and think about interDOI: 10.1111/dmcn.12246
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vention options. From an ICF perspective, CP impacts on
a person’s ‘functioning’, (inclusive of body structures [e.g.
limbs], body functions [e.g. intellectual function], activities
[e.g. walking], and participation [e.g. playing sport]), which
in turn may cause ‘disabilities’, such as impairments, activity limitations, and participation restrictions. Moreover,
each person with CP lives within a personalized environment and thus their context also contributes to determining their independence, comprising personal factors (e.g.
motivation) and environmental factors (e.g. architectural
accessibility).9,10 Thus, there are many potential problems
a child with CP may face and seek intervention for. The
field has chosen a philosophical shift away from almost
exclusively redressing physical impairments underlying
functional problems to adopting an additional focus on
maximizing children’s environment, their independence in
daily activities, and their community participation.11 Furthermore, clinicians applying the recommended goal-based
approach seek to choose interventions guided by what
would best help the family achieve their goals.12–14 Couple
these philosophical preferences with widespread barriers to
research implementation (such as limited time, insufficient
library access, limited research appraisal skills, attitudinal
blocks to research, and differing patient preferences), and
there is no assurance that children with CP will receive
evidence-based interventions.1,15,16
The aim of this paper was to describe systematically the
best available evidence for CP interventions using the
GRADE17 system and to complement these findings with
the Evidence Alert Traffic Light System18 in order to provide knowledge translation guidance to clinicians about what
to do. The purpose of rating the whole CP intervention evidence base within the one paper was to provide clinicians,
managers, and policy-makers with a ‘helicopter’ view of best
available intervention evidence that could be used to (1)
inform decision-making by succinctly describing current
evidence about CP interventions across the wide span of disciplines involved in care; (2) rapidly aid comparative clinical
decision-making about similar interventions; and (3) provide
a comprehensive resource that could be used by knowledge
brokers to help prioritize the creation of knowledge translation tools to promote evidence implementation.19

METHOD
Study design
A systematic review of systematic reviews (i.e. the highest
level of CP intervention research evidence available) was
conducted in order to provide an overview of the current
state of CP intervention evidence. Systematic reviews were
preferentially sought since reviews provide a summary of
large bodies of evidence and reviews help to explain differences among studies. Moreover, reviews limit bias which
assists clinicians, managers, and policy-makers with decision-making about current best available evidence.20 However, for interventions for which no systematic reviews
existed, lower levels of evidence were included to illuminate the current state of the evidence.
886 Developmental Medicine & Child Neurology 2013, 55: 885–910
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What this paper adds
Of 64 discrete CP interventions, 24% are proven to be effective.
70% have uncertain effects and routine outcome measurement is necessary.
6% are proven to be ineffective.
Effective interventions reflect current neuroscience and pharmacological
knowledge.
All effective interventions worked at only one level of the ICF.

Search strategy
Our review was carried out using a protocol based upon
recommendations from the Cochrane Collaboration and
PRISMA statements.21,22 Relevant articles were identified
by searching the CINAHL (1983–2012); Cochrane Database of Systematic Reviews (1993–2013; www.cochrane.org); Database of Reviews of Effectiveness (DARE);
EMBASE (1980–2012); ERIC; Google Scholar; MEDLINE (1956–2012); OTSeeker (www.otseeker.com); Physiotherapy Evidence Database (PEDro [www.pedro.fhs.usyd.
edu.au]); Psychological database for Brain Impairment
Treatment Efficacy (PsycBITE [www.psycbite.com]); PsycINFO (1935–2012); PubMED; and Speech Pathology
Database for Best Interventions and Treatment Efficacy
(speechBITE [www.speechbite.com]). Searches were supplemented by hand searching. The search of published
studies was performed in July and August 2011 and
updated in December 2012. Interventions and keywords
for investigation were identified using (1) contributing
authors’ knowledge of the field; (2) internationally recognized CP websites such as the American Academy of Cerebral Palsy and Developmental Medicine (www.aacpdm.
org), CanChild (www.canchild.ca), the Cerebral Palsy Alliance (www.cerebralpalsy.org.au), Cincinnati Children’s
Hospital (www.cincinnatichildrens.org), Karolinksa Insitutet (www.ki.se), NetChild (www.netchild.nl), NeuroDevNet (www.neurodevnet.ca), and Reaching for the Stars
(www.reachingforthestars.org); and (3) the top 20 hits in
Google using the search term ‘cerebral palsy’ as an indicator of popular subject matter.
Electronic databases were searched with EBSCO host
software using PICOs [patient/problem, intervention, comparison, and outcome] search terms. The full search strategy is available from the authors on request.
Inclusion criteria
Published studies about intervention for children with CP
fulfilling criteria under the headings below were included.
Type of study
First, studies of level 1 evidence (systematic reviews),
rated using the Oxford 2011 Levels of Evidence were
preferentially sought.23 The Oxford 2011 Levels of
Evidence for treatment benefits include level 1, a systematic review of randomized trials or n-of-1 trials; level 2, a
randomized trial or observational study with dramatic
effect; level 3, a non-randomized controlled cohort/
follow-up study; level 4, a case series, case–control study,
or a historically controlled study; and level 5, mechanismbased reasoning.

Evidence of Oxford levels 2 to 4 were included only if
(1) level 1 evidence did not exist on the topic and then the
next best available highest level of evidence was included;
or if (2) level 2 randomized controlled trial(s) had been
published since the latest systematic review, which substantially changed knowledge about the topic.
Second, retrieved bodies of evidence were coded using
the GRADE17 system and Evidence Alert Traffic Light
System18 using two independent raters, with 100%
agreement reached. The GRADE17 system was chosen
because it is a criterion standard evidence-grading tool
and is endorsed by the World Health Organization. Definitions of the GRADE terms appear in the notes to
Table I and a full description of panel rating processes
are available from www.gradeworkinggroup.org/publications/JCE_series (retrieved 8 March 2013). Notably, the
GRADE system rates both (1) the quality of the evidence (randomized trials, high; observational studies, low;
and other levels of evidence, very low, but it is worth
mentioning that high-quality evidence is downgraded if
methodological flaws exist and low-quality evidence is
upgraded if high and certain effect sizes exist [e.g. population-based CP register data])17 and (2) the strength of
the recommendation for use, which weighs up trade-offs
between the benefits and harms of using the intervention, whereby a panel considers (a) the methodological
quality of the evidence supporting estimates of likely
benefit and likely risk; (b) inconvenience; (c) the importance of the outcome that the treatment prevents; (d)
the magnitude of the treatment effect; (e) the precision
of the estimate of the treatment effect; (f) the risks associated with therapy; (g) the burdens of therapy; (h) the
costs; and (i) the varying values.17 The GRADE methodology means that sometimes bodies of evidence may be
assigned a strong recommendation even when the quality
of the evidence is low. This is either because there is a
high likelihood of harm from no intervention (e.g. anticonvulsants to prevent seizures or ulcer prevention pressure care) or because the treatment has a low effect size
and is expensive to provide, but a safe, more effective,
cost-comparable alternative exists (e.g. phenol vs botulinum toxin A; or neurodevelopmental therapy [NDT] vs
motor learning). The Evidence Alert Traffic Light System18 was chosen because it is a GRADE-complementary
knowledge translation tool, designed to assist clinicians
to obtain easily readable, clinically useful answers within
minutes.6 The Evidence Alert also provides a simple,
common language between clinicians, families, managers,
and funders, based upon three-level colour coding that
recommends a course of action for implementation of
the evidence within clinical practice. The Evidence Alert
System18 has been shown to increase by threefold clinicians’ reading habits about CP research.24 Figure 1
describes the GRADE system and the Evidence Alert
System and their relationship to each other. Table I
shows the included studies, best evidence levels grades
and traffic light classification.25–185

Where multiple systematic reviews existed and newer
level 1 to 2 evidence superseded the findings of earlier
level 1 evidence, the grades were assigned based on the
most recent high-quality evidence.

Types of intervention
Studies were included if they involved the provision of and
intervention by either a medical practitioner or allied
health professional.
Types of participants
Studies were included if they explicitly involved human
participants and more than 25% of the participants were
children with CP.
Studies were excluded from the review if (1) they were
diagnostic studies, prognostic studies, or interventions
aimed at preventing CP (e.g. magnesium sulphate186 and
hypothermia187); (2) they provided lower levels of evidence,
unless no systematic review had been published; (3) participants were adults, although if a study predominantly
(>75%) studied children but included a small proportion of
young adults (<25%) the paper was included; (4) they
reviewed generic prophylaxis interventions (e.g. good parenting, standard neonatal care for all infants, i.e. not CPspecific interventions); (5) they reviewed a whole discipline,
not individual interventions (e.g. physiotherapy, occupational therapy, speech pathology); (6) they were considered
alternative and complementary interventions with no published evidence; (7) a second publication of the same study
published the same results; and (8) they were unpublished
or not peer reviewed.
Data abstraction
A data abstraction sheet based on the Cochrane’s recommendations21 was developed. Abstracts identified from
searches were screened by two independent raters (CP
research experts and knowledge brokers) to determine their
eligibility for further review. Abstracts were retained for
full review if they met the inclusion criteria or if more
information was required from the full text to confirm that
the study met all the eligibility criteria. Two independent
reviewers then reviewed full-text versions of all retained
articles and all additional articles identified by hand searching. Full-text articles were retained if they met inclusion
criteria. Agreement on inclusion and exclusion assignment
of the full-text articles was unanimous. Data extracted from
included studies comprised the authors and date of the
study; the type and purpose of the intervention implemented; the study design; the original authors’ conclusions
about efficacy across study outcomes; and the original
authors’ conclusions on strength of evidence (based on
their assessment of whether there was no evidence of benefit, qualified support, or strong support). For lower level
evidence, risk of bias was assessed using the Cochrane
criteria.
The data extracted from each included study were summarized, tabulated, and assigned a level of evidence rating
Review
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Alternative and augmentative communication:
technology alternatives to verbal speech, e.g.
communication boards, speech generating
devices

Animal-assisted therapy: service animals to
provide companionship and assist with
independence, e.g. seizure first aid, door
opening, crossing roads

Anticonvulsants: medications to prevent
seizures

Assistive technology: equipment or devices to
improve independence e.g. walking frames,
wheelchairs, adapted computer access

Baclofen (oral): antispasticity medication

3

4

5

6

7

2

Reduced spasticity (BS)

Improved transfers via a hoist
(A)
Improved weight bearing and
bone mineral density via a
standing frame (BS)
Improved sleep positioning via
a sleep system (BS)
Reduced carer burden (E)

Improved independence in
activities of daily living (A and
P)
Improved computer access via
a switch or key guard (A)
Improved independence in
early mobility via powered
wheelchairs (A and P)
Improved participation in
education, communication
and play via alternative
computer access (P)
Improved function via robotic
training or virtual reality (A)

Improved general
communication skills (A)
Improved communication skills
of pre-school children (A)
Improved communication skills
of conversational partners (P)
Enhanced supplementation of
verbal speech (A)
Improved socialization and
mood; reduced stress, anxiety
and loneliness; and improved
leisure (BS and P)
Improved independence via
service dogs (P)
Improved seizure control (BS)

Improved gross motor function
(A)
Reduce muscle spasticity
locally via injections (BS)

1

Acupuncture: electro-stimulation to scalp and
body via needles and manual pressure
Alcohol: muscular injections to induce chemical
denervation for treating local spasticity

Intervention outcome (ICF level)

Intervention

Table I: Included studies, best available evidence levels, grades and traffic lights

Lower-quality supporting evidence
Lower-quality supporting evidence
Lower-quality supporting evidence
Lower-quality supporting evidence

Lower-quality supporting evidence
No evidence in CP. Since high quality evidence
exists in non-CP populations and there are high
risks of adverse events from uncontrolled
seizures therefore – do use anticonvulsants
Lower-quality supporting evidence

Lower-quality supporting evidence
Lower-quality supporting evidence

Lower-quality supporting evidence

Lower-quality supporting evidence

Pennington27
Branson28
Pennington29
Hanson30
Millar31
~ oz Lasa32
Mun

Winkle33

Wilson34
Davies35
36

–

Jones
Livingstone37
Chantry38
Sandlund39
Laufer40
Parsons41
Sandlund39
Snider42
Wang43
Jung44

Lower-quality supporting evidence
Lower-quality supporting evidence

26

Lower-quality supporting evidence

Insufficient evidence

47

Delagado

Nicolson

Wynn46

Pin

Insufficient evidence

Insufficient evidence to support, but BoNT-A exists
as a highly effective alternative – therefore
probably do not use alcohol unless BoNT-A total
dose limitations in play
Lower-quality supporting evidence

Delgado26

45

Insufficient evidence

Panel comments

Zhang25

Citations

1

1

1

1

1
1
1
1
1
1

1
1

2
1

1

Low

Very low

Very low

Low

Very low

Very low

Very low

Low

Very low

Low

N/A

–

2

Very low

Very low

Very low

Very low

Very low

Very low

N/A

Low

Quality
of
evidence

1

1
1
1

1

1

1

1

1

Oxford
evidence
level

Weak +

Weak +

Weak +

Yellow
MEASURE
Yellow
MEASURE
Yellow
MEASURE

Yellow
MEASURE
Yellow
MEASURE

Weak +
Weak +

Yellow
MEASURE

Yellow
MEASURE

Yellow
MEASURE
Yellow
MEASURE

Yellow
MEASURE

Yellow
MEASURE
Green GO

Yellow |
MEASURE
Yellow
MEASURE
Yellow
MEASURE
Yellow
MEASURE
Yellow
MEASURE

Yellow
MEASURE
Yellow
MEASURE

Traffic light
action

Weak +

Weak +

Weak +

Weak +

Weak +

Strong +

Weak +

Weak +

Weak +

Weak +

Weak +

Weak +

Weak !

Weak +

Strength of recommendation

GRADE
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Botulinum toxin (BoNT-A): medication injected
into overactive spastic muscles to locally block
spasticity

12

Reduced drooling (BS)

Reduced pain (BS)

Lim
Reddihough74
Walshe75

73

Koog61
Love63
Ryll69
Boyd59
Fehlings65
Hoare70
Hoare71
Rawicki72

Improved walking function (A)

Improved hand function and
performance of functional
hand activities (A)

Novak68

Reduced hypertonia of the neck
muscles (BS)

Reduced upper limb muscle
spasticity (BS)

Reduced lower limb muscle
spasticity (BS)

Ade-Hall57
AlbaveraHernandez58
Boyd59
Heinen60
Koog61
Lukban62
Love63
Mulligan64
Fehlings65
Reeuwijk66
Wasiak67

Effective short term and given the adverse social
outcomes from no treatment – do use

Insufficient evidence

Effective in combination with occupational therapy

Insufficient evidence. Note: function was
preferentially measured over spasticity reduction
in high quality studies. Since the drug is highly
effective in lower limb muscles, we expect
comparable results – therefore do use BoNT-A
Insufficient evidence. Since high-quality evidence
supports tone reduction in primary dystonia (nonCP populations), we expect similar results –
therefore probably do use BoNT-A
Probably effective in combination with
physiotherapy therefore do use

Effective. Small RCTs suggest a positive effect and
there are high risks of adverse events from no
treatment
Effective and safe

Fehlings55
Hough56

Improved bone mineral density
(BS)

Lower-quality supporting evidence

Bloom54

Improved hand function (A)

Bisphosphonates: medication to suppress bone
reabsorption to treat osteoporosis

Insufficient evidence

Dursun53

11

Effective if combined with other treatments

Biofeedback: electronic feedback about muscle
activity to teach voluntary control

10

Effective. Equal effectiveness to constraint-induced
movement therapy

Gordon51
Sakzewski4
Sakzewski52
Dursun53

Improved hand function, i.e.
bilateral hand use for children
with hemiplegia (A)
Improved muscle activation
and active range of motion
(BS)
Improved walking (A)

Bimanual training: repetitive task training in the
use of two hands together

9

Insufficient evidence

Whittingham50

Panel comments
Effective, but low CP numbers were included in the
study samples and publication bias existed

Improved child behaviour (from
the Stepping Stones Triple P
Programme) (A)
Improved parenting skills (E)

Behaviour therapy: positive behaviour support,
behavioural interventions, and positive
parenting

8

Citations
Roberts48
Sanders49

Intervention outcome (ICF level)

Intervention

Table I: Continued

1
1
1

1
1
1
1
1
1
1
1

1

1
1
1
1
1
1
1
1
1

1
1

1
1

4

2

2
1
2
2

1

2
2

Oxford
evidence
level

Moderate

Very low

High

Moderate

N/A

Moderate

High

Moderate

Very low

Low

Low

High

Very low

Low

Quality
of
evidence

Green GO

Yellow
MEASURE
Green GO

Strong +

Weak +
Strong +

Green GO

Yellow
MEASURE

Green GO

Green GO

Yellow
MEASURE
Yellow
MEASURE
Green GO

Yellow
MEASURE

Yellow
MEASURE
Green GO

Yellow
MEASURE

Traffic light
action

Strong +

Weak +

Strong +

Strong +

Strong +

Weak +

Weak +

Weak +

Strong +

Weak +

Weak +

Strength of recommendation

GRADE
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Coaching parents: emotional support,
information exchange and a structured
process of tutoring parenting behaviours
Cognitive behaviour therapy (CBT): identifying
unhelpful thoughts and behaviours and
teaching cognitive restructuring and selfmanagement of constructive thinking and
actions
Communication training: training
communication partners to effectively
communicate, e.g. Interaction Training; Hanen;
It Takes Two to Talk
Conductive education (CE): a Hungarian
educational classroom-based approach to
teaching movement using rhythmic intention,
routines and groups

Constraint-induced movement therapy (CIMT):
constraining the dominant hand in a mitt or
cast, to enable intensive training of the
hemiplegic hand

Context-focused therapy: changing the task or
the environment (but not the child) to
promote successful task performance
Counselling (parents): fostering understanding
of how life problems lead to distress,
relationship breakdown and mental health
issues, to improve communication and
interpersonal skills

14

18

19

20

17

16

15

Improved passive range of
motion of the lower limbs
(BS)

Casting: Plaster casts applied to limbs to (a)
stretch muscles for muscle lengthening, i.e.
contracture reduction casts changed regularly;
or (b) reduce spasticity

13

1

Conflicting evidence. Majority of studies show no
difference to no treatment
Effective. Even more RCTs have been published
after the included reviews confirming
effectiveness

Improved parental coping and
mental health (E)
Improved parental coping via
parent to parent support (E)

Improved function (A)

Improved hand function of the
affected hand for children
with hemiplegia (A)

Improved cognition (BS)

Palit90

–

1
1

Conflicting evidence. Majority of studies show no
difference to no treatment

No evidence in CP. No published research
evidence, opinion papers existed
Insufficient evidence

Effective. Note: a single rigorous RCT shows equal
effectiveness to child-focused therapy

1
1

Conflicting evidence. Majority of studies show no
difference to no treatment

Darrah84
TuersleyDixon85
Darrah84
TuersleyDixon85
TuersleyDixon85
Boyd59
Hoare86
Huang87
Nascimento88
Sakzewski4
Law89

Improved ‘orthofunction’
(response to biological and
social demands) (BS)
Improved performance of
functional activities (A)

4

–

1
1
1
1
1
2

1
1

Insufficient evidence

Pennington29
Pennington83

Improved interaction between
children and their parents (P)

–

4

1
1

No evidence in CP. Since high-quality evidence
supports CBT in non-CP populations – therefore
probably do use CBT

Insufficient evidence. Newer understandings of
spasticity indicate a ‘local’ intervention will not
improve a ‘central’ condition – therefore probably
do not use casting for spasticity reduction
Insufficient evidence. More research needed with
stronger designs

Effective but gains are small

1
1
1
1
1
1
1
1
1
1
1
1

–

Graham82

Katalinic
Teplicky82

79

Effective. Gains in ankle range of motion are very
small but are potentially clinically meaningful for
children that need more dorsiflexion to walk,
therefore – do use
Insufficient evidence

Autti-Ramo76
Blackmore77
Effgen78
Katalinic79
Autti-Ramo76
Lannin80
Teplicky81
Autti-Ramo76
Blackmore77
Effgen78
Katalinic79
Blackmore77
Insufficient evidence

Panel comments

Citations

Oxford
evidence
level

Improved depression, anxiety,
sleep, attention, behaviour
and enuresis (BS)

Improved parenting skills and
coping (E)

Augmented effects of BoNT
(BS)
Reduced muscle spasticity (BS)

Improved passive range of
motion of the upper limbs
(BS)
Improved function (A)

Intervention outcome (ICF level)

Intervention

Table I: Continued

Very low

N/A

High

Moderate

Low

Low

Low

Very low

N/A

Very low

Low

Low

Low

Low

Low

Quality
of
evidence

Green GO

Yellow
MEASURE
Yellow
MEASURE

Strong +

Weak +
Weak +

Strong +

Yellow
MEASURE
Green GO

Yellow
MEASURE

Yellow
MEASURE

Weak !

Weak !

Weak !

Yellow
MEASURE

Yellow
MEASURE

Weak +

Weak +

Yellow
MEASURE

Yellow
MEASURE

Green GO

Weak +

Weak !

Weak +

Yellow
MEASURE

Yellow
MEASURE

Weak +

Weak !

Green GO

Traffic light
action

Strong +
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Diazepam: antispasticity medication

Dysphagia management: promoting safe
swallowing by changing food textures, sitting
position, oral motor skills and using oral
appliances and equipment

Early intervention (EI): therapy and early
education to promote acquisition of
milestones, via group or individual stimulus

Electrical stimulation (ES, NMES, FES):
electrical stimulation of a muscle through a
skin electrode to induce passive muscle
contractions for strengthening or motor
activation

Fitness training: planned structured activities
involving repeated movement of skeletal
muscles that result in energy expenditure to
improve or maintain levels of physical fitness

Fundoplication (including Nissen and
laparoscopic; gastric plication): surgical
procedure to strengthen the barrier to acid
reflux, e.g. by wrapping the fundus around the
oesophagus

22

23

24

25

26

27

28

Reduction of gastrooesophageal reflux (BS)

Improved function and
participation (A and P)

Augmented effects of
Botulinum toxin (BS)
Improved aerobic fitness (BS)

Improved muscle strength (BS)

Improved gait parameters (BS)

Improved cognitive outcomes
(BS)

Improved mobility, quality of
life and general health (A and
P)
Reduce spasticity (generalized)
(BS)
Reduce spasticity (generalized)
(BS)
Improved safety of swallow via
thickened fluids i.e. less
aspiration (BS)
Improved safety of swallow via
upright positioning, i.e. less
aspiration (BS)
Improved motor outcomes (BS
and A)

21

Cranial osteopathy: palpation using small
movements to ease musculoskeletal strain
and treat the central nervous system
Dantrolene: antispasticity medication

Intervention outcome (ICF level)

Intervention

Table I: Continued

Butler102
Rogers103
Verschure n102
VernonRoberts103

BlauwHospers93
Blauw
Hospers94
Turnbull95
Ziviani96
BlauwHospers93
Blauw
Hospers94
Turnbull95
Ziviani96
Cauraugh97
Wright97
Kerr98
Scianni99
Wright97
Lannin100
Wright101
Butler102
Rogers103
Verschuren102

Snider92

Snider

92

Delgado

Effective short term and only in those that have
sufficient motor skills to undertake aerobic
training. No carryover when training stops.
Therefore do use but only in the right patient and
plan to continue the programme long term
Insufficient evidence. Aerobic fitness does not
appear to translate to activity and participation
gains
No CP-specific evidence

Conflicting evidence. More evidence needed

Insufficient evidence. Effective in laboratory,
unknown effectiveness in the community
Lower-quality supporting evidence

High quality evidence supports EI in non-CP
populations. Moderate evidence supports EI
program memes for at risk pre-term infants,
aimed at mimicking the intrauterine environment

Evidence supports general stimulation,
developmental approaches and parent coaching
programmes. Gains are superior to NDT or
traditional physiotherapy

Conflicting evidence

Lower-quality supporting evidence

Effective short term, therefore – do use

Insufficient evidence

Delgado26
26

Ineffective. Note: a single rigorous RCT shows no
benefit when compared to no treatment

Panel comments

Wyatt91

Citations

1
1
1
1

1
1
1
1
1
1
1
1
1
1
1
1

1

1
1
1

1

1

1

1

1

1

2

Oxford
evidence
level

N/A

Moderate

Moderate

Low

Moderate

Low

Low

Moderate

Low

Low

Moderate

Low

High

Quality
of
evidence

Weak +

Weak !

Strong +

Yellow
MEASURE

Yellow
MEASURE

Yellow
MEASURE
Green GO

Weak +

Weak +

Yellow
MEASURE
Yellow
MEASURE

Weak +

Yellow
MEASURE

Yellow
MEASURE

Weak +

Weak +

Yellow
MEASURE

Yellow
MEASURE

Yellow
MEASURE
Green GO

Red STOP

Traffic light
action

Weak +

Weak +

Strong +

Weak !

Strong !

Strength of recommendation

GRADE
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Goal-directed training/functional training: task
specific practice of child-set goal-based
activities using a motor learning approach

Hand surgery: surgery to improve hand
function and alignment
Hip surgery: orthopaedic surgery to improve
musculoskeletal alignment of the hip

30

31

Hippotherapy: therapeutic horse riding to
practice balance and symmetry

Home programmes: therapeutic practice of
goal-based tasks by the child, led by the
parent and supported by the therapist, in the
home environment
Hydrotherapy: aquatic-based exercises

Hyperbaric oxygen (HBO): inhaled 100% oxygen
inside a pressurized hyperbaric chamber

34

35

37

36

Hip surveillance: active surveillance and
treatment for hip joint integrity to prevent hip
dislocation

33

32

Improved growth and weight
(BS)

Gastrostomy: surgical placement of a non-oral
feeding tube to prevent or reverse growth
failure, or prevent aspiration pneumonia, e.g.
percutaneous endoscopic gastrostomy (PEG),
jejunostomy

29

Improved performance of
functional activities (A)

Improved vitals and gross
motor function (BS and A)

Novak
Novak13
Novak13

Improved performance of
functional activities (A)
Improved participation (P)

125

Chrysagis
Getz126
Gorter127
Collet128
McDonagh129

124

123

Davis

Snider119
Sterba120
Zadnikar121
Whalen122

Brunner116
Huh117
Gordon118

Stott

115

Novak13
Wallen14
Smeulders114

Arrowsmith104
Kong105
SamsonFang106
Sleigh107,108
Sullivan109
Sullivan110
VernonRoberts111
Ketelaar112
Lowing113
Novak13
Sakzewski52
Wallen14

Citations

Improved gross motor function
(A)
Improved participation (P)

Improved hip and trunk
symmetry and stability (BS)

Improved thumb-in-palm
posture (BS)
Reduced hip subluxation via
soft tissue surgery (adductor
release) (BS)
Reduced hip subluxation via
bony surgery (BS)
Reduced hip dislocation and
need for orthopaedic surgery
(BS)

Improved self-care (A)

Improved gross motor function
(A)
Improved hand function (A)

Intervention outcome (ICF level)

Intervention

Table I: Continued

Ineffective. Adverse events can also occur

Insufficient evidence. Sensitive measures required
in future studies
Effective. Note: a single rigorous RCT shows
effectiveness, with a low probability of bias
Insufficient evidence. Sensitive measures required
in future studies
Lower-quality supporting evidence

Effective. Larger studies needed

Hip surveillance is a regular assessment process
so as the right treatments can be provided in a
timely manner, as such the studies were
appropriately designed as observational studies
not RCTs. Do use as there are substantive
adverse events from no surveillance
Effective

Studies were retrospective and uncontrolled

Most studies were uncontrolled

2
3
2
2
2

Effective. Some probability of bias within included
studies
Effective. Can be delivered via a home programme
or used in combination with CIMT and bimanual
training. Low probability of bias within included
studies
Effective. Low probability of bias within included
studies
Lower-quality supporting evidence

2
1
1
2
1

1
2
2

2

1
1
1
1

4
4
1

1

2
2
1

3
3
1
1
1
3
3
4

Adverse events occur

Panel comments
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High

Strong !

Weak +

Weak !

Moderate
Low

Strong +

Red STOP

Yellow
MEASURE
Yellow
MEASURE

Yellow
MEASURE
Yellow
MEASURE
Green GO

Weak +
Weak !

Yellow
MEASURE

Yellow
MEASURE
Green GO

Weak +

Strong +

Weak +

Weak +

Yellow
MEASURE
Yellow
MEASURE

Weak +

Moderate

Moderate

Low

Low

Moderate

Very low

Very low

Very low

Green GO

Strong +

Strong +
High

High

Yellow
MEASURE
Green GO

Weak +
Low

Traffic light
action
Yellow
MEASURE

Strength of recommendation
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Quality
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GRADE
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Reduced lower limb spasticity
(BS)

Intrathecal baclofen (ITB): antispasticity
medication delivered directly to the spinal
cord via a pump surgically implanted within
the abdomen

Massage: therapeutic stroking and circular
motions applied by a massage therapist to
muscles to relieve pain and tension

Neurodevelopmental therapy (NDT, Bobath):
direct, passive handling and guidance to
optimise function

Occupational therapy after BoNT: improved
hand use via CIMT, goal-directed training,
strength training and functional hand splints.
improved symptom management via casting
and immobilisation splints

38

39

40

41

Brown141
Butler142
Martin143

Brown141
Butler142
Boyd59
Fehlings65
Hoare70
Hoare71
Lannin99

Enhanced social emotional and
cognitive skills (BS and PF)
Improved goal achievement of
upper limb activities (A)

HernandezReif138
Nilsson139
Alizad140
HernandezReif138
HernandezReif138
Brown141
Butler142
Brown141
Butler142

Butler130
Creedon131
Dan132
Delgado26
Kolaski133
Butler130
Creedon131
Dan132
Delgado26
Kolaski133
Albanese134
Butler130
Hoving135
Hoving136
Kolaski133
Pin137

Citations

Improved function (A)

Prevent contracture
development (BS)

Normalized movement (BS)

Improved function (A)

Reduced spasticity (BS)

Reduced pain (BS)

Improved function and health
related quality of life (A, P and
PF)
Improved walking ability in
ambulant children (A)

Reduced dystonia (BS)

Reduced upper limb spasticity
(BS)

Intervention outcome (ICF level)

Intervention

Table I: Continued

Effective

Ineffective because immediate gains in range of
motion observed within the session do not carry
over
Conflicting systematic review evidence. Early
reviews suggested no benefits. The more recent
review included one new trial suggesting
possible benefit of higher doses of NDT
compared with lower doses of NDT; however,
this is not a conventional method for establishing
treatment efficacy and should be interpreted with
caution. Other evidence shows that motor
learning produces superior functional gains to
NDT
Ineffective. No evidence to support claim

1
1
1
1
1
1
1

1
1
1

1
1
1
1

Ineffective. No gains superior to other treatments

High

Low

Low

Low

Low

Low

Low

2
2
2
2

Low

Very low

Low

Very low

Low

Low

Quality
of
evidence

2

1
1
1
1
1
1
1
1
1
1
1
1
2
2
1
1

Conflicting evidence

Conflicting evidence

Insufficient evidence. Some children with CP
improve but many experience adverse events
including inability to walk
Conflicting evidence

Lower-quality supporting evidence

Lower-quality supporting evidence

Insufficient evidence. The effect on upper limb is
less than for the lower limb and some authors
question whether ITB is clinically worthwhile for
the purposes of reducing upper limb spasticity

Predominantly low-quality supporting evidence.
The size of the gains varies between studies

Panel comments

Oxford
evidence
level

Red STOP
Green GO

Strong +
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Strong !

Weak !

Strong !
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Orthopaedic surgery: surgical prevention or
correction of musculoskeletal disorders and
associated muscles, joints, and ligaments, e.g.
muscle lengthening
Orthotics (splints): removable external devices
designed to support weak or ineffective joints
or muscles

Parent training: educating and coaching parents
to change their child’s behaviour or skills, plus
improve parenting
Phenol: muscular injections to induce chemical
denervation for treating local spasticity

Play therapy: play and creative arts to enhance
emotional wellbeing and advance play skills

Pressure care: prevention of pressure ulcers via
good positioning, repositioning, and suitable
support surfaces

43

45

47

48

46

Improved child coping and
reduced stress (BS and PF)
Reduced ulcer development via
high-specification foam
mattresses, alternating
pressure mattresses, and
medical grade sheepskins (BS)
Reduced ulcer development
from wheelchair seat cushions
(BS)

Improved play skills (A)

Prevention of hip dislocation
via hip orthoses and
botulinum toxin (BS)
Improved parenting skills to
facilitate child development
(E)
Reduce spasticity locally (BS)

Improved upper limb function
(A)
Prevention of contracture (BS)

Improved lower limb function
(A)

Improved stride length and
range of motion via AFOs (BS)

Improved verbal speech as a
result of non-speech oral
motor exercises (BS)
Improved safety of swallowing
and reduced drooling (BS)
Correct equinus foot deformity
(BS)

Oral motor treatment: sensory stimulation to
lips, jaw, tongue, soft palate, larynx, and
respiratory muscles to influence the
oropharyngeal mechanism

42

44

Intervention outcome (ICF level)

Intervention

Table I: Continued

McInnes151

McInnes

151

Redditi
Hanzlik150
–

Delgado26

Whittingham50

Graham149

Teplicky81

Autti-Ramo76
Blackmor e77
Effgen78
Figueiredo146
Harris147
Morris148
Teplicky81
Autti-Ramo76
Blackmore77
Effgen78
Figueiredo146
Harris147
Morris148
Teplicky81
Teplicky81

Insufficient evidence

Snider92
Wilcox144
Shore145

Insufficient evidence

Effective. Alternating pressure mattresses more
cost-effective than alternating pressure overlays

No evidence in CP

No CP studies appraised. Since high-quality
evidence supports BoNT-A. However, in clinical
care, phenol is sometimes used positively in
combination with BoNT-A to enable injection of
more muscles groups to remain within safe total
dose restrictions
Insufficient evidence

High-quality evidence shows ineffective in non-CP
populations, but insufficient CP studies to be
certain
High-quality evidence shows may slow hip
dislocation rate slightly but essentially ineffective
for preventing hip dislocation
Lower-quality supporting evidence

Insufficient evidence

Insufficient evidence

Lower-quality supporting evidence with no
superior surgical technique evident. Studies
indicated that early surgery was a major risk
factor for recurrent equinus deformity
Positive effects on ankle range of motion, gait
kinetics and kinematics, but the quality of the
evidence is low

No evidence in CP. Insufficient evidence to support
or refute in non-CP200 populations

Panel comments

–

Citations

N/A

–

1

Low

Low

Low

2

1

N/A
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High

Very low

Very low

Very low

Very low

Low

Very low

N/A

Quality
of
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1

1

2

1

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

1
1
1

–

Oxford
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Weak +

Weak +

Weak !

Weak +
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Weak !

Weak !

Weak !

Weak +

Weak +

Weak !

Weak !
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Sensory integration (SI): therapeutic activities
to organize sensation from the body and
environment, to facilitate adaptive responses,
e.g. hammock swinging

Sensory processing: therapeutic activities to
organize more appropriate responsiveness
(i.e. not hyper-responsive and not
hyporesponsive) to task and environmental
demands, including self-regulation
Single event multilevel surgery with therapy:
multiple simultaneous surgical procedures at
different levels of the lower limb to either
improve gait or prevent deterioration
Social stories: an individualized book describing
a situation, skill, or concept and the relevant
social cues, perspectives, and common
responses to prepare a child for a social
situation
Solution-focused brief therapy: resource
orientated and goal focused approach to
generating solutions to life challenges

52

53

56

55

54

Selective dorsal rhizotomy (SDR): neurosurgical
procedure that selectively severs nerve roots
in the spinal cord, to relieve spasticity

51

50

Test164

Reduced parental depression,
improved coping and
improved parenting skills (E)

No evidence in CP. Since low-quality evidence
shows emergent effectiveness in non-CP
populations198

McGinley163

Improved long-term functional
mobility (A)

–

Insufficient evidence

–

Improved function (A)

Improved communication and
management of emotions and
behaviours (A)

Lower-quality supporting evidence

Vargas162

Improved motor skills (A)

Evidence for improved gross motor function, but
no supporting evidence for general activities and
participation and this should not be the primary
goal for using SDR
Ineffective. Since meta-analyses of SI compared
with no treatment had average effect sizes of 0.03
(for most recent studies)
Ineffective. Since Goal directed training, CIMT or
bimanual therapy exist as effective alternatives.
Meta-analyses of SI compared to no treatment
had average effect sizes of 0.03 (for most recent
studies), and 0.09 for SI compared to alternative
treatments. Note reviews for non-CP populations
excluded
No evidence in CP. Since performance-based
approaches (e.g. CO-OP) are more favourable
than impairment-based approaches, e.g. sensory
processing (in non-CP populations)

Effective

Effective

Lower-quality supporting evidence

Lower-quality supporting evidence

Vargas162

Grunt
McLaughlin160
Steinbok161
Grunt159
McLaughlin160
Steinbok161
Grunt159
McLaughlin160
Steinbok161

159

Lower-quality supporting evidence

Farley153
Ryan154
Chung155
Farley153
Roxborough156
Ryan154
Farley153
McNamara157
Ryan154
Michael158
Insufficient evidence

Lower-quality supporting evidence

Panel comments

Strunk152

Citations

Improved sensory organization
(BS)

Improved function and
participation (A and P)

Improved gait kinematics (BS)

Reduced spasticity (BS)

Reduced pressure via tilt (BS)

Improved hand function (A)

Improved pulmonary function
(BS)
Improved posture and postural
control (BS)

Improve family functioning and
reduce parental stress (E)
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Respite: temporary caregiving break for parents
where the child is usually accommodated
outside the home
Seating and positioning: assistive technology
that enables a person to sit upright with
functional, symmetrical or comfortable
posture, to enable function

Intervention outcome (ICF level)

Intervention
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–

1

N/A

Very low

Very low

N/A

–

1

Low

Low

Very low

Low

Moderate

Very low

Very low

Very low

Very low

Very low

Quality
of
evidence

1

1

1
1
1
1
1
1
1
1
1

1
1
1
1
1
1
1
1
1
1

1

Oxford
evidence
level

Yellow
MEASURE
Green GO

Green GO

Yellow
MEASURE

Weak +
Strong +

Strong +

Weak +

Weak +

Weak +

Weak +

Weak !

Strong !

Strong !

Yellow
MEASURE

Yellow
MEASURE

Yellow
MEASURE

Yellow
MEASURE

Red STOP

Red STOP

Yellow
MEASURE

Weak +

Weak +

Yellow
MEASURE
Yellow
MEASURE

Yellow
MEASURE

Traffic light
action

Weak +

Weak +

Strength of recommendation

GRADE
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Stretching: use of an external passive force
(e.g. parent) exerted upon the limb to move it
into a new and lengthened position

Therasuits: a breathable soft dynamic orthotic
full body suit, designed to improve
proprioception, reduce reflexes, restore
synergies and provide resistance
Tizanidine: antispasticity medication

Treadmill training: walking practice on a
treadmill, which includes partial body support

Vitamin D (with our without calcium or growth
hormones): dietary vitamin supplement for
bone density
Vojta: therapist applied pressure to defined
zones on the body whilst positioned in prone,
supine or side lying, where the stimulus leads
to automatically and involuntarily complex
movement

58

59

61

62

63

60

Improved lower limb strength
via progressive resistance
training (BS)

Strength training (resistance): use of
progressively more challenging resistance to
muscular contraction to build muscle strength
and anaerobic endurance

57

Improve strength and
movement, plus lessen
severity of CP (BS)

Improved bone mineral density
(BS)

Improved functional walking
(A)

Reduce spasticity (generalized)
(BS)
Improved weight bearing (BS)

Improved gross motor function
(A)

Contracture prevention via
splinting or positioning (BS)

Improved upper limb strength
via progressive resistance
training (BS)
Improved function via
progressive resistance training
(A)
Improved function via
functional training using
resistance within functional
tasks (A)
Contracture prevention via
manual stretching (BS)

Intervention outcome (ICF level)

Intervention
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Lower-level supporting evidence. However,
overground walking more effective than partial
body weight-supported treadmill training

Damiano175
Mutlu176
Willoughby177
Zwicker174
Fehlings55
Hough56
Brandt178
d’Avignon179
Kanda180
Liu181
Wu182
Zhang183
Zhao188

Lower-quality supporting evidence

Zwicker174

Conflicting evidence. Studies claim to ‘cure’ early
CP, which is not consistent with any of the other
literature about CP having no known cure. Also
the studies reported high dropout rates due to
child distress. Studies have a high probability of
bias, e.g. lack of: random sequence generation;
concealed allocation, study blinding,
psychometrically sound instruments; plus
incomplete outcome data collection and selective
reporting

Insufficient evidence

Insufficient evidence

Ineffective. Comprehensive and robust metaanalysis showed no immediate, or short– to
medium-term benefits (<7mo), but, since only a
small number of CP studies were included within
the review, it is not possible to be certain about
this recommendation for CP
Insufficient evidence

Katalinic79
Wiart171

Delgado26

Lower-quality supporting evidence

Martin143

Conflicting evidence. One trial suggests positive
effect the other suggest no benefits

Insufficient evidence

Scianni168

Autti-Ramo76
Pin45
Teplicky81
Alagesan172
Bailes173

Effective short term for improving muscle strength

Effective short term for improving muscle strength.
Improved muscle strength does not carry over to
function, other treatment approaches will be
needed for functional gains

Panel comments

Dodd165
Effgen78
Jeglinsky166
Martin143
Mockford167
Scianni168
Taylor169
Kim170

Citations

2
2
3
2
2
2
2

1
1
1
1
1
1

1

1

1
1
1
2
2

1
1

1

1

1
1
1
1
1
1
1
2

Oxford
evidence
level

Very low

Low

Low

Low

Low

Low

Low

Moderate

Low

Low

Low

Low

Quality
of
evidence

Weak !

Yellow
MEASURE

Yellow
MEASURE

Weak +

Weak +

Weak +

Yellow
MEASURE
Yellow
MEASURE
Yellow
MEASURE

Yellow
MEASURE

Yellow
MEASURE

Yellow
MEASURE

Yellow
MEASURE

Weak +

Weak !

Weak +

Weak !

Weak +

Yellow
MEASURE

Yellow
MEASURE

Weak +

Weak !

Yellow
MEASURE

Traffic light
action

Weak +

Strength of recommendation

GRADE

del PozoCruz185
Improved gait (BS and A)

Under ‘Quality of evidence’, ‘High’ means that further research is very unlikely to change our confidence in the estimate of effect; ‘Moderate’ means that further research is likely to have
an important impact on our confidence in the estimate of effect and may change the estimate; ‘Low’ means that further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate; and ‘Very low’ means that any estimate of effect is very uncertain.17 Under ‘Strength of recommendation’, ‘Strong +’
means ‘do it’, indicating a judgement that most well-informed people would make; ‘Weak +’ means ‘probably do it’, indicating a judgement that a majority of well-informed people would
make but a substantial minority would not; ‘Weak !’ means ‘probably do not do it’, indicating a judgement that a majority of well-informed people would make but a substantial minority
would not; ‘Strong !’ means ‘do not do it’, indicating a judgement that most well-informed people would make.17 A, activities; BS, body structures and function; P, participation; RCT, randomized controlled trial; E, environmental; PF, personal factors.

Yellow
MEASURE
Very low
1

Weak !

Yellow
MEASURE
Weak !
Very low
1

Lower-quality supporting evidence in non-CP
population, but no effect in CP. Small numbers of
CP studies we cannot be certain about this
recommendation for CP
Insufficient evidence
del PozoCruz185
Improved strength (BS)

Whole-body vibration: assistive technology that
transmits low-frequency vibration to the body
through a broad contact area of a vibrating
surface, e.g. feet in standing, buttocks in
sitting, or whole body

Panel comments
Citations
Intervention outcome (ICF level)
Intervention

64

Traffic light
action
Strength of recommendation

GRADE

Quality
of
evidence
Oxford
evidence
level

Table I: Continued

using the Oxford Levels of Evidence; a categorization
using GRADE; a colour coding scheme using the Evidence
Alert Traffic Light system, and an ICF domain (Table I).
More specifically, each intervention outcome sought by
included study authors was assigned an ICF domain based
upon published literature.176 It has been acknowledged in
the literature that ICF coding is notoriously complex to
apply since CP is a disability not a disease, and thus direct
interventions do not ultimately alter underlying disease
processes.10 To overcome this challenge, we applied ICF
codes using CP literature precedents, where the outcome
measure within the included trials had been ICF coded by
other authoritative researchers.10 Of note, ICF linking
rules typically cluster together (1) body structure and functions; and (2) activities and participation. To prevent loss
of findings obscured within aggregated data, we separated
activities from participation because we wanted to illuminate whether or not participation outcomes were being
achieved. All the data required to answer the study questions were published within the papers, so no contact with
authors was necessary.

Ethics and registration
The study did not involve contact with people, so the need
for ethical approval was waived by the Cerebral Palsy Alliance’s Human Research ethics committee. This systematic
review was not registered.
RESULTS
Using the search strategy, 33 485 citations were identified,
of which 166 articles met the inclusion criteria for review
(Fig. 2).
Participants
For the purpose of this study, participants had CP, which is
a complex and heterogeneous condition. We included studies about children with CP of any motor subtype (spastic,
dyskinetic, or ataxic), any topography (hemiplegic/unilateral, diplegic/bilateral, or quadriplegic/bilateral), and any
functional ability level (Gross Motor Function Classification System [GMFCS]188 levels I to V and Manual Ability
Classification System [MACS]189 levels I to V). There was
substantial emphasis in the medical literature on interventions to reduce spasticity, the most prevalent motor impairment.190 There was also a heavy emphasis in the therapy
literature on interventions designed to improve motor outcomes consistent with CP being a physical disability. The
higher-quality studies defined the child’s motor function
abilities using the GMFCS and MACS to enable better
interpretation of treatment effects taking into account the
severity of the disability. However, there was insufficient
homogeneity of reporting across studies to enable reporting
by GMFCS level, which was our original intended strategy.
Levels of evidence and ICF
High levels of evidence existed in the literature summarizing interventions for children with CP (Table I). Of the
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Favourable

Grade of evidence

Traffic alert action

Quality

Recommendation

High

Strong +

Green: Go

Moderate
Low
Weak +
Very low

Yellow: Measure

Unfavourable

Very low
Weak –

Low
Moderate
High

Strong –

High =

Further research is very unlikely
to change our confidence in the
estimate of effect
Moderate = Further research is likely to have
an important impact on our confidence
in the estimate of effect and may
change the estimate
Further research is very likely to
Low =
have an important impact on our
confidence in the estimate of effect
and is likely to change the estimate

Strong +
Weak +
Weak –
Strong –

Do it
Probably do it
Probably don’t do it
Don’t do it

Red: Stop
Green = Go: Effective, therefore do it
Yellow = Measure: Uncertain effect,
therefore measure
outcomes to determine
if progress is made
Red = Stop: Ineffective, therefore don’t do it

Very low = Any estimate of effect is very uncertain

Figure 1: Relationship between the GRADE and Traffic Light System.

Total no. of
articles
(n = 33 485)

No. of potential
articles after
deletion by
title (n = 231)

No. of potential
articles after
deletion by
abstract
(n = 171)

CINAHL
Cochrane
DARE
ERIC
Google scholar
Medline
OT seeker
PEDro
PsychBITE
PsychINFO
PubMED
SpeechBITE

n = 148
n = 77
n = 118
n = 16
n = 308 000
n = 154
n = 32
n = 72
n=1
n = 66
n = 1996
n=5

Reasons for deletion included:
Not systematic reviews; not
>25% sample had cerebral
palsy; duplicates; protocols
only; and practice guidelines

No. of potential
articles after
deletion by fulltext (n = 166)
Total no. of
articles included
(n = 166)

Systematic reviews
RCTs
Non-randomised
Case series

n = 124
n = 25
n=7
n=4

Figure 2: Flow diagram of included articles.
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166 included studies, the breakdown by level of evidence
as rated on the Oxford Levels of Evidence was level 1
(n=124), 74%; level 2 (n=30), 18%; level 3 (n=6), 4%; and
level 4 (n=6), 4%.
When the included articles were tallied in 5-year intervals by publication date, it was clear that the number of
systematic reviews published about CP intervention had
exponentially increased in recent years (Fig. 3).
Almost none (2 of 166) of the systematic reviews
retrieved graded the body of evidence summarized using
the GRADE system. We therefore carried out assignment
of GRADEs using the recommended expert panel methodology. Using the GRADE system, of the 64 different CP
interventions reviewed across 131 intervention outcomes
16% of outcomes assessed (n=21) were graded ‘do it’ (i.e.
green light, go interventions); 58% (n=76) were graded
‘probably do it’ (i.e. yellow light, measure outcomes); 20%
(n=26) were graded ‘probably do not do it’ (i.e. yellow
light, measure outcomes; see Fig. 1); and 6% (n=8) were
graded ‘do not do it’ (i.e. red light, stop interventions; see
Fig. 1). In line with the appraisal criteria for this review,
occupational therapy, physiotherapy, and medicine were
the disciplines that encompassed the highest number of
proven effective interventions for CP within their evidence
base, which is not surprising given the long historical
research emphasis on redressing the physical aspects of
CP. In the fields of psychology, speech pathology, social
work, and education, the evidence base for all interventions
reviewed was lower level or inconclusive (yellow), but, in
keeping with interdisciplinary care, psychologists and social

Number of published cerebral palsy
intervention systematic reviews

80
n = 72

70
60
50
40

n = 35

30
20
10
0

n = 14
n=3
1993–1997 1998–2002 2003–2007 2008–2012
Years published

Figure 3: Number of published cerebral palsy intervention systematic
reviews.

workers applied high-level evidence from other diagnostic
groups (e.g. bimanual, cognitive behaviour therapy, counselling, Triple P49). In the field of speech pathology, it is
worth noting that it is difficult to conduct studies of augmentative and alternative communication (AAC) using
conventional rigorous methodologies because included participants often have different disability types and, accordingly, differing levels of expressive, receptive, and social
communication abilities. AAC interventions require multifactorial measurement because effective device utilization
relies on changes in all of these domains from best-practice
speech, language, and teaching strategies and from changing the mode of communication. Thus, adequately measuring and attributing interventions effects to each component
of these integrated treatment approaches remains challenging. Amongst the alternative and complementary medicine
interventions offered by some clinicians, the findings were
of even poorer quality, because an even greater proportion
of the interventions were proven ineffective. However, the
real rate of ineffective alternative and complementary interventions may be even higher as so many had to be
excluded from this review as a result of the lack of any
published peer-reviewed literature about the approaches
(e.g. advanced biomechanical rehabilitation).
Each intervention was coded using the ICF by the intervention’s desired outcome. Out of the 131 intervention
outcomes for children with CP identified in this study,
n=66 (51%) were aimed at the body structures and function level; n=39 (30%) were aimed at the activity level; n=7
(5%) were aimed at the participation level; n=8 (6%) were
aimed at the environment level; and the remaining n=11
(8%) were aimed at combinations of ICF levels.

Green light go interventions
In the papers retrieved, the following CP interventions
were shown to be effective: (1) botulinum toxin (BoNT),
diazepam, and selective dorsal rhizotomy for reducing
muscle spasticity; (2) casting for improving and maintain-

ing ankle range of motion; (3) hip surveillance for maintaining hip joint integrity; (4) constraint-induced
movement therapy, bimanual training, context-focused
therapy, goal-directed/functional training, occupational
therapy following BoNT, and home programmes for
improving motor activity performance and/or self-care;
(5) fitness training for improving fitness; (6) bisphosphonates for improving bone density; (7) pressure care for
reducing the risk of pressure ulcers; and (8) anticonvulsants
for managing seizures (despite no CP-specific anticonvulsant evidence existing, the panel rated the strength of the
recommendation as strong plus (do it) because good-quality evidence supports anticonvulsants in non-CP populations,191 and serious harm, even death, can arise from no
treatment).
Green light effective interventions were mapped against
the ICF by the outcomes that had been measured in the
literature and the corresponding traffic light code was
applied (Table II). First, Table II shows that green-light
effective interventions were all aimed at either the body
structures and function level or the activities levels on the
ICF. The conspicuous finding here was that there were no
proven effective interventions for addressing the participation, environment, or personal factors levels of the ICF,
even though these are philosophical priorities. Second,
Table II shows that when effective body structures and
functions interventions were measured for an effect at the
activities level (all of the time) evidence of effect was either
lower level or inconclusive and, therefore, was coded yellow light. In other words, the positive effects of body
structure interventions did not translate ‘upstream’ to the
activities level. This finding seems to suggest that you ‘get
what you give’. This finding has, however, an alternative
interpretation – we do not yet know if body structures and
functions intervention improves outcomes at the activities
level because of the measurement artefact created by randomized trials only being powered to detect change in one
primary end-point. Third, Table II shows that green light
activity-level interventions were effective at the activities
level of the ICF, but minimal measurement had been
undertaken to illuminate whether or not there was also any
translation of impact ‘downstream’ to the body structures
and functions level.

Yellow light measure outcomes interventions
A high proportion (70%) of the CP interventions within
clinical care had either lower-level evidence supporting
their effectiveness or inconclusive evidence, including acupuncture; alcohol (intramuscular injections for spasticity
reduction); AAC; animal-assisted therapy; assistive technology; baclofen (oral); behaviour therapy and coaching;
cognitive behaviour therapy; communication training;
conductive education; counselling; oral dantrolene; dysphagia management; early intervention (for motor outcomes); electrical stimulation; fundoplication; gastrostomy;
hand surgery; hip surgery; hippotherapy; hydrotherapy;
intrathecal baclofen; massage; orthoses; oral–motor
Review
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Table II: Green light interventions (and their other indications) by level of ICF
ICF level

Intervention
Body structures and function interventions
1. Anticonvulsants
2. Botulinum toxin
3. Bisphosphonates
4. Casting (ankle)
5. Diazepam
6. Fitness training
7. Hip surveillance
8. Pressure care
9. Selective dorsal rhizotomy
Activities interventions
10. Bimanual training
11. Constraint-induced movement therapy
12. Context-focused therapy
13. Goal-directed training/functional training
14. Home programmes
15. Occupational therapy post botulinum toxin
(upper limb)

Body
structures
and
function
G
G
G
G
G
G
G
G
G

Activity

Participation

Environment

Personal
factors

Y
Y

Y

Y

Y

G
G
G
G
G
G

Y

G=green intervention when aimed at this level of the International Classification of Functioning, Disability and Health (ICF); Y=yellow
intervention when aimed at this level of the ICF.

therapy; orthopaedic surgery; parent training; phenol
(intramuscular injections); play therapy; respite; seating and
positioning; sensory processing; single-event multilevel surgery; social stories; solution-focused brief therapy; strength
training; stretching; therasuits; oral tizanidine; treadmill
training; oral vitamin D; Vojta; and whole-body vibration.
It is important to note that cognitive–behavioural therapy,192–196 early intervention,196–198 parent training,49,50
and solution-focused brief therapy199 all have good-quality
supporting evidence in non-CP populations. It is also
important to note that oral–motor therapy200 and sensory
processing201 have equivocal evidence in non-CP populations for which they were designed, and so there is no
strong or compelling reason to think either intervention
would work better in CP. Of note, there was great variability in the volume and quality of the evidence available at
the yellow-light level. For example, some intervention evidence bases were downgraded to low quality, as per the
GRADE guidelines for dealing with imperfect randomized
controlled trials (e.g. hippotherapy and biofeedback). However, for some interventions simply next to no evidence has
been published and what has been published involves
very small numbers and is of low quality (e.g. whole-body
vibration).
The yellow-light included reviews that could not demonstrate robust evidence of effectiveness when strict systematic review criteria about design quality, adequate
sample size, and independent replication were used to
judge the evidence. Yellow-light reviews contained only
marginal amounts of good-quality evidence when criteria
were applied to reduce the possibility of biases explaining
the proposed treatment benefits. Most yellow-light systematic review authors commented upon the low quality of the
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designs used, serious methodological flaws, the relevance
and sensitivity of the outcomes measures adopted, the difficulty in assembling large homogeneous samples for niche
interventions, and most authors concluded that more rigorous research was needed.

Red light stop interventions
Craniosacral therapy, hip bracing, hyperbaric oxygen,
NDT, and sensory integration have all been shown to be
ineffective in children with CP, and are therefore not recommended for standard care. Appropriately, effective alternatives exist that seek to provide the same clinical outcome
of interest.
To assist with comparative clinical decision-making
amongst intervention options for the same desired outcome, we mapped the interventions that seek to provide
analogous outcomes using bubble charts. In the bubble
charts, the size of the circle correlated to the volume of
published evidence. The circle size was calculated using
(1) the number of published papers on the topic; and (2)
the total score for the level of evidence (calculated by
reverse coding of the Oxford Levels of Evidence, i.e. expert
opinion=1, randomized controlled trial [RCT]=5). The
location of the circle on the y-axis of the graph corresponds to the GRADE system rating. The colour of the
circle correlates to the Evidence Alert System (Fig. 4).
DISCUSSION
High levels of evidence existed in the literature summarizing
intervention options for children with CP. Akin to other
fields of medicine and allied health, there has been an exponential increase in the number of systematic reviews published about CP intervention6 revealing the emergence of
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highly effective prevention interventions.186,187 There is no
reason to think that this trend may decline. This finding has
important implications for managers, knowledge brokers,
and clinicians about finding effective and efficient ways for
health professionals to remain up to date with the latest
practice. Best available knowledge translation evidence suggests that managers and senior clinical mentors can help
staff maintain up-to-date knowledge via interactive evidence-based practice continuing education sessions and
journal clubs, but multiple tailored strategies will be
required to change their use of evidence.202 This systematic
review could form the basis of policy, educational, and
knowledge translation material because it is a comprehensive
summary of the evidence base.

Recommendations for practice
Based upon the best available evidence, standard care for
children with CP should include the following suite of
interventions options (where the interventions would
address the family’s goals): (1) casting for improving ankle
range of motion for weight bearing and/or walking; (2) hip
surveillance for maintaining hip joint integrity; (3) bimanual training, constraint-induced movement therapy, context-focused therapy, goal-directed/functional training,
and/or home programmes for improving motor activities
902 Developmental Medicine & Child Neurology 2013, 55: 885–910

or self-care function; (4) BoNT, diazepam, or selective
dorsal rhizotomy for spasticity management; (5) fitness
training for aerobic fitness; (6) pressure care for reducing
the risk of ulcers; (7) bisphosphonates for improving bone
mineral density; and (8) anticonvulsants for managing seizures. When delivering interventions to children with CP,
it is paramount that clinicians choose evidence-based interventions at the activities and participation level that hone
the child’s strengths and reflect their interests and motivations, and ultimately seek to help children live an inclusive
and contented life. However, when choosing interventions
at the body structure and functions level, the primary purpose is to mitigate the natural history of CP (such as hip
dislocation) and the probable physical decline from secondary impairments,118 rather than trying to fix the condition.
We must also remain mindful that conflicts can arise
between what families hope for and what the evidence suggests will be helpful or is realistically possible.202 Part of
being truly family centred is to act as an information
resource to the family, which will include honest and open
disclosure about prognosis using evidence-based tools to
guide these difficult conversations.203 Similarly, designing
services based upon goals set by the family5,64 is best practice and can also help to set the scene for discussing what
is realistic and possible from intervention.

Going forward, systematic and disciplined use of outcome measures within all specialties is required for
generating new evidence and confirming treatment effects
of commonly used interventions. Routine outcome
measurement is especially important when yellow-light
interventions are being applied, and could circumnavigate
some of the genuine research barriers including low availability of research funds and difficulties in assembling large
homogenous samples. This recommendation is particularly
vital for the fields of speech pathology, social work, and
psychology that provide key services to children with CP,
without strong evidence, as of yet, to support their practice. These professions have been overshadowed in the CP
research arena until recently, when the field stopped solely
redressing physical impairments and started to look further
afield to engendering outcomes in well-being and participation. In addition, systematic and disciplined use of outcome measures is also needed when prescribing assistive
technology and assistive devices (such as wheelchairs, walking frames, and communication devices) for children with
CP, because devices form a large part of standard care. To
date, specialized equipment and technology has been vastly
under-researched, probably because the benefits are easily
observable (such as independent mobility) and the studies
are expensive to conduct; however, in light of device abandonment issues and associated costs, extensive efficacy
research is warranted at both an individual and a population level. Moreover, prescribing assistive technology with
a specialized appearance (such as orthotics, suits, computerized devices, robotics) may well elevate expectations of
good outcomes and give rise to an overinflated perception
of high-quality expert care. Thus, it is essential to know if
the interventions are working, so as to prevent device
abandonment, false hopes, and unnecessary effort.
When yellow-light interventions are used, it is imperative
that clinicians utilize a sufficiently sensitive outcome measure to confirm whether or not the intervention is working
and if it is helping the child achieve their family’s goals. The
Canadian Occupational Performance Measure (COPM) and
Goal Attainment Scaling (GAS)5,64,204 have been widely
adopted in the literature for assessing goal achievement
because they are valid, reliable, sensitive to change, and clinically affordable. Moreover, both measures work well within
the family-centred approach because they encourage familyled goal setting and facilitate individualization, which is
important for such a heterogeneous condition as CP. For
yellow-light interventions, in addition to measuring whether
goals are achieved, it may be desirable to measure if the
intervention is actually achieving what it purports to do for
each individual. Systematic individual outcome measurement, conducted at a population level with data aggregation,
would introduce the possibility of rapidly expanding the
evidence base amongst this heterogeneous population.
Parents, young people, and doctors have identified eight
consensus measurement domains, important for assessing
the impact of a CP intervention, that span the ICF levels.205
We identified systematic reviews that provided measurement

recommendations for evaluating these eight domains in a
way that was sensitive to change. The first of these eight
domains is impairment, which can be subdivided into (1)
spasticity, measured using the Modified Tardieu Scale5,64
and (2) fine motor, measured using the Melbourne Assessment of Unilateral Upper Limb Function11 and the Quality
of Upper Extremity Skills Test.11 The second domain is
general health. Valid and reliable instruments exist regarding
general health in the literature, but less is understood about
whether these measures are sensitive to change in CP, and
therefore no recommendations are made at this juncture.
Third is the gross motor skills domain, measured using the
Gross Motor Function Measure.73,206,207 The fourth domain
is self-care/fine motor skills, which can be subdivided into
(a) self-care, measured using the Paediatric Evaluation of
Disability Inventory206 and the Activities Scale for
Kids207,208 and (b) fine motor, measured using the Assisting
Hand Assessment for activities performance measurement.11
Fifth is the speech/communication domain, measured using
GAS.209 The sixth domain is integration/participation which
can be measured using the COPM or GAS204 (note that
other domain-specific measures exist such as the LIFE-H,
but this does not have adequate sensitivity to detect change).
Finally, regarding both the seventh domain, quality of life,
and the eighth domain, caregiver instruments, valid and reliable instruments exist in the literature, but less is understood
about whether these measures are sensitive to change, and
therefore recommendations for use are not made at this
juncture.
In line with the principles of evidence-based care and as
a cost-saving measure, it is highly recommended that craniosacral therapy, hip bracing, hyperbaric oxygen, neurodevelopmental therapy, and sensory integration should all be
discontinued from CP care. Interestingly, these ineffective
interventions for the most part are founded upon out-dated
neurological theories about CP. For example, hyperbaric
oxygen as a treatment for CP was based on the now disproven assumption that all CP arises from a lack of oxygen
during birth (true for only 5–10% of cases190) and that
increased oxygenation ought to help repair brain function.
Neurodevelopmental therapy sought to reduce hyper-reflexia by repositioning the limb on stretch, providing a local
pattern-breaking effect mimicking spasticity reduction, but
we now know (1) that local effects do not translate to a
reduction in centrally driven spasticity long term210; and
(2) that no substantive evidence exists to support the idea
that inhibition of primitive reflex patterns promotes motor
development.12 Likewise, ‘bottom-up’ approaches, in which
children’s underlying motor deficits are treated with the
aim of preparing them for function (such as neurodevelopmental therapy and sensory integration) were commendable pursuits when originally invented but disappointingly
have little carryover into functional activities.12
Over a decade ago, CP research experts12 and systematic
review authors called for ‘concerted efforts to investigate
other therapy approaches that may prove more clearly
beneficial’.142 These therapy experts were referring to
Review
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performance-based or ‘top-down’ approaches based on
motor learning theory, in which interventions focus
directly on specific task training in activities of interest and
are not concerned with underlying impairments in body
structures and function.201 This visionary advice, in concert with the researchers who rigorously tested their theories, has transformed CP rehabilitation in recent years.
The majority of the ‘do it’ or green-light effective CP
therapy evidence generated in the last 10 years are in fact
top-down therapy approaches, aimed at improving activities performance and inducing neuroplasticity, and include
bimanual training, constraint-induced movement therapy,
context-focused therapy, goal-directed/functional training,
occupational therapy after toxin, and home programmes.
Consistent with the theoretical underpinnings, research has
not focused on whether these top-down approaches had a
positive effect at the body structures and function level of
the ICF (Table II).
Given the sudden increase in new effective treatment
options available, it is essential that the field widely
embraces and implements these interventions in order to
ensure that children with CP achieve the best possible outcomes. Adoption of evidence-based practice also involves
the difficult task of getting clinicians to stop providing
ineffective treatments that they ‘love’.211 It has been suggested that the field requires professionals ‘who want to do
the best they can for their patients, who are willing to continually question their own managements, and who have
readily available sources of information about what does
work’.211 Our present systematic review seeks to provide
the CP field with a comprehensive overview about what
works for children with CP and what does not (Fig. 4).
Based on best available evidence, the challenge now is for
the field to stop permissive endorsement of proven ineffective interventions on the basis of perceived low risk and
clinical expertise. This recommendation includes ceasing
provision of the ever-popular NDT. This is because NDT
has been a mainstay physiotherapy and occupational therapy treatment for many years, but for the most part, the
evidence base is unfavourable. Of note, contemporary
NDT therapists eclectically include additional evidencebased treatment approaches under the NDT banner (e.g.
motor learning and the philosophy of family-centred practice), and it is difficult to distil which treatment approaches
are being used with fidelity and what features of the treatment are actually working.
Nevertheless, three systematic reviews have been conducted of traditional NDT,141–143 including 18 discrete
RCTs: 15 measuring efficacy and three measuring optimal
dose. Of the 15 RCTs measuring NDT efficacy, 12 trials
(studying 674 children) found no statistically favourable
benefits from NDT; these trials were of varying quality
(high, moderate, and low), whereas three trials (studying
38 children) showed improvements in body structures and
functions such as gait parameters, spirometry, and milestone acquisition. The three favourable trials were all at
high risk of bias when assessed using the Cochrane criteria,
904 Developmental Medicine & Child Neurology 2013, 55: 885–910

including small sample sizes (n<16) and extremely low
methodological quality such as a lack of blinding, intention-to-treat analysis, concealed allocation, etc. In the three
NDT dosing RCTs, two studies (studying n=96 children)
found no difference between intense or regular NDT,
whereas one more recent study, by Tsorlakis212 (n=34),
showed favourable outcomes from higher-intensity NDT
over lower-intensity NDT. The most recent NDT systematic review143 cited the Tsorlakis212 RCT as the sole highlevel evidence for NDT being favourable, excluding older
evidence and thus all the unfavourable NDT RCTs. Since
this is not a standard systematic review methodology for
providing proof of efficacy, the results of this systematic
review143 should be interpreted with caution. The difference in inclusion criteria between the systematic reviews
explains why the newer systematic review143 suggests a
more favourable benefit from NDT than the earlier systematic reviews that concluded ineffectiveness.141,142
In order to determine the strength of recommendation,
the panel weighed up the balance of benefits and harms from
NDT and concluded that there was strong evidence that
NDT does not improve contracture and tone, along with
weak evidence that NDT does not improve function. This
was because, first, when the methodological quality of the
evidence base was considered, the highest quality evidence
suggested NDT was ineffective, with only low-quality, high
risk of bias studies finding a favourable benefit from NDT.
Second, the importance of the outcome that NDT aims to
prevent was considered: (1) regarding contracture, which is
painful and can limit function, high-quality RCTs showed
that casting was a superior treatment to NDT for contracture management and therefore the panel favoured casting;
(2) regarding tone reduction, the highest quality evidence
suggested that NDT was ineffective for this indication and
other evidence shows BoNT exists as a highly effective alternative and therefore the panel favoured BoNT or other
effective pharmacological agents. Third, the magnitude and
precision of treatment effect was considered: only 3 out of
15 trials found any benefit of NDT, and in these studies the
treatment effects were small with very low precision estimates as a result of methodological flaws. Fourth, the burdens and costs of the therapy were considered: NDT is
time-consuming and expensive for families, and, what is
more, a high-quality RCT shows that substantially better
functional motor gains are achieved from motor learning
than from NDT at equal doses.213 Therefore, despite the
evidence being less well understood for the likelihood of
NDT influencing functional motor gains (yellow light), the
panel favoured motor learning since superior gains were
possible from an equal dose. Furthermore, since no other
body structure and function intervention in this review
showed gains beyond the body structure and function level
up into the activity level, it is hard to imagine why NDT
would be the exception to this trend.
In summary, high-quality evidence demonstrates that
casting is superior to NDT for managing contracture;
BoNT exists as a highly effective alternative to NDT for

managing tone since NDT is ineffective for this indication;
and despite less being known about whether NDT
improves function, high-quality evidence indicates that
motor leaning is superior to NDT for improving function.
Consequently, there are no circumstances where any of the
aims of NDT could not be achieved by a more effective
treatment. Thus, on the grounds of wanting to do the best
for children with CP, it is hard to rationalize a continued
place for traditional NDT within clinical care.

Recommendations for research
In future, systematic review authors should assign a GRADE
to the body of evidence summarized, to enable clinicians to
more quickly interpret the findings of the review for clinical
practice. For the motor learning interventions that were
‘green light’, researchers have repeatedly called for future
investigations to determine optimal dosing, to better assess
the widely held belief that ‘more is better’. Understanding
optimal intensity of therapy is important for maximizing
outcomes, accurately costing services, and offering familyfriendly, achievable interventions. For all the green-light
interventions, additional studies that evaluate long-term outcomes are necessary. First, because families of children with
CP have life-long caregiving responsibilities, an understanding the impact of these time-intensive and expensive interventions would help with expectation management and
planning for lifetime care. Second, it is unknown if some
interventions continue to add an incremental benefit when
used repeatedly over years or whether the gains are one-off
and short term only. Long-term outcome data are essential
for costing and optimizing the outcomes of children with
CP.
For the yellow-light interventions with lower-quality evidence or a paucity of research to support effectiveness, recommendations for research include the use of individual
patient meta-analyses to accelerate data aggregation; collaborations that strategize multicentre data collection to overcome sample size barriers; and the use of CP registries and
single-system designs if RCTs are deemed impossible or
ethically undesirable to conduct. Use of these research
methodologies is advisable and appropriate across all disciplines but would have particular value if applied to the disciplines of orthopaedic surgery, speech pathology,214–216 and
social work, in order to better substantiate the important
contributions these clinicians make to CP care. The CP field
would also benefit from social workers and psychologists
confirming the assumed benefits of proven interventions
from non-CP populations amongst children with CP.
When the whole evidence base was viewed from a global
perspective, there was a startling lack of interventions
available to improve children’s participation within their
community. Given that this has been identified by many of
the systematic review authors as a priority area for intervention, more research designed to measure the effects
of participation interventions and funds dedicated to this
end is urgently needed. Furthermore, until participationspecific measures with sensitivity to change have been

developed, researchers need to measure the effects of participation intervention using GAS or the COPM.

Study limitations
All systematic reviews are prone to publication bias from
the included trial data; therefore, this systematic review of
systematic reviews may incorporate this inherent bias.
There is also no guarantee that absolutely all relevant systematic reviews were retrieved, despite the thorough search
strategy. Publication bias, however, is unlikely to be more
of a problem when identifying systematic reviews than
when identifying clinical trials. Moreover, conducting a
systematic review of systematic reviews is a study limitation
in its own right because the method does not create any
information that was not already available. Furthermore,
using a high-level synthesis helicopter view means that specific intervention details about how the intervention took
place, who benefitted from the intervention, and for how
long the intervention was carried out for were not
reported; clinicians would need to turn to the included
papers to obtain this information. In its place we hope that
the knowledge synthesis will help to bridge the gap
between research and practice by providing comparisons of
varying interventions to aid decision making.
CONCLUSION
In conclusion, we found compelling evidence from systematic reviews to suggest that the following interventions
are effective at the body structures and function level
alone: anticonvulsants, ankle casting, BoNT, bisphosphonates, diazepam, fitness training, hip surveillance, pressure
care, and selective dorsal rhizotomy. We also found compelling evidence from systematic reviews to suggest that
the following interventions improve function at the activities level: bimanual training, constraint-induced movement
therapy, context-focused therapy, goal-directed/functional
training, home programmes, and occupational therapy
after BoNT. No interventions were shown to work conclusively at more than one level of the ICF. Therefore, if
a body structures and function outcome is desired, the
intervention must be selected from the suite of evidencebased body structures and function interventions. Conversely, if an activities-level outcome is sought, top-down
learning interventions, acting at the activities level, must
be applied.
The lack of certain efficacy evidence for large proportions of the interventions in use within standard care is a
problem for people with CP, healthcare providers, purchasers of healthcare, and funders. More research using rigorous designs is urgently needed as CP is the most common
physical disability of childhood with a life-long impact.190
SUPPORTING INFORMATION
Additional Supporting Information may be found in the online
version of this article:
Table SI: Search strategy.
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Type of Use

Dissertation/Thesis

Requestor type

student

Format

print and electronic

Portion

figures/tables/images

Number of
figures/tables/images

1

List of figures/tables/images Figure 3
Will you be translating?

no

Circulation/distribution

6

Distributing to

Multiple Regions

Order reference number

None

Title of your thesis /
dissertation

Optimising motor learning of infants at high risk of cerebral palsy
using environmental and goal oriented interventions

Expected completion date

Jun 2015

Customer Tax ID

AUAustralia

Billing Type

Credit Card

Credit card info

Visa ending in 3339

Credit card expiration

07/2016

Total

51.47 AUD

Terms and Conditions

American Medical Association's Terms and Conditions
1. The publisher for the copyrighted material you seek permission to license ("Licensed
Material") is the American Medical Association ("Publisher"). By clicking "accept" in
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connection with completing this licensing transaction, you agree that the following terms
and conditions apply to this transaction (along with the Billing and Payment terms and
conditions established by Copyright Clearance Center, Inc. ["CCC"] at the time that you
opened your Rightslink account and that are available at any time at
http://myaccount.copyright.com).
Publisher hereby grants to you a non-exclusive license to use the Licensed Material subject
to the limitations set forth herein. Licenses are for one-time use only and are limited to the
use identified in your request with a maximum distribution equal to the number that you
identified in the licensing process. Any form of republication must be completed within one
year from the date hereof (although copies prepared before then may be distributed
thereafter); and any electronic posting is limited to a period of one year.
You may only obtain permission via this website to use material owned by the
Publisher. If you seek a license to use a figure, photograph, table, or illustration from an
AMA publication, journal, or article, it is your responsibility to examine each such item as
published to determine whether a credit to, or copyright notice of, a third-party owner was
published adjacent to the item. Permission to use any material published in an AMA
publication, journal, or article which is reprinted with permission of a third party must be
obtained from the third-party owner. The Publisher disclaims any responsibility for
any use you make of items owned by third parties without their permission.
Licenses may be exercised anywhere in the world.
You may not alter or modify the Licensed Material in any manner, except for the following:
◦ The Licensed Material may be superficially modified within the scope of the license
granted (color, layout, etc) to suit the style/format of the proposed republication
provided that specific content or data are not altered, omitted, or selectively
presented; modification must not alter the meaning of the material or in any way
reflect negatively on the publisher, the journal, or author(s).
◦ Within the scope of the license granted, the Licensed Material may be translated
from the original English into another language where specifically covered in the
grant of license.
Publisher reserves all rights not specifically granted in (i) the license details provided by
you and accepted in the course of this licensing transaction, (ii) these terms and
conditions, and (iii) CCC's Billing and Payment terms and conditions.
While you may exercise the rights licensed immediately upon issuance of the license at the
end of the licensing process for the transaction, provided that you have disclosed complete
and accurate details of your proposed use, no license is finally effective unless and until full
payment is received from you (either by Publisher or by CCC) as provided in CCC's Billing
and Payment terms and conditions. If full payment is not received on a timely basis, then
any license preliminarily granted shall be deemed automatically revoked and shall be void
as if never granted. Further, in the event that you breach any of these terms and
conditions or any of CCC's Billing and Payment terms and conditions, the license is
automatically revoked and shall be void as if never granted. Use of Licensed Materials as
described in a revoked license, as well as any use of the Licensed Materials beyond the
scope of an unrevoked license, may constitute copyright infringement and Publisher
reserves the right to take any and all action to protect its copyright in the Licensed
Materials.
You must include the following copyright and permission notice in connection with any
reproduction of the Licensed Material: "Copyright © (Year of Publication) American Medical
Association. All rights reserved."
THE LICENSED MATERIAL IS PROVIDED ON AN "AS IS" BASIS. PUBLISHER MAKES NO
REPRESENTATIONS WITH RESPECT TO, AND DISCLAIMS ALL WARRANTIES, EXPRESS OR
IMPLIED, RELATING TO, THE LICENSED MATERIAL, INCLUDING WITHOUT LIMITATION,
IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE
You hereby indemnify and agree to hold harmless Publisher and CCC, and their respective
officers, directors, employees, and agents, from and against any and all claims, liability,
damages, costs, and expenses, including reasonable attorneys' fees, arising out of your use
of the Licensed Material other than as specifically authorized pursuant to this license,
including claims for defamation or infringement of or damage to rights of copyright,
publicity, privacy, or other tangible or intangible property.
This license is personal to you and may not be sublicensed, assigned, or transferred by you
to any other person without Publisher's written permission.
This license may not be amended except in writing signed by both parties (or, in the case
of Publisher, by CCC on Publisher's behalf).
Publisher hereby objects to any terms contained in any purchase order, acknowledgement,
check endorsement, or other writing prepared by you in which terms are inconsistent with
these terms and conditions or CCC's Billing and Payment terms and conditions. These
terms and conditions, together with CCC's Billing and Payment terms and conditions (which
are incorporated herein), comprise the entire agreement between you and Publisher (and
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CCC) concerning this licensing transaction. In the event of any conflict between your
obligations established by these terms and conditions and those established by CCC's
Billing and Payment terms and conditions, these terms and conditions shall prevail.
14. This license and the licensing transaction shall be governed by and construed in accordance
with the laws of the State of Illinois. You hereby agree that any dispute that may arise in
connection with this license or the licensing transaction shall be submitted to binding
arbitration in Chicago, Illinois, in accordance with the American Arbitration Association's
rules for resolution of commercial disputes, and any award resulting from such arbitration
may be entered as a judgment in any court with jurisdiction thereof.
15. Other Terms and Conditions: None

V-09072011; V1.0
Questions? customercare@copyright.com or +1-855-239-3415 (toll free in the US) or
+1-978-646-2777.
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JOHN WILEY AND SONS LICENSE
TERMS AND CONDITIONS
Jun 21, 2015

This Agreement between Catherine Morgan ("You") and John Wiley and Sons ("John Wiley
and Sons") consists of your license details and the terms and conditions provided by John
Wiley and Sons and Copyright Clearance Center.
License Number

3653870485143

License date

Jun 21, 2015

Licensed Content Publisher

John Wiley and Sons

Licensed Content Publication Developmental Disabilities Research Reviews
Licensed Content Title

Cerebral Palsy—Don\'t Delay

Licensed Content Author

Sarah McIntyre,Cathy Morgan,Karen Walker,Iona Novak

Licensed Content Date

Jan 29, 2013

Pages

16

Type of use

Dissertation/Thesis

Requestor type

Author of this Wiley article

Format

Print and electronic

Portion

Full article

Will you be translating?

No

Title of your thesis /
dissertation

Optimising motor learning of infants at high risk of cerebral palsy
using environmental and goal oriented interventions

Expected completion date

Jun 2015

Expected size (number of
pages)

15

Requestor Location

Catherine Morgan
Cerebral Palsy Alliance
187 Allambie Rd
Allambie Heights
Sydney, Australia 2100
Attn: Catherine Morgan

Billing Type

Invoice

Billing Address

Catherine Morgan
Cerebral Palsy Alliance
187 Allambie Rd
Allambie Heights
Sydney, Australia 2100
Attn: Catherine Morgan

Total

0.00 AUD

Terms and Conditions

TERMS AND CONDITIONS
This copyrighted material is owned by or exclusively licensed to John Wiley & Sons, Inc. or
one of its group companies (each a"Wiley Company") or handled on behalf of a society with
which a Wiley Company has exclusive publishing rights in relation to a particular work
(collectively "WILEY"). By clicking accept in connection with completing this licensing
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transaction, you agree that the following terms and conditions apply to this transaction
(along with the billing and payment terms and conditions established by the Copyright
Clearance Center Inc., ("CCC's Billing and Payment terms and conditions"), at the time that
you opened your Rightslink account (these are available at any time at
http://myaccount.copyright.com).
Terms and Conditions
• The materials you have requested permission to reproduce or reuse (the "Wiley
Materials") are protected by copyright.
• You are hereby granted a personal, non-exclusive, non-sub licensable (on a standalone basis), non-transferable, worldwide, limited license to reproduce the Wiley
Materials for the purpose specified in the licensing process. This license is for a onetime use only and limited to any maximum distribution number specified in the
license. The first instance of republication or reuse granted by this licence must be
completed within two years of the date of the grant of this licence (although copies
prepared before the end date may be distributed thereafter). The Wiley Materials shall
not be used in any other manner or for any other purpose, beyond what is granted in
the license. Permission is granted subject to an appropriate acknowledgement given to
the author, title of the material/book/journal and the publisher. You shall also
duplicate the copyright notice that appears in the Wiley publication in your use of the
Wiley Material. Permission is also granted on the understanding that nowhere in the
text is a previously published source acknowledged for all or part of this Wiley
Material. Any third party content is expressly excluded from this permission.
• With respect to the Wiley Materials, all rights are reserved. Except as expressly
granted by the terms of the license, no part of the Wiley Materials may be copied,
modified, adapted (except for minor reformatting required by the new Publication),
translated, reproduced, transferred or distributed, in any form or by any means, and no
derivative works may be made based on the Wiley Materials without the prior
permission of the respective copyright owner. You may not alter, remove or suppress
in any manner any copyright, trademark or other notices displayed by the Wiley
Materials. You may not license, rent, sell, loan, lease, pledge, offer as security,
transfer or assign the Wiley Materials on a stand-alone basis, or any of the rights
granted to you hereunder to any other person.
• The Wiley Materials and all of the intellectual property rights therein shall at all times
remain the exclusive property of John Wiley & Sons Inc, the Wiley Companies, or
their respective licensors, and your interest therein is only that of having possession of
and the right to reproduce the Wiley Materials pursuant to Section 2 herein during the
continuance of this Agreement. You agree that you own no right, title or interest in or
to the Wiley Materials or any of the intellectual property rights therein. You shall have
no rights hereunder other than the license as provided for above in Section 2. No right,
license or interest to any trademark, trade name, service mark or other branding
("Marks") of WILEY or its licensors is granted hereunder, and you agree that you
shall not assert any such right, license or interest with respect thereto.
• NEITHER WILEY NOR ITS LICENSORS MAKES ANY WARRANTY OR
REPRESENTATION OF ANY KIND TO YOU OR ANY THIRD PARTY,
EXPRESS, IMPLIED OR STATUTORY, WITH RESPECT TO THE MATERIALS
OR THE ACCURACY OF ANY INFORMATION CONTAINED IN THE
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MATERIALS, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED
WARRANTY OF MERCHANTABILITY, ACCURACY, SATISFACTORY
QUALITY, FITNESS FOR A PARTICULAR PURPOSE, USABILITY,
INTEGRATION OR NON-INFRINGEMENT AND ALL SUCH WARRANTIES
ARE HEREBY EXCLUDED BY WILEY AND ITS LICENSORS AND WAIVED
BY YOU
• WILEY shall have the right to terminate this Agreement immediately upon breach of
this Agreement by you.
• You shall indemnify, defend and hold harmless WILEY, its Licensors and their
respective directors, officers, agents and employees, from and against any actual or
threatened claims, demands, causes of action or proceedings arising from any breach
of this Agreement by you.
• IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR
ANY OTHER PARTY OR ANY OTHER PERSON OR ENTITY FOR ANY
SPECIAL, CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY OR
PUNITIVE DAMAGES, HOWEVER CAUSED, ARISING OUT OF OR IN
CONNECTION WITH THE DOWNLOADING, PROVISIONING, VIEWING OR
USE OF THE MATERIALS REGARDLESS OF THE FORM OF ACTION,
WHETHER FOR BREACH OF CONTRACT, BREACH OF WARRANTY, TORT,
NEGLIGENCE, INFRINGEMENT OR OTHERWISE (INCLUDING, WITHOUT
LIMITATION, DAMAGES BASED ON LOSS OF PROFITS, DATA, FILES, USE,
BUSINESS OPPORTUNITY OR CLAIMS OF THIRD PARTIES), AND
WHETHER OR NOT THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY
OF SUCH DAMAGES. THIS LIMITATION SHALL APPLY
NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY
LIMITED REMEDY PROVIDED HEREIN.
• Should any provision of this Agreement be held by a court of competent jurisdiction
to be illegal, invalid, or unenforceable, that provision shall be deemed amended to
achieve as nearly as possible the same economic effect as the original provision, and
the legality, validity and enforceability of the remaining provisions of this Agreement
shall not be affected or impaired thereby.
• The failure of either party to enforce any term or condition of this Agreement shall not
constitute a waiver of either party's right to enforce each and every term and condition
of this Agreement. No breach under this agreement shall be deemed waived or
excused by either party unless such waiver or consent is in writing signed by the party
granting such waiver or consent. The waiver by or consent of a party to a breach of
any provision of this Agreement shall not operate or be construed as a waiver of or
consent to any other or subsequent breach by such other party.
• This Agreement may not be assigned (including by operation of law or otherwise) by
you without WILEY's prior written consent.
• Any fee required for this permission shall be non-refundable after thirty (30) days
from receipt by the CCC.
• These terms and conditions together with CCC s Billing and Payment terms and
conditions (which are incorporated herein) form the entire agreement between you and
WILEY concerning this licensing transaction and (in the absence of fraud) supersedes
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all prior agreements and representations of the parties, oral or written. This Agreement
may not be amended except in writing signed by both parties. This Agreement shall be
binding upon and inure to the benefit of the parties' successors, legal representatives,
and authorized assigns.
• In the event of any conflict between your obligations established by these terms and
conditions and those established by CCC s Billing and Payment terms and
conditions, these terms and conditions shall prevail.
• WILEY expressly reserves all rights not specifically granted in the combination of (i)
the license details provided by you and accepted in the course of this licensing
transaction, (ii) these terms and conditions and (iii) CCC s Billing and Payment
terms and conditions.
• This Agreement will be void if the Type of Use, Format, Circulation, or Requestor
Type was misrepresented during the licensing process.
• This Agreement shall be governed by and construed in accordance with the laws of
the State of New York, USA, without regards to such state s conflict of law rules.
Any legal action, suit or proceeding arising out of or relating to these Terms and
Conditions or the breach thereof shall be instituted in a court of competent jurisdiction
in New York County in the State of New York in the United States of America and
each party hereby consents and submits to the personal jurisdiction of such court,
waives any objection to venue in such court and consents to service of process by
registered or certified mail, return receipt requested, at the last known address of such
party.
WILEY OPEN ACCESS TERMS AND CONDITIONS
Wiley Publishes Open Access Articles in fully Open Access Journals and in Subscription
journals offering Online Open. Although most of the fully Open Access journals publish
open access articles under the terms of the Creative Commons Attribution (CC BY) License
only, the subscription journals and a few of the Open Access Journals offer a choice of
Creative Commons Licenses:: Creative Commons Attribution (CC-BY) license Creative
Commons Attribution Non-Commercial (CC-BY-NC) license and Creative Commons
Attribution Non-Commercial-NoDerivs (CC-BY-NC-ND) License. The license type is
clearly identified on the article.
Copyright in any research article in a journal published as Open Access under a Creative
Commons License is retained by the author(s). Authors grant Wiley a license to publish the
article and identify itself as the original publisher. Authors also grant any third party the
right to use the article freely as long as its integrity is maintained and its original authors,
citation details and publisher are identified as follows: [Title of Article/Author/Journal Title
and Volume/Issue. Copyright (c) [year] [copyright owner as specified in the Journal]. Links
to the final article on Wiley s website are encouraged where applicable.
The Creative Commons Attribution License
The Creative Commons Attribution License (CC-BY) allows users to copy, distribute and
transmit an article, adapt the article and make commercial use of the article. The CC-BY
license permits commercial and non-commercial re-use of an open access article, as long as
the author is properly attributed.
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The Creative Commons Attribution License does not affect the moral rights of authors,
including without limitation the right not to have their work subjected to derogatory
treatment. It also does not affect any other rights held by authors or third parties in the
article, including without limitation the rights of privacy and publicity. Use of the article
must not assert or imply, whether implicitly or explicitly, any connection with, endorsement
or sponsorship of such use by the author, publisher or any other party associated with the
article.
For any reuse or distribution, users must include the copyright notice and make clear to
others that the article is made available under a Creative Commons Attribution license,
linking to the relevant Creative Commons web page.
To the fullest extent permitted by applicable law, the article is made available as is and
without representation or warranties of any kind whether express, implied, statutory or
otherwise and including, without limitation, warranties of title, merchantability, fitness for a
particular purpose, non-infringement, absence of defects, accuracy, or the presence or
absence of errors.
Creative Commons Attribution Non-Commercial License
The Creative Commons Attribution Non-Commercial (CC-BY-NC) License permits use,
distribution and reproduction in any medium, provided the original work is properly cited
and is not used for commercial purposes.(see below)
Creative Commons Attribution-Non-Commercial-NoDerivs License
The Creative Commons Attribution Non-Commercial-NoDerivs License (CC-BY-NC-ND)
permits use, distribution and reproduction in any medium, provided the original work is
properly cited, is not used for commercial purposes and no modifications or adaptations are
made. (see below)
Use by non-commercial users
For non-commercial and non-promotional purposes, individual users may access, download,
copy, display and redistribute to colleagues Wiley Open Access articles, as well as adapt,
translate, text- and data-mine the content subject to the following conditions:
• The authors' moral rights are not compromised. These rights include the right of
"paternity" (also known as "attribution" - the right for the author to be identified as
such) and "integrity" (the right for the author not to have the work altered in such a
way that the author's reputation or integrity may be impugned).
• Where content in the article is identified as belonging to a third party, it is the
obligation of the user to ensure that any reuse complies with the copyright policies of
the owner of that content.
• If article content is copied, downloaded or otherwise reused for non-commercial
research and education purposes, a link to the appropriate bibliographic citation
(authors, journal, article title, volume, issue, page numbers, DOI and the link to the
definitive published version on Wiley Online Library) should be maintained.
Copyright notices and disclaimers must not be deleted.
• Any translations, for which a prior translation agreement with Wiley has not been
agreed, must prominently display the statement: "This is an unofficial translation of an
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article that appeared in a Wiley publication. The publisher has not endorsed this
translation."
Use by commercial "for-profit" organisations
Use of Wiley Open Access articles for commercial, promotional, or marketing purposes
requires further explicit permission from Wiley and will be subject to a fee. Commercial
purposes include:
• Copying or downloading of articles, or linking to such articles for further
redistribution, sale or licensing;
• Copying, downloading or posting by a site or service that incorporates advertising
with such content;
• The inclusion or incorporation of article content in other works or services (other than
normal quotations with an appropriate citation) that is then available for sale or
licensing, for a fee (for example, a compilation produced for marketing purposes,
inclusion in a sales pack)
• Use of article content (other than normal quotations with appropriate citation) by forprofit organisations for promotional purposes
• Linking to article content in e-mails redistributed for promotional, marketing or
educational purposes;
• Use for the purposes of monetary reward by means of sale, resale, licence, loan,
transfer or other form of commercial exploitation such as marketing products
• Print reprints of Wiley Open Access articles can be purchased from:
corporatesales@wiley.com
Further details can be found on Wiley Online Library
http://olabout.wiley.com/WileyCDA/Section/id-410895.html

Other Terms and Conditions:

v1.9
Questions? customercare@copyright.com or +1-855-239-3415 (toll free in the US) or
+1-978-646-2777.
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AMERICAN ACADEMY OF PEDIATRICS LICENSE
TERMS AND CONDITIONS
Jun 21, 2015

This is a License Agreement between Catherine Morgan ("You") and American Academy of
Pediatrics ("American Academy of Pediatrics") provided by Copyright Clearance Center
("CCC"). The license consists of your order details, the terms and conditions provided by
American Academy of Pediatrics, and the payment terms and conditions.
All payments must be made in full to CCC. For payment instructions, please see
information listed at the bottom of this form.
License Number

3653870123164

License date

Jun 21, 2015

Licensed content publisher

American Academy of Pediatrics

Licensed content publication Pediatrics
Licensed content title

Enriched Environments and Motor Outcomes in Cerebral Palsy:
Systematic Review and Meta-analysis

Licensed content author

Catherine Morgan, Iona Novak, Nadia Badawi

Licensed content date

Sep 1, 2013

Volume number

132

Issue number

3

Start page

e735

End page

e746

Type of Use

Dissertation/Thesis

Requestor type

Individual

Format

Print and Electronic

Portion

Full article

Order reference number

None

Billing Type

Invoice

Billing Address

Catherine Morgan
Cerebral Palsy Alliance
187 Allambie Rd
Allambie Heights
Sydney, Australia 2100
Attn: Catherine Morgan

Total

0.00 USD

Terms and Conditions

AAP TERMS ANDCONDITIONS
The American Academy of Pediatrics grants permission to use the content cited above for
the purpose stated. This letter shall serve as a receipt for payment of the permissions fee(s)
and as an approval agreement.
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1. The following credit line must appear:
Reproduced with permission from Journal <Journal>, Vol. <Vol>, Page(s)
<Pages>, Copyright © <Year> by the AAP
2. The requester guarantees to reprint the materials exactly as originally published. Obvious
typographical errors maybe corrected. No deletions, alterations, or other changes may be
made to the information or statistical data without the written consent of the American
Academy of Pediatrics.
3. Rights granted herein are not exclusive and the American Academy of Pediatrics reserves
the right to grant the same permission to others. Permission is granted for only the
reproduction media specified.
4. Original artwork or copies of articles cannot be supplied, but PDF files may be downloaded
from www.aappublications.org . Quantities of reprints and eprints can be obtained by
contacting Terry Dennsteadt, Reprint Sales Manager – AAP Journals, The Walchli Tauber
Group, Inc., 2225 Old Emmorton Road, Suite 201, Bel Air, MD 21046. 443.512.8899 x 112
office, 443.512.8909 fax, terry.dennsteadt@wt-group.com.
5. This permission is granted on a one-time, annual basis only. Reproduction of this material
is confined to the purpose and/or media for which permission is hereby given. Future use
of this material is subject to the conditions stated herein. Gratis permissions are not issued
for use in materials available for commercial sale, even for educational use.
6. If the permission fee for the requested use of our material is waived in this instance, please
be aware future requests for AAP materials are subject to fees.
7. Reservation of Rights: Publisher reserves all rights not specifically granted in the
combination of (i) the license details provided by you and accepted in the course of this
licensing transaction, (ii) these terms and conditions and (iii) CCC's Billing and Payment
terms and conditions.
8. License Contingent Upon Payment. Provided that you have disclosed complete and accurate
details of your proposed use, no license is effective unless and until full payment is
received from you(either by publisher or by CCC) as provided in the CCC's Billing and
Payment terms and conditions. If full payment is not received on a timely basis, then any
license preliminarily granted shall be deemed automatically revoked and shall be void as if
never granted. Further, in the event that you breach terms and conditions or any of CCC's
Billing and Payment terms and conditions, the license is automatically revoked and shall be
void as if never granted.
9. Warranties: Publisher makes no representations or warranties of any kind, express or
implied, including but not limited to, accuracy, timeliness or completeness of the
information contained in the licensed materials, or merchantability, title or fitness of a use
for a particular purpose.
10. Indemnity: You hereby indemnify and agree to hold harmless publisher and CCC, and their
respective officers, directors, employees and agents, from and against any and all claims
arising out of your use of the licensed material other than specifically authorized pursuant
to this license.
11. No Transfer of License: This license is personal to you and may not be sublicensed,
assigned or transferred by you to any other person without publisher's written permission.
12. No Amendment Except in Writing: This license may not be amended except in writing
signed by both requestor and publisher.
13. This permission, if permission has been granted for use of figures/tables/images, does not
cover any third party copyrighted work which may appear in the material requested and
does not apply to materials credited to publications other than American Academy of
Pediatrics (AAP) journals. For materials credited to non-AAP journal publications, you will
need to obtain permission from the publication referenced in the material legend or credit
line before proceeding with usage of the materials. You agree to hold harmless and
indemnify the AAP against any claims arising from your use of any content in your work
that is credited to non-AAP sources.
14. This permission does not apply to and is not valid for photographs depicting identifiable
individuals, including images where individuals' eyes have been blacked out or images
depicting victims of abuse.
15. If the requester is translating the material, the following translation disclaimer must be
included:
The materials reused with permission from the American Academy of Pediatrics
("AAP") appeared originally in English, published by the AAP. The AAP assumes
no responsibility for any inaccuracy or error in the contents of these materials,
including any inaccuracy or error arising from the translation from English.
16. Other Terms and Conditions:

v1.4
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Questions? customercare@copyright.com or +1-855-239-3415 (toll free in the US) or
+1-978-646-2777.
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JOHN WILEY AND SONS LICENSE
TERMS AND CONDITIONS
Jun 30, 2015

This Agreement between Catherine Morgan ("You") and John Wiley and Sons ("John Wiley
and Sons") consists of your license details and the terms and conditions provided by John
Wiley and Sons and Copyright Clearance Center.

License Number

3659011361092

License date

Jun 30, 2015

Licensed Content Publisher

John Wiley and Sons

Licensed Content Publication Developmental Medicine & Child Neurology
Licensed Content Title

A systematic review of interventions for children with cerebral palsy:
state of the evidence

Licensed Content Author

Iona Novak,Sarah Mcintyre,Catherine Morgan,Lanie Campbell,Leigha
Dark,Natalie Morton,Elise Stumbles,Salli-Ann Wilson,Shona
Goldsmith

Licensed Content Date

Aug 21, 2013

Pages

26

Type of use

Dissertation/Thesis

Requestor type

Author of this Wiley article

Format

Print and electronic

Portion

Full article

Will you be translating?

No

Title of your thesis /
dissertation

Optimising motor learning of infants at high risk of cerebral palsy
using environmental and goal oriented interventions

Expected completion date

Jun 2015

Expected size (number of
pages)

15

Requestor Location

Catherine Morgan
Cerebral Palsy Alliance
187 Allambie Rd
Allambie Heights
Sydney, Australia 2100
Attn: Catherine Morgan

Billing Type

Invoice

Billing Address

Catherine Morgan
Cerebral Palsy Alliance
187 Allambie Rd
Allambie Heights
Sydney, Australia 2100
Attn: Catherine Morgan
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Total

1/07/2015 8:48 am

0.00 AUD

Terms and Conditions

TERMS AND CONDITIONS
This copyrighted material is owned by or exclusively licensed to John Wiley & Sons, Inc. or
one of its group companies (each a"Wiley Company") or handled on behalf of a society with
which a Wiley Company has exclusive publishing rights in relation to a particular work
(collectively "WILEY"). By clicking �accept� in connection with completing this
licensing transaction, you agree that the following terms and conditions apply to this
transaction (along with the billing and payment terms and conditions established by the
Copyright Clearance Center Inc., ("CCC's Billing and Payment terms and conditions"), at
the time that you opened your Rightslink account (these are available at any time at
http://myaccount.copyright.com).
Terms and Conditions
The materials you have requested permission to reproduce or reuse (the "Wiley
Materials") are protected by copyright.
You are hereby granted a personal, non-exclusive, non-sub licensable (on a standalone basis), non-transferable, worldwide, limited license to reproduce the Wiley
Materials for the purpose specified in the licensing process. This license is for a onetime use only and limited to any maximum distribution number specified in the
license. The first instance of republication or reuse granted by this licence must be
completed within two years of the date of the grant of this licence (although copies
prepared before the end date may be distributed thereafter). The Wiley Materials shall
not be used in any other manner or for any other purpose, beyond what is granted in
the license. Permission is granted subject to an appropriate acknowledgement given to
the author, title of the material/book/journal and the publisher. You shall also duplicate
the copyright notice that appears in the Wiley publication in your use of the Wiley
Material. Permission is also granted on the understanding that nowhere in the text is a
previously published source acknowledged for all or part of this Wiley Material. Any
third party content is expressly excluded from this permission.
With respect to the Wiley Materials, all rights are reserved. Except as expressly
granted by the terms of the license, no part of the Wiley Materials may be copied,
modified, adapted (except for minor reformatting required by the new Publication),
translated, reproduced, transferred or distributed, in any form or by any means, and no
derivative works may be made based on the Wiley Materials without the prior
permission of the respective copyright owner. You may not alter, remove or suppress
in any manner any copyright, trademark or other notices displayed by the Wiley
Materials. You may not license, rent, sell, loan, lease, pledge, offer as security, transfer
or assign the Wiley Materials on a stand-alone basis, or any of the rights granted to
you hereunder to any other person.
The Wiley Materials and all of the intellectual property rights therein shall at all times
remain the exclusive property of John Wiley & Sons Inc, the Wiley Companies, or
their respective licensors, and your interest therein is only that of having possession of
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and the right to reproduce the Wiley Materials pursuant to Section 2 herein during the
continuance of this Agreement. You agree that you own no right, title or interest in or
to the Wiley Materials or any of the intellectual property rights therein. You shall have
no rights hereunder other than the license as provided for above in Section 2. No right,
license or interest to any trademark, trade name, service mark or other branding
("Marks") of WILEY or its licensors is granted hereunder, and you agree that you
shall not assert any such right, license or interest with respect thereto.
NEITHER WILEY NOR ITS LICENSORS MAKES ANY WARRANTY OR
REPRESENTATION OF ANY KIND TO YOU OR ANY THIRD PARTY,
EXPRESS, IMPLIED OR STATUTORY, WITH RESPECT TO THE MATERIALS
OR THE ACCURACY OF ANY INFORMATION CONTAINED IN THE
MATERIALS, INCLUDING, WITHOUT LIMITATION, ANY IMPLIED
WARRANTY OF MERCHANTABILITY, ACCURACY, SATISFACTORY
QUALITY, FITNESS FOR A PARTICULAR PURPOSE, USABILITY,
INTEGRATION OR NON-INFRINGEMENT AND ALL SUCH WARRANTIES
ARE HEREBY EXCLUDED BY WILEY AND ITS LICENSORS AND WAIVED
BY YOU
WILEY shall have the right to terminate this Agreement immediately upon breach of
this Agreement by you.
You shall indemnify, defend and hold harmless WILEY, its Licensors and their
respective directors, officers, agents and employees, from and against any actual or
threatened claims, demands, causes of action or proceedings arising from any breach
of this Agreement by you.
IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR
ANY OTHER PARTY OR ANY OTHER PERSON OR ENTITY FOR ANY
SPECIAL, CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY OR
PUNITIVE DAMAGES, HOWEVER CAUSED, ARISING OUT OF OR IN
CONNECTION WITH THE DOWNLOADING, PROVISIONING, VIEWING OR
USE OF THE MATERIALS REGARDLESS OF THE FORM OF ACTION,
WHETHER FOR BREACH OF CONTRACT, BREACH OF WARRANTY, TORT,
NEGLIGENCE, INFRINGEMENT OR OTHERWISE (INCLUDING, WITHOUT
LIMITATION, DAMAGES BASED ON LOSS OF PROFITS, DATA, FILES, USE,
BUSINESS OPPORTUNITY OR CLAIMS OF THIRD PARTIES), AND WHETHER
OR NOT THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH
DAMAGES. THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY
FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED
HEREIN.
Should any provision of this Agreement be held by a court of competent jurisdiction
to be illegal, invalid, or unenforceable, that provision shall be deemed amended to
achieve as nearly as possible the same economic effect as the original provision, and
the legality, validity and enforceability of the remaining provisions of this Agreement
shall not be affected or impaired thereby.
The failure of either party to enforce any term or condition of this Agreement shall not
constitute a waiver of either party's right to enforce each and every term and condition
of this Agreement. No breach under this agreement shall be deemed waived or
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excused by either party unless such waiver or consent is in writing signed by the party
granting such waiver or consent. The waiver by or consent of a party to a breach of
any provision of this Agreement shall not operate or be construed as a waiver of or
consent to any other or subsequent breach by such other party.
This Agreement may not be assigned (including by operation of law or otherwise) by
you without WILEY's prior written consent.
Any fee required for this permission shall be non-refundable after thirty (30) days
from receipt by the CCC.
These terms and conditions together with CCC�s Billing and Payment terms and
conditions (which are incorporated herein) form the entire agreement between you and
WILEY concerning this licensing transaction and (in the absence of fraud) supersedes
all prior agreements and representations of the parties, oral or written. This Agreement
may not be amended except in writing signed by both parties. This Agreement shall be
binding upon and inure to the benefit of the parties' successors, legal representatives,
and authorized assigns.
In the event of any conflict between your obligations established by these terms and
conditions and those established by CCC�s Billing and Payment terms and
conditions, these terms and conditions shall prevail.
WILEY expressly reserves all rights not specifically granted in the combination of (i)
the license details provided by you and accepted in the course of this licensing
transaction, (ii) these terms and conditions and (iii) CCC�s Billing and Payment
terms and conditions.
This Agreement will be void if the Type of Use, Format, Circulation, or Requestor
Type was misrepresented during the licensing process.
This Agreement shall be governed by and construed in accordance with the laws of
the State of New York, USA, without regards to such state�s conflict of law rules.
Any legal action, suit or proceeding arising out of or relating to these Terms and
Conditions or the breach thereof shall be instituted in a court of competent jurisdiction
in New York County in the State of New York in the United States of America and
each party hereby consents and submits to the personal jurisdiction of such court,
waives any objection to venue in such court and consents to service of process by
registered or certified mail, return receipt requested, at the last known address of such
party.
WILEY OPEN ACCESS TERMS AND CONDITIONS
Wiley Publishes Open Access Articles in fully Open Access Journals and in Subscription
journals offering Online Open. Although most of the fully Open Access journals publish
open access articles under the terms of the Creative Commons Attribution (CC BY) License
only, the subscription journals and a few of the Open Access Journals offer a choice of
Creative Commons Licenses:: Creative Commons Attribution (CC-BY) license Creative
Commons Attribution Non-Commercial (CC-BY-NC) license and Creative Commons
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Attribution Non-Commercial-NoDerivs (CC-BY-NC-ND) License. The license type is
clearly identified on the article.
Copyright in any research article in a journal published as Open Access under a Creative
Commons License is retained by the author(s). Authors grant Wiley a license to publish the
article and identify itself as the original publisher. Authors also grant any third party the
right to use the article freely as long as its integrity is maintained and its original authors,
citation details and publisher are identified as follows: [Title of Article/Author/Journal Title
and Volume/Issue. Copyright (c) [year] [copyright owner as specified in the Journal]. Links
to the final article on Wiley�s website are encouraged where applicable.
The Creative Commons Attribution License
The Creative Commons Attribution License (CC-BY) allows users to copy, distribute and
transmit an article, adapt the article and make commercial use of the article. The CC-BY
license permits commercial and non-commercial re-use of an open access article, as long as
the author is properly attributed.
The Creative Commons Attribution License does not affect the moral rights of authors,
including without limitation the right not to have their work subjected to derogatory
treatment. It also does not affect any other rights held by authors or third parties in the
article, including without limitation the rights of privacy and publicity. Use of the article
must not assert or imply, whether implicitly or explicitly, any connection with, endorsement
or sponsorship of such use by the author, publisher or any other party associated with the
article.
For any reuse or distribution, users must include the copyright notice and make clear to
others that the article is made available under a Creative Commons Attribution license,
linking to the relevant Creative Commons web page.
To the fullest extent permitted by applicable law, the article is made available as is and
without representation or warranties of any kind whether express, implied, statutory or
otherwise and including, without limitation, warranties of title, merchantability, fitness for a
particular purpose, non-infringement, absence of defects, accuracy, or the presence or
absence of errors.
Creative Commons Attribution Non-Commercial License
The Creative Commons Attribution Non-Commercial (CC-BY-NC) License permits use,
distribution and reproduction in any medium, provided the original work is properly cited
and is not used for commercial purposes.(see below)
Creative Commons Attribution-Non-Commercial-NoDerivs License
The Creative Commons Attribution Non-Commercial-NoDerivs License (CC-BY-NC-ND)
permits use, distribution and reproduction in any medium, provided the original work is
properly cited, is not used for commercial purposes and no modifications or adaptations are
made. (see below)
Use by non-commercial users
For non-commercial and non-promotional purposes, individual users may access, download,
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copy, display and redistribute to colleagues Wiley Open Access articles, as well as adapt,
translate, text- and data-mine the content subject to the following conditions:
The authors' moral rights are not compromised. These rights include the right of
"paternity" (also known as "attribution" - the right for the author to be identified as
such) and "integrity" (the right for the author not to have the work altered in such a
way that the author's reputation or integrity may be impugned).
Where content in the article is identified as belonging to a third party, it is the
obligation of the user to ensure that any reuse complies with the copyright policies of
the owner of that content.
If article content is copied, downloaded or otherwise reused for non-commercial
research and education purposes, a link to the appropriate bibliographic citation
(authors, journal, article title, volume, issue, page numbers, DOI and the link to the
definitive published version on Wiley Online Library) should be maintained.
Copyright notices and disclaimers must not be deleted.
Any translations, for which a prior translation agreement with Wiley has not been
agreed, must prominently display the statement: "This is an unofficial translation of an
article that appeared in a Wiley publication. The publisher has not endorsed this
translation."
Use by commercial "for-profit" organisations
Use of Wiley Open Access articles for commercial, promotional, or marketing purposes
requires further explicit permission from Wiley and will be subject to a fee. Commercial
purposes include:
Copying or downloading of articles, or linking to such articles for further
redistribution, sale or licensing;
Copying, downloading or posting by a site or service that incorporates advertising
with such content;
The inclusion or incorporation of article content in other works or services (other than
normal quotations with an appropriate citation) that is then available for sale or
licensing, for a fee (for example, a compilation produced for marketing purposes,
inclusion in a sales pack)
Use of article content (other than normal quotations with appropriate citation) by forprofit organisations for promotional purposes
Linking to article content in e-mails redistributed for promotional, marketing or
educational purposes;
Use for the purposes of monetary reward by means of sale, resale, licence, loan,
transfer or other form of commercial exploitation such as marketing products
Print reprints of Wiley Open Access articles can be purchased from:
corporatesales@wiley.com
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